CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: eugenol
Accession: CHEBI:4917
browse the term
Definition: A phenylpropanoid formally derived from guaiacol with an allyl chain substituted para to the hydroxy group. It is a major component of clove essential oil, and exhibits antibacterial, analgesic and antioxidant properties. It has been widely used in dentistry to treat toothache and pulpitis.
Synonyms: related_synonym: 1,3,4-Eugenol; 1-Hydroxy-2-methoxy-4-allylbenzene; 1-Hydroxy-2-methoxy-4-prop-2-enylbenzene; 1-Hydroxy-2-methoxy-4-propenylbenzene; 1-allyl-3-methoxy-4-hydroxybenzene; 1-allyl-4-hydroxy-3-methoxybenzene; 2-Hydroxy-5-allylanisole; 2-Methoxy-4-(2-propen-1-yl)phenol; 2-Methoxy-4-(2-propenyl)phenol; 2-Methoxy-4-(prop-2-en-1-yl)phenol; 2-Methoxy-4-allylphenol; 2-Methoxy-4-prop-2-enylphenol; 2-methoxy-4-prop-2-enyl-phenol; 4-Allyl-1-hydroxy-2-methoxybenzene; 4-Allyl-2-methoxyphenol; 4-Allylcatechol-2-methyl ether; 4-Allylguaiacol; 4-Hydroxy-3-methoxy-1-allylbenzene; Allylguaiacol; Caryophyllic acid; Eugenic acid; Formula=C10H12O2; InChI=1S/C10H12O2/c1-3-4-8-5-6-9(11)10(7-8)12-2/h3,5-7,11H,1,4H2,2H3; InChIKey=RRAFCDWBNXTKKO-UHFFFAOYSA-N; SMILES=COC1=CC(CC=C)=CC=C1O; p-Allylguaiacol; p-Eugenol
xref: BPDB:2008; Beilstein:1366759; CAS:97-53-0; Chemspider:13876103; Drug_Central:4648; FooDB:FDB012171; HMDB:HMDB0005809; KEGG:C10453; KEGG:D04117; KNApSAcK:C00000619; LINCS:LSM-2720
xref_mesh: MESH:D005054
xref: MetaCyc:CPD-6481; PDBeChem:EOL; PMID:11033063; PMID:11806158; PMID:14745850; PMID:15574415; PMID:18218839; PMID:20809147; PMID:22075131; PMID:22923067; PMID:23181601; PMID:23261812; PMID:23264268; PMID:2329164; PMID:23313798; PMID:23325490; PMID:23422484; PMID:23422489; PMID:23444040; PMID:23594212; PMID:23666640; PMID:23677922; PMID:23707945; PMID:23768603; PMID:23768604; PMID:23791894; PMID:23837051; PMID:23841789; PMID:23852671; PMID:28044068; PMID:29079364; PMID:32737935; PMID:33291666; PMID:33916044; PMID:8596779; PMID:9084914; Reaxys:1366759; Wikipedia:Eugenol
G
ABCA6
ATP binding cassette subfamily A member 6
decreases expression
EXP
Eugenol results in decreased expression of ABCA6 mRNA
CTD
PMID:17374397
NCBI chr17:69,078,702...69,141,895
Ensembl chr17:69,078,702...69,141,895
G
ACHE
acetylcholinesterase (Yt blood group)
multiple interactions
ISO
Eugenol inhibits the reaction [Chlorpyrifos results in decreased expression of ACHE protein]
CTD
PMID:32096903
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
G
AHR
aryl hydrocarbon receptor
multiple interactions increases activity affects localization
EXP
[Eugenol co-treated with acetyleugenol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [Eugenol co-treated with acetyleugenol] results in increased activity of AHR protein; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein]; Eugenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] Eugenol results in increased activity of AHR protein Eugenol affects the localization of AHR protein
CTD
PMID:17275817 PMID:22686307 PMID:29191726
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
G
AHRR
aryl hydrocarbon receptor repressor
increases expression
EXP
Eugenol results in increased expression of AHRR mRNA
CTD
PMID:22686307
NCBI chr 5:321,714...438,285
Ensembl chr 5:321,714...438,291
G
AKR1B1
aldo-keto reductase family 1 member B
increases expression
EXP
Eugenol results in increased expression of AKR1B1 mRNA
CTD
PMID:20566472
NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284
G
AKR1B10
aldo-keto reductase family 1 member B10
increases expression
EXP
Eugenol results in increased expression of AKR1B10 mRNA
CTD
PMID:20566472 PMID:26198647 PMID:30806763
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
G
AKR1C1
aldo-keto reductase family 1 member C1
increases expression
EXP
Eugenol results in increased expression of AKR1C1 mRNA
CTD
PMID:20566472
NCBI chr10:4,963,415...4,983,283
Ensembl chr10:4,963,253...4,983,283
G
AKR1C2
aldo-keto reductase family 1 member C2
increases expression
EXP
Eugenol results in increased expression of AKR1C2 mRNA
CTD
PMID:26198647
NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
G
AKR1C3
aldo-keto reductase family 1 member C3
increases expression
EXP
Eugenol results in increased expression of AKR1C3 mRNA
CTD
PMID:20566472
NCBI chr10:5,048,781...5,107,686
Ensembl chr10:5,035,354...5,107,686
G
ALPL
alkaline phosphatase, biomineralization associated
increases expression
EXP
Eugenol results in increased expression of ALPL mRNA
CTD
PMID:22083529
NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410
G
APAF1
apoptotic peptidase activating factor 1
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of APAF1 protein]
CTD
PMID:20434464
NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,149...98,735,433
G
AR
androgen receptor
multiple interactions
EXP
Eugenol binds to and results in decreased activity of AR protein
CTD
PMID:20226658
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
ARHGAP17
Rho GTPase activating protein 17
decreases expression
EXP
Eugenol results in decreased expression of ARHGAP17 mRNA
CTD
PMID:17374397
NCBI chr16:24,919,389...25,015,369
Ensembl chr16:24,919,389...25,015,666
G
ARL4C
ADP ribosylation factor like GTPase 4C
increases expression
EXP
Eugenol results in increased expression of ARL4C mRNA
CTD
PMID:17374397
NCBI chr 2:234,493,041...234,497,081
Ensembl chr 2:234,493,041...234,497,081
G
ATF3
activating transcription factor 3
increases expression
EXP
Eugenol results in increased expression of ATF3 mRNA
CTD
PMID:23999411
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
G
B2M
beta-2-microglobulin
increases expression
EXP
Eugenol results in increased expression of B2M mRNA
CTD
PMID:17936526
NCBI chr15:44,711,517...44,718,145
Ensembl chr15:44,711,358...44,718,851
G
BAD
BCL2 associated agonist of cell death
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAD mRNA]
CTD
PMID:20434464
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
G
BAX
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX protein] Eugenol results in increased expression of BAX mRNA
CTD
PMID:20434464 PMID:20537511
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
multiple interactions decreases expression
EXP ISO
[Eugenol results in increased activity of sulforaphane] which results in decreased expression of BCL2; [sulforaphane results in increased activity of Eugenol] which results in decreased expression of BCL2 Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 mRNA]; Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 protein] Eugenol results in decreased expression of BCL2 mRNA
CTD
PMID:20434464 PMID:20537511 PMID:21382956 PMID:21939359
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL2L1
BCL2 like 1
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2L1 mRNA]
CTD
PMID:20434464
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
BCLAF1
BCL2 associated transcription factor 1
decreases expression
EXP
Eugenol results in decreased expression of BCLAF1 mRNA
CTD
PMID:17374397
NCBI chr 6:136,256,627...136,289,846
Ensembl chr 6:136,256,627...136,289,851
G
BDNF
brain derived neurotrophic factor
increases expression
ISO
Eugenol results in increased expression of BDNF mRNA
CTD
PMID:15157811
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
BID
BH3 interacting domain death agonist
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BID mRNA]
CTD
PMID:20434464
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
G
BMP6
bone morphogenetic protein 6
increases expression
EXP
Eugenol results in increased expression of BMP6 mRNA
CTD
PMID:17374397
NCBI chr 6:7,726,099...7,881,728
Ensembl chr 6:7,726,099...7,881,728
G
BUB1
BUB1 mitotic checkpoint serine/threonine kinase
decreases expression
EXP
Eugenol results in decreased expression of BUB1 mRNA
CTD
PMID:17374397
NCBI chr 2:110,637,528...110,678,063
Ensembl chr 2:110,637,528...110,678,063
G
CALCRL
calcitonin receptor like receptor
increases expression
EXP
Eugenol results in increased expression of CALCRL mRNA
CTD
PMID:17374397
NCBI chr 2:187,341,964...187,448,252
Ensembl chr 2:187,341,964...187,448,460
G
CASP3
caspase 3
multiple interactions increases expression increases activity increases cleavage
ISO EXP
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP3 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP3 protein] Eugenol results in increased expression of CASP3 mRNA Eugenol results in increased activity of CASP3 protein Eugenol inhibits the reaction [Chlorpyrifos results in increased expression of CASP3 protein]; Eugenol inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein] Eugenol results in increased expression of CASP3 protein modified form Eugenol results in increased cleavage of CASP3 protein
CTD
PMID:20434464 PMID:20537511 PMID:21656368 PMID:25455450 PMID:30518369 PMID:32096903 More...
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP7
caspase 7
increases expression
EXP
Eugenol results in increased expression of CASP7 mRNA
CTD
PMID:30518369
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
G
CASP9
caspase 9
multiple interactions increases expression increases activity
ISO EXP
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein] Eugenol results in increased expression of CASP9 mRNA Eugenol results in increased activity of CASP9 protein
CTD
PMID:20434464 PMID:25455450 PMID:30518369
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CAT
catalase
increases expression decreases activity multiple interactions
EXP ISO
Eugenol results in increased expression of CAT mRNA Eugenol results in decreased activity of CAT protein Eugenol inhibits the reaction [Acetic Acid results in increased activity of CAT protein]; Eugenol inhibits the reaction [Chlorpyrifos results in decreased expression of CAT protein] CAT protein inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol]
CTD
PMID:15576237 PMID:20566472 PMID:32096903 PMID:33245926 PMID:36007673
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCL13
C-C motif chemokine ligand 13
increases expression
EXP
Eugenol results in increased expression of CCL13 mRNA
CTD
PMID:17936526
NCBI chr17:34,356,480...34,358,610
Ensembl chr17:34,356,480...34,358,610
G
CCL19
C-C motif chemokine ligand 19
increases expression
EXP
Eugenol results in increased expression of CCL19 mRNA
CTD
PMID:17936526
NCBI chr 9:34,689,570...34,691,276
Ensembl chr 9:34,689,570...34,691,276
G
CCL2
C-C motif chemokine ligand 2
decreases expression increases secretion increases expression
EXP ISO
Eugenol results in decreased expression of CCL2 mRNA Eugenol results in increased secretion of CCL2 protein Eugenol results in increased expression of CCL2 mRNA
CTD
PMID:15585374 PMID:17374397 PMID:17936526 PMID:22245253
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL20
C-C motif chemokine ligand 20
increases expression
EXP
Eugenol results in increased expression of CCL20 mRNA
CTD
PMID:30806763
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
G
CCL3
C-C motif chemokine ligand 3
increases expression increases secretion
EXP
Eugenol results in increased expression of CCL3 mRNA Eugenol results in increased secretion of CCL3 protein
CTD
PMID:15585374 PMID:23624239
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
G
CCL3L1
C-C motif chemokine ligand 3 like 1
increases expression
EXP
Eugenol results in increased expression of CCL3L1 mRNA
CTD
PMID:20713136
Ensembl chr17:36,194,869...36,196,758
G
CCL4
C-C motif chemokine ligand 4
increases expression increases secretion
EXP
Eugenol results in increased expression of CCL4 mRNA; Eugenol results in increased expression of CCL4 protein Eugenol results in increased secretion of CCL4 protein
CTD
PMID:15585374 PMID:18353026 PMID:30806763
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
G
CCNB1
cyclin B1
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CCNB1 mRNA]
CTD
PMID:19851710
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
G
CCND1
cyclin D1
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CCND1 mRNA]
CTD
PMID:19851710
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CCR2
C-C motif chemokine receptor 2
decreases expression
EXP
Eugenol results in decreased expression of CCR2 mRNA
CTD
PMID:17374397
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CCR5
C-C motif chemokine receptor 5
increases expression
EXP
Eugenol results in increased expression of CCR5 mRNA
CTD
PMID:17936526 PMID:20713136
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
CCR7
C-C motif chemokine receptor 7
increases expression
EXP
Eugenol results in increased expression of CCR7 mRNA
CTD
PMID:17374397
NCBI chr17:40,553,769...40,565,472
Ensembl chr17:40,553,769...40,565,472
G
CD24
CD24 molecule
decreases expression
EXP
Eugenol results in decreased expression of CD24 protein
CTD
PMID:31926151
NCBI chr 6:106,969,831...106,976,855
Ensembl chr 6:106,969,831...106,975,627
G
CD274
CD274 molecule
increases expression
EXP
Eugenol results in increased expression of CD274 protein
CTD
PMID:23624239
NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
G
CD36
CD36 molecule (CD36 blood group)
decreases expression
EXP
Eugenol results in decreased expression of CD36 mRNA
CTD
PMID:17374397
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
G
CD44
CD44 molecule (IN blood group)
decreases expression
EXP
Eugenol results in decreased expression of CD44 protein
CTD
PMID:31926151
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
G
CD86
CD86 molecule
multiple interactions increases expression
EXP
[Dicumarol results in decreased activity of NQO1 protein] inhibits the reaction [Eugenol results in increased expression of CD86 protein]
CTD
PMID:12423654 PMID:20488241 PMID:21742781 PMID:23624239 PMID:30806763
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
CDK6
cyclin dependent kinase 6
decreases expression
EXP
Eugenol results in decreased expression of CDK6 protein
CTD
PMID:22686307
NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573
G
CDKN1A
cyclin dependent kinase inhibitor 1A
multiple interactions
ISO
Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A protein] Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1A protein]
CTD
PMID:19851710 PMID:20043298
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDKN1B
cyclin dependent kinase inhibitor 1B
increases expression
EXP
Eugenol results in increased expression of CDKN1B protein
CTD
PMID:22686307
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
G
CISH
cytokine inducible SH2 containing protein
decreases expression
ISO
Eugenol results in decreased expression of CISH mRNA
CTD
PMID:15618236
NCBI chr 3:50,606,489...50,611,774
Ensembl chr 3:50,606,489...50,611,774
G
CLEC4A
C-type lectin domain family 4 member A
decreases expression
EXP
Eugenol results in decreased expression of CLEC4A protein
CTD
PMID:23624239
NCBI chr12:8,102,907...8,138,607
Ensembl chr12:8,123,617...8,138,607
G
CREB1
cAMP responsive element binding protein 1
affects expression
EXP
Eugenol affects the expression of CREB1 mRNA
CTD
PMID:20385217
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
CREM
cAMP responsive element modulator
increases expression
EXP
Eugenol results in increased expression of CREM mRNA
CTD
PMID:17374397
NCBI chr10:35,126,846...35,212,958
Ensembl chr10:35,126,791...35,212,958
G
CTNNB1
catenin beta 1
decreases expression multiple interactions
ISO EXP
Eugenol results in decreased expression of CTNNB1 mRNA Eugenol results in decreased expression of and affects the phosphorylation of and affects the localization of CTNNB1 protein
CTD
PMID:31926151
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
G
CTSL
cathepsin L
increases expression
EXP
Eugenol results in increased expression of CTSL mRNA
CTD
PMID:17374397
NCBI chr 9:87,726,119...87,731,469
Ensembl chr 9:87,724,051...87,731,469
G
CXCL1
C-X-C motif chemokine ligand 1
increases expression multiple interactions
EXP ISO
Eugenol results in increased expression of CXCL1 mRNA Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 mRNA]
CTD
PMID:12963494 PMID:20713136
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL8
C-X-C motif chemokine ligand 8
multiple interactions increases secretion increases expression
EXP
Acetylcysteine inhibits the reaction [Eugenol results in increased expression of CXCL8 mRNA]; Eugenol results in increased expression of and results in increased secretion of CXCL8 protein Eugenol results in increased secretion of CXCL8 protein Eugenol results in increased expression of CXCL8 mRNA; Eugenol results in increased expression of CXCL8 protein
CTD
PMID:20713136 PMID:21920952 PMID:23624239 PMID:25617811 PMID:30806763
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CXCR4
C-X-C motif chemokine receptor 4
increases expression
EXP
Eugenol results in increased expression of CXCR4 mRNA
CTD
PMID:20713136
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
G
CYCS
cytochrome c, somatic
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CYCS mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CYCS protein]
CTD
PMID:20434464
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
multiple interactions increases expression decreases expression decreases activity
EXP
[CYP1A1 protein co-treated with Copper] results in increased activity of Eugenol; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; Eugenol inhibits the reaction [CYP1A1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene]; Eugenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] Eugenol results in increased expression of CYP1A1 mRNA Eugenol results in decreased expression of CYP1A1 mRNA Eugenol results in decreased activity of CYP1A1 protein
CTD
PMID:15576237 PMID:17275817 PMID:20713136 PMID:22686307 PMID:29191726
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
multiple interactions
EXP
[CYP1A2 protein co-treated with Copper] results in increased activity of Eugenol
CTD
PMID:15576237
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
multiple interactions decreases activity
EXP
Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; Eugenol inhibits the reaction [CYP1B1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene] Eugenol results in decreased activity of CYP1B1 protein
CTD
PMID:17275817
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
CYP27A1
cytochrome P450 family 27 subfamily A member 1
decreases expression
EXP
Eugenol results in decreased expression of CYP27A1 mRNA
CTD
PMID:20713136
NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293
G
CYP2C9
cytochrome P450 family 2 subfamily C member 9
multiple interactions
EXP
[CYP2C9 protein co-treated with Copper] results in increased activity of Eugenol
CTD
PMID:15576237
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6
multiple interactions increases metabolic processing
EXP
[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol; [CYP2D6 protein results in increased metabolism of Eugenol] which results in increased abundance of 2-hydroxychavicol; [Eugenol co-treated with Copper co-treated with CYP2D6 protein] results in increased abundance of 8-Hydroxy-2'-Deoxyguanosine; bathocuproine inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol]; CAT protein inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol]; methional inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol]
CTD
PMID:15576237
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
multiple interactions
ISO EXP
Eugenol inhibits the reaction [Thioacetamide results in increased expression of CYP2E1 protein] [CYP2E1 protein co-treated with Copper] results in increased activity of Eugenol
CTD
PMID:15576237 PMID:20036707
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
DKC1
dyskerin pseudouridine synthase 1
decreases expression
EXP
Eugenol results in decreased expression of DKC1 mRNA
CTD
PMID:17374397
NCBI chr X:154,762,864...154,777,689
Ensembl chr X:154,762,742...154,777,689
G
DLGAP5
DLG associated protein 5
decreases expression
EXP
Eugenol results in decreased expression of DLGAP5 mRNA
CTD
PMID:17374397
NCBI chr14:55,148,135...55,191,585
Ensembl chr14:55,148,112...55,191,608
G
DNAJB4
DnaJ heat shock protein family (Hsp40) member B4
increases expression
EXP
Eugenol results in increased expression of DNAJB4 mRNA
CTD
PMID:23999411 PMID:27965148
NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964
G
DNASE2
deoxyribonuclease 2, lysosomal
increases expression
ISO
Eugenol results in increased expression of DNASE2A mRNA
CTD
PMID:15618236
NCBI chr19:12,875,209...12,881,449
Ensembl chr19:12,875,209...12,881,595
G
DRD1
dopamine receptor D1
multiple interactions
ISO
[2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine binds to and results in increased activity of DRD1 protein] which results in increased susceptibility to Eugenol
CTD
PMID:9537685
NCBI chr 5:175,440,036...175,444,182
Ensembl chr 5:175,440,036...175,444,182
G
DUSP1
dual specificity phosphatase 1
increases expression
EXP
Eugenol results in increased expression of DUSP1 mRNA
CTD
PMID:30806763
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
G
E2F1
E2F transcription factor 1
decreases expression
EXP
Eugenol results in decreased expression of E2F1 mRNA; Eugenol results in decreased expression of E2F1 protein
CTD
PMID:15574415
NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
G
E2F2
E2F transcription factor 2
decreases expression
EXP
Eugenol results in decreased expression of E2F2 mRNA; Eugenol results in decreased expression of E2F2 protein
CTD
PMID:15574415
NCBI chr 1:23,505,212...23,531,233
Ensembl chr 1:23,506,438...23,531,233
G
E2F3
E2F transcription factor 3
decreases expression
EXP
Eugenol results in decreased expression of E2F3 mRNA; Eugenol results in decreased expression of E2F3 protein
CTD
PMID:15574415
NCBI chr 6:20,401,879...20,493,714
Ensembl chr 6:20,401,879...20,493,714
G
E2F4
E2F transcription factor 4
decreases expression
EXP
Eugenol results in decreased expression of E2F4 mRNA
CTD
PMID:15574415
NCBI chr16:67,192,155...67,198,918
Ensembl chr16:67,192,155...67,198,918
G
E2F5
E2F transcription factor 5
decreases expression
EXP
Eugenol results in decreased expression of E2F5 mRNA
CTD
PMID:15574415
NCBI chr 8:85,177,154...85,214,518
Ensembl chr 8:85,177,154...85,217,158
G
E2F6
E2F transcription factor 6
increases expression
EXP
Eugenol results in increased expression of E2F6 mRNA
CTD
PMID:15574415
NCBI chr 2:11,444,375...11,466,161
Ensembl chr 2:11,444,375...11,466,177
G
EGFR
epidermal growth factor receptor
decreases expression increases expression
ISO
Eugenol results in decreased expression of EGFR protein Eugenol results in increased expression of EGFR mRNA
CTD
PMID:15618236
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
G
EGR1
early growth response 1
multiple interactions
ISO
[[Eugenol results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP] which results in increased expression of EGR1 mRNA
CTD
PMID:12767924
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
EGR2
early growth response 2
decreases expression
EXP
Eugenol results in decreased expression of EGR2 mRNA
CTD
PMID:17374397
NCBI chr10:62,811,996...62,819,167
Ensembl chr10:62,811,996...62,819,167
G
EMB
embigin
decreases expression
EXP
Eugenol results in decreased expression of EMB mRNA
CTD
PMID:17374397
NCBI chr 5:50,396,192...50,443,345
Ensembl chr 5:50,396,192...50,443,248
G
EPCAM
epithelial cell adhesion molecule
decreases expression
EXP ISO
Eugenol results in decreased expression of EPCAM mRNA; Eugenol results in decreased expression of EPCAM protein
CTD
PMID:31926151
NCBI chr 2:47,369,311...47,387,020
Ensembl chr 2:47,345,158...47,387,601
G
ESR1
estrogen receptor 1
affects binding multiple interactions
EXP
Eugenol binds to ESR1 protein Eugenol inhibits the reaction [Estradiol binds to ESR1 protein]
CTD
PMID:12495555
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
ESR2
estrogen receptor 2
affects binding multiple interactions
EXP
Eugenol binds to ESR2 protein Eugenol inhibits the reaction [Estradiol binds to ESR2 protein]
CTD
PMID:12495555
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
G
F13A1
coagulation factor XIII A chain
decreases expression
EXP
Eugenol results in decreased expression of F13A1 mRNA
CTD
PMID:17374397
NCBI chr 6:6,144,084...6,320,662
Ensembl chr 6:6,144,084...6,321,013
G
FASN
fatty acid synthase
decreases expression
ISO
Eugenol results in decreased expression of FASN mRNA
CTD
PMID:21870829
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
G
FBXO9
F-box protein 9
decreases expression
EXP
Eugenol results in decreased expression of FBXO9 mRNA
CTD
PMID:17374397
NCBI chr 6:53,064,998...53,100,873
Ensembl chr 6:53,051,991...53,100,873
G
FCGR2B
Fc gamma receptor IIb
increases expression
EXP
Eugenol results in increased expression of FCGR2B mRNA
CTD
PMID:17374397
NCBI chr 1:161,647,243...161,678,654
Ensembl chr 1:161,663,143...161,678,654
G
FECH
ferrochelatase
increases expression
EXP
Eugenol results in increased expression of FECH mRNA
CTD
PMID:20566472
NCBI chr18:57,544,377...57,586,702
Ensembl chr18:57,544,377...57,586,732
G
FERRY3
FERRY endosomal RAB5 effector complex subunit 3
decreases expression
EXP
Eugenol results in decreased expression of FERRY3 mRNA
CTD
PMID:17374397
NCBI chr12:4,487,735...4,538,469
Ensembl chr12:4,487,735...4,538,508
G
FLT1
fms related receptor tyrosine kinase 1
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of FLT1 mRNA]
CTD
PMID:20434464
NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
G
FOSL2
FOS like 2, AP-1 transcription factor subunit
increases expression
EXP
Eugenol results in increased expression of FOSL2 mRNA
CTD
PMID:17374397
NCBI chr 2:28,392,858...28,417,317
Ensembl chr 2:28,392,448...28,417,317
G
FTL
ferritin light chain
increases expression
EXP
Eugenol results in increased expression of FTL mRNA
CTD
PMID:20566472
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
G
G6PD
glucose-6-phosphate dehydrogenase
increases expression
EXP
Eugenol results in increased expression of G6PD mRNA
CTD
PMID:20566472
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GADD45A
growth arrest and DNA damage inducible alpha
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of GADD45A mRNA]
CTD
PMID:19851710
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
G
GADD45B
growth arrest and DNA damage inducible beta
increases expression
ISO
Eugenol results in increased expression of GADD45B mRNA
CTD
PMID:15618236
NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,259
G
GCLC
glutamate-cysteine ligase catalytic subunit
increases expression
EXP
Eugenol results in increased expression of GCLC mRNA
CTD
PMID:20566472 PMID:26198647 PMID:30806763
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
G
GCLM
glutamate-cysteine ligase modifier subunit
increases expression
EXP
Eugenol results in increased expression of GCLM mRNA
CTD
PMID:20566472 PMID:26198647 PMID:27965148 PMID:30806763
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GLYCAM1
glycosylation dependent cell adhesion molecule 1 (pseudogene)
increases expression
EXP
Eugenol results in increased expression of GLYCAM1 mRNA
CTD
PMID:17936526
NCBI chr12:54,608,187...54,610,462
Ensembl chr12:54,608,187...54,610,462 Ensembl chr12:54,608,187...54,610,462
G
GPAT3
glycerol-3-phosphate acyltransferase 3
increases expression
EXP
Eugenol results in increased expression of GPAT3 mRNA
CTD
PMID:26198647
NCBI chr 4:83,535,587...83,605,875
Ensembl chr 4:83,535,914...83,605,875
G
GPX3
glutathione peroxidase 3
increases expression
EXP
Eugenol results in increased expression of GPX3 mRNA
CTD
PMID:20566472
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
G
GSK3B
glycogen synthase kinase 3 beta
increases expression
EXP
Eugenol results in increased expression of GSK3B mRNA
CTD
PMID:17374397
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
G
GSR
glutathione-disulfide reductase
increases expression
EXP
Eugenol results in increased expression of GSR mRNA
CTD
PMID:20566472
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
GSTA1
glutathione S-transferase alpha 1
decreases activity
EXP
Eugenol analog results in decreased activity of GSTA1 protein
CTD
PMID:8620581
NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860
G
GSTA2
glutathione S-transferase alpha 2
decreases activity increases expression
ISO
Eugenol analog results in decreased activity of GSTA2 protein Eugenol results in increased expression of GSTA2 protein
CTD
PMID:8406240 PMID:8620581
NCBI chr 6:52,750,087...52,763,475
Ensembl chr 6:52,750,087...52,763,475
G
GSTM1
glutathione S-transferase mu 1
decreases activity
EXP ISO
Eugenol analog results in decreased activity of GSTM1 protein
CTD
PMID:8620581
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
GSTM2
glutathione S-transferase mu 2
decreases activity
ISO
Eugenol analog results in decreased activity of GSTM2 protein
CTD
PMID:8620581
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
G
GSTP1
glutathione S-transferase pi 1
decreases activity
EXP ISO
Eugenol analog results in decreased activity of GSTP1 protein
CTD
PMID:8620581
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
GYPB
glycophorin B (MNS blood group)
decreases expression
EXP
Eugenol results in decreased expression of GYPB mRNA
CTD
PMID:17374397
NCBI chr 4:143,995,188...144,019,380
Ensembl chr 4:143,996,104...144,019,380
G
HEATR5B
HEAT repeat containing 5B
decreases expression
EXP
Eugenol results in decreased expression of HEATR5B mRNA
CTD
PMID:17374397
NCBI chr 2:36,980,895...37,084,372
Ensembl chr 2:36,968,383...37,084,372
G
HIF1A
hypoxia inducible factor 1 subunit alpha
increases expression
EXP
Eugenol results in increased expression of HIF1A mRNA
CTD
PMID:20713136
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
G
HLA-B
major histocompatibility complex, class I, B
increases expression
EXP
Eugenol results in increased expression of HLA-B mRNA
CTD
PMID:17374397
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
decreases expression
ISO
Eugenol results in decreased expression of HMGCR mRNA
CTD
PMID:21870829
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
G
HMOX1
heme oxygenase 1
increases expression
ISO EXP
Eugenol results in increased expression of HMOX1 mRNA
CTD
PMID:20566472 PMID:20713136 PMID:23445166 PMID:26244607 PMID:30806763 PMID:31967339 More...
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HNRNPA3
heterogeneous nuclear ribonucleoprotein A3
decreases expression
EXP
Eugenol results in decreased expression of HNRNPA3 mRNA
CTD
PMID:17374397
NCBI chr 2:177,212,794...177,223,959
Ensembl chr 2:177,212,694...177,223,959
G
HRAS
HRas proto-oncogene, GTPase
decreases expression
ISO
Eugenol results in decreased expression of HRAS protein
CTD
PMID:20537511
NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321
G
HSPA6
heat shock protein family A (Hsp70) member 6
increases expression
EXP
Eugenol results in increased expression of HSPA6 mRNA
CTD
PMID:23999411
NCBI chr 1:161,524,540...161,526,894
Ensembl chr 1:161,524,540...161,526,894
G
HSPH1
heat shock protein family H (Hsp110) member 1
increases expression
EXP
Eugenol results in increased expression of HSPH1 mRNA
CTD
PMID:23999411
NCBI chr13:31,134,973...31,162,388
Ensembl chr13:31,134,973...31,162,388
G
IBSP
integrin binding sialoprotein
decreases expression
EXP
Eugenol results in decreased expression of IBSP mRNA; Eugenol results in decreased expression of IBSP protein
CTD
PMID:21706355
NCBI chr 4:87,799,554...87,812,435
Ensembl chr 4:87,799,554...87,812,435
G
ICAM1
intercellular adhesion molecule 1
increases expression
EXP
Eugenol results in increased expression of ICAM1 mRNA; Eugenol results in increased expression of ICAM1 protein
CTD
PMID:30806763
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IDI1
isopentenyl-diphosphate delta isomerase 1
decreases expression
EXP
Eugenol results in decreased expression of IDI1 mRNA
CTD
PMID:17374397
NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119
G
IFNG
interferon gamma
increases secretion multiple interactions
ISO
Eugenol results in increased secretion of IFNG protein [Methoxychlor co-treated with Eugenol] results in increased expression of IFNG protein; [Parathion co-treated with Eugenol] results in increased expression of IFNG protein
CTD
PMID:20920556 PMID:22245253
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IKBKB
inhibitor of nuclear factor kappa B kinase subunit beta
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of IKBKB protein]
CTD
PMID:19851710
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
G
IL10
interleukin 10
multiple interactions
ISO
[Eugenol co-treated with Acetylcysteine] inhibits the reaction [Nicotine results in decreased secretion of IL10 protein]; Eugenol inhibits the reaction [Nicotine results in decreased expression of IL10 mRNA]
CTD
PMID:21237301
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL12A
interleukin 12A
multiple interactions
ISO
Eugenol inhibits the reaction [Nicotine results in increased secretion of [IL12A protein co-treated with IL12B protein]]
CTD
PMID:21237301
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
G
IL12B
interleukin 12B
multiple interactions
ISO
Eugenol inhibits the reaction [Nicotine results in increased expression of IL12B mRNA]; Eugenol inhibits the reaction [Nicotine results in increased secretion of [IL12A protein co-treated with IL12B protein]]
CTD
PMID:21237301
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
G
IL16
interleukin 16
multiple interactions increases secretion
EXP
Eugenol results in increased expression of and results in increased secretion of IL16 protein Eugenol results in increased secretion of IL16 protein
CTD
PMID:23624239 PMID:30806763
NCBI chr15:81,182,712...81,314,058
Ensembl chr15:81,159,575...81,314,058
G
IL18
interleukin 18
increases expression
EXP
Eugenol results in increased expression of IL18 protein
CTD
PMID:23063874
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1A
interleukin 1 alpha
increases expression
EXP
Eugenol results in increased expression of IL1A mRNA
CTD
PMID:30806763 PMID:33715048
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
multiple interactions increases expression decreases expression
EXP ISO
[Eugenol results in increased activity of sulforaphane] which results in decreased expression of IL1B; [sulforaphane results in increased activity of Eugenol] which results in decreased expression of IL1B; Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL1B protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] Eugenol results in increased expression of IL1B mRNA Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein] Eugenol results in decreased expression of IL1B mRNA
CTD
PMID:12963494 PMID:17509409 PMID:20713136 PMID:21382956 PMID:21807015 PMID:21939359 More...
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1R2
interleukin 1 receptor type 2
increases expression
EXP
Eugenol results in increased expression of IL1R2 mRNA
CTD
PMID:20713136 PMID:30806763
NCBI chr 2:101,991,960...102,028,544
Ensembl chr 2:101,991,960...102,028,544
G
IL2
interleukin 2
increases expression increases secretion
ISO
Eugenol results in increased expression of IL2 protein Eugenol results in increased secretion of IL2 protein
CTD
PMID:22245253 PMID:22381623
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
G
IL4R
interleukin 4 receptor
increases expression
ISO
Eugenol results in increased expression of IL4RA protein
CTD
PMID:22381623
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
IL6
interleukin 6
multiple interactions increases secretion increases expression
ISO
Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of IL6 protein] Eugenol results in increased secretion of IL6 protein Eugenol inhibits the reaction [Thioacetamide results in increased activity of IL6 protein] Eugenol results in increased expression of IL6 mRNA
CTD
PMID:20036707 PMID:20043298 PMID:21870829 PMID:22245253
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL7R
interleukin 7 receptor
increases expression
EXP
Eugenol results in increased expression of IL7R mRNA
CTD
PMID:20713136
NCBI chr 5:35,856,891...35,879,603
Ensembl chr 5:35,852,695...35,879,603
G
INHBA
inhibin subunit beta A
decreases expression
ISO
Eugenol results in decreased expression of INHBA mRNA
CTD
PMID:15618236
NCBI chr 7:41,685,114...41,705,406
Ensembl chr 7:41,667,168...41,705,834
G
IPCEF1
interaction protein for cytohesin exchange factors 1
decreases expression
EXP
Eugenol results in decreased expression of IPCEF1 mRNA
CTD
PMID:17374397
NCBI chr 6:154,154,496...154,356,803
Ensembl chr 6:154,154,496...154,356,803
G
ITGA6
integrin subunit alpha 6
increases expression
EXP
Eugenol results in increased expression of ITGA6 mRNA
CTD
PMID:17936526
NCBI chr 2:172,427,336...172,506,459
Ensembl chr 2:172,234,216...172,506,459
G
ITGB1
integrin subunit beta 1
increases expression
EXP
Eugenol results in increased expression of ITGB1 mRNA
CTD
PMID:17936526
NCBI chr10:32,900,318...32,958,230
Ensembl chr10:32,887,273...33,005,792
G
KCNA5
potassium voltage-gated channel subfamily A member 5
decreases activity
EXP
Eugenol results in decreased activity of KCNA5 protein
CTD
PMID:17720863
NCBI chr12:5,043,879...5,046,788
Ensembl chr12:5,043,879...5,046,788
G
KCNJ2
potassium inwardly rectifying channel subfamily J member 2
decreases expression
EXP
Eugenol results in decreased expression of KCNJ2 mRNA
CTD
PMID:17374397
NCBI chr17:70,169,532...70,180,044
Ensembl chr17:70,168,673...70,180,044
G
KIF23
kinesin family member 23
decreases expression
EXP
Eugenol results in decreased expression of KIF23 mRNA
CTD
PMID:17374397
NCBI chr15:69,414,349...69,448,427
Ensembl chr15:69,414,246...69,448,427
G
MAFF
MAF bZIP transcription factor F
increases expression
EXP
Eugenol results in increased expression of MAFF mRNA
CTD
PMID:20566472
NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507
G
MAFG
MAF bZIP transcription factor G
increases expression
EXP
Eugenol results in increased expression of MAFG mRNA
CTD
PMID:20566472
NCBI chr17:81,918,270...81,931,244
Ensembl chr17:81,918,270...81,927,735
G
MAFK
MAF bZIP transcription factor K
increases expression
EXP
Eugenol results in increased expression of MAFK mRNA
CTD
PMID:20566472
NCBI chr 7:1,530,702...1,543,043
Ensembl chr 7:1,530,702...1,543,043
G
MCTS1
MCTS1 re-initiation and release factor
decreases expression
EXP
Eugenol results in decreased expression of MCTS1 mRNA
CTD
PMID:17374397
NCBI chr X:120,604,101...120,621,159
Ensembl chr X:120,594,010...120,621,159
G
ME1
malic enzyme 1
increases expression
EXP
Eugenol results in increased expression of ME1 mRNA
CTD
PMID:20566472
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
G
MGST1
microsomal glutathione S-transferase 1
increases expression
EXP
Eugenol results in increased expression of MGST1 mRNA
CTD
PMID:20566472
NCBI chr12:16,347,115...16,593,331
Ensembl chr12:16,347,142...16,609,259
G
MIR146A
microRNA 146a
increases expression
EXP
Eugenol results in increased expression of MIR146A mRNA
CTD
PMID:37326882
NCBI chr 5:160,485,352...160,485,450
Ensembl chr 5:160,485,352...160,485,450
G
MMP2
matrix metallopeptidase 2
multiple interactions decreases expression
ISO EXP
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP2 protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MMP2 mRNA] Eugenol results in decreased expression of MMP2 mRNA
CTD
PMID:20434464 PMID:30518369
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP9
matrix metallopeptidase 9
multiple interactions decreases expression
ISO EXP
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP9 protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MMP9 mRNA] Eugenol results in decreased expression of MMP9 mRNA
CTD
PMID:20434464 PMID:30518369
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MPO
myeloperoxidase
multiple interactions
ISO
Eugenol inhibits the reaction [Acetic Acid results in increased activity of MPO protein]; Eugenol inhibits the reaction [Thioacetamide results in increased activity of MPO protein]
CTD
PMID:20036707 PMID:33245926
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
MRPL35
mitochondrial ribosomal protein L35
decreases expression
EXP
Eugenol results in decreased expression of MRPL35 mRNA
CTD
PMID:17374397
NCBI chr 2:86,199,433...86,213,794
Ensembl chr 2:86,199,355...86,213,790
G
MS4A7
membrane spanning 4-domains A7
increases expression
EXP
Eugenol results in increased expression of MS4A7 mRNA
CTD
PMID:17374397
NCBI chr11:60,378,532...60,395,948
Ensembl chr11:60,378,485...60,395,951
G
MT1X
metallothionein 1X
increases expression
EXP
Eugenol results in increased expression of MT1X mRNA
CTD
PMID:20566472
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
G
MT3
metallothionein 3
increases expression
ISO
Eugenol results in increased expression of MT3 mRNA
CTD
PMID:15157811
NCBI chr16:56,589,528...56,591,085
Ensembl chr16:56,589,074...56,591,088
G
MTOR
mechanistic target of rapamycin kinase
increases activity
ISO
Eugenol results in increased activity of MTOR protein
CTD
PMID:36007673
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
MXD1
MAX dimerization protein 1
increases expression
EXP
Eugenol results in increased expression of MXD1 mRNA
CTD
PMID:20713136
NCBI chr 2:69,915,109...69,942,945
Ensembl chr 2:69,897,688...69,942,945
G
MYB
MYB proto-oncogene, transcription factor
decreases expression
EXP
Eugenol results in decreased expression of MYB mRNA
CTD
PMID:17374397
NCBI chr 6:135,181,308...135,219,172
Ensembl chr 6:135,181,308...135,219,173
G
MYC
MYC proto-oncogene, bHLH transcription factor
multiple interactions
ISO
Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC protein]
CTD
PMID:20537511
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
NAMPT
nicotinamide phosphoribosyltransferase
increases expression
EXP
Eugenol results in increased expression of NAMPT mRNA
CTD
PMID:17374397
NCBI chr 7:106,248,298...106,285,888
Ensembl chr 7:106,248,298...106,285,966
G
NFE2L2
NFE2 like bZIP transcription factor 2
affects expression decreases expression multiple interactions
EXP
Eugenol affects the expression of NFE2L2 protein Eugenol results in decreased expression of NFE2L2 mRNA Eugenol promotes the reaction [NFE2L2 protein results in increased expression of NQO1 mRNA]
CTD
PMID:17275817 PMID:31967339
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NFKB1
nuclear factor kappa B subunit 1
multiple interactions affects expression
EXP ISO
Eugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] Eugenol affects the expression of NFKB1 mRNA Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 protein]
CTD
PMID:10871845 PMID:19851710 PMID:20385217
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NFKBIA
NFKB inhibitor alpha
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of NFKBIA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of NFKBIA protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKBIA protein modified form] Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NFKBIA protein modified form]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]
CTD
PMID:12963494 PMID:19851710 PMID:20043298
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NOS2
nitric oxide synthase 2
multiple interactions
ISO
Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NOS2 protein]; Eugenol inhibits the reaction [Nicotine results in increased expression of NOS2 mRNA]; Eugenol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein]
CTD
PMID:20043298 PMID:21237301
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOTCH1
notch receptor 1
decreases expression
ISO EXP
Eugenol results in decreased expression of NOTCH1 protein Eugenol results in decreased expression of NOTCH1 mRNA; Eugenol results in decreased expression of NOTCH1 protein
CTD
PMID:31926151
NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression increases activity multiple interactions
EXP
Eugenol results in increased expression of NQO1 mRNA; Eugenol results in increased expression of NQO1 protein Eugenol results in increased activity of NQO1 protein [Dicumarol results in decreased activity of NQO1 protein] inhibits the reaction [Eugenol results in increased expression of CD86 protein]; Eugenol promotes the reaction [NFE2L2 protein results in increased expression of NQO1 mRNA]
CTD
PMID:17275817 PMID:20566472 PMID:21742781
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NR1I2
nuclear receptor subfamily 1 group I member 2
increases expression
EXP
Eugenol results in increased expression of NR1I2 mRNA
CTD
PMID:29933105
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
G
NUP88
nucleoporin 88
increases expression
EXP
Eugenol results in increased expression of NUP88 mRNA
CTD
PMID:17374397
NCBI chr17:5,384,833...5,419,662
Ensembl chr17:5,359,668...5,420,164
G
OR5D18
olfactory receptor family 5 subfamily D member 18
affects binding multiple interactions increases activity
ISO
Eugenol binds to OR5D18 protein [[Eugenol results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP] which results in increased expression of EGR1 mRNA; [Eugenol binds to and results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP; [Eugenol binds to and results in increased activity of OR5D18 protein] which results in increased transport of Calcium; [Eugenol binds to OR5D18 protein] which results in increased transport of Calcium; [Eugenol results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP; Eugenol binds to and results in increased activity of OR5D18 protein; isomethyleugenol inhibits the reaction [[Eugenol binds to OR5D18 protein] which results in increased transport of Calcium]
CTD
PMID:12767924 PMID:14685265 PMID:15716417 PMID:19723634
NCBI chr11:55,819,630...55,820,571
Ensembl chr11:55,819,630...55,820,571
G
P2RX3
purinergic receptor P2X 3
multiple interactions
ISO
Eugenol inhibits the reaction [P2RX3 protein affects the activity of Adenosine Triphosphate]
CTD
PMID:19967073
NCBI chr11:57,335,950...57,372,396
Ensembl chr11:57,338,352...57,372,396
G
PAICS
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase
decreases expression
EXP
Eugenol results in decreased expression of PAICS mRNA
CTD
PMID:17374397
NCBI chr 4:56,410,507...56,464,578
Ensembl chr 4:56,435,741...56,464,578
G
PARP1
poly(ADP-ribose) polymerase 1
multiple interactions
ISO
Eugenol affects the reaction [Methylnitronitrosoguanidine affects the cleavage of PARP1 protein]
CTD
PMID:20434464
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PCNA
proliferating cell nuclear antigen
multiple interactions
ISO
Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA protein] Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA protein]
CTD
PMID:19851710 PMID:20043298
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
G
PDE4B
phosphodiesterase 4B
increases expression
EXP
Eugenol results in increased expression of PDE4B mRNA
CTD
PMID:17374397
NCBI chr 1:65,792,510...66,374,579
Ensembl chr 1:65,792,514...66,374,579
G
PGD
phosphogluconate dehydrogenase
increases expression
EXP
Eugenol results in increased expression of PGD mRNA
CTD
PMID:20566472
NCBI chr 1:10,399,064...10,420,511
Ensembl chr 1:10,398,592...10,420,511
G
PICALM
phosphatidylinositol binding clathrin assembly protein
increases expression
EXP
Eugenol results in increased expression of PICALM mRNA
CTD
PMID:17374397
NCBI chr11:85,957,175...86,069,860
Ensembl chr11:85,957,175...86,069,882
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
increases expression
ISO
Eugenol results in increased expression of PIK3R1 mRNA
CTD
PMID:20724125 PMID:21870829
NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,740...68,301,821
G
PLAT
plasminogen activator, tissue type
increases expression
EXP
Eugenol results in increased expression of PLAT mRNA
CTD
PMID:17374397
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
G
PMAIP1
phorbol-12-myristate-13-acetate-induced protein 1
increases expression
EXP
Eugenol results in increased expression of PMAIP1 mRNA
CTD
PMID:20713136
NCBI chr18:59,899,996...59,904,305
Ensembl chr18:59,899,996...59,904,305
G
POU5F1
POU class 5 homeobox 1
decreases expression
ISO EXP
Eugenol results in decreased expression of POU5F1 protein Eugenol results in decreased expression of POU5F1 mRNA; Eugenol results in decreased expression of POU5F1 protein
CTD
PMID:31926151
NCBI chr 6:31,164,337...31,170,682
Ensembl chr 6:31,164,337...31,180,731
G
PPARG
peroxisome proliferator activated receptor gamma
multiple interactions increases expression
EXP ISO
Eugenol analog binds to and results in increased activity of PPARG protein Eugenol results in increased expression of PPARG mRNA 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eugenol analog binds to and results in increased activity of PPARG protein]; Eugenol analog binds to and results in increased activity of PPARG protein
CTD
PMID:20064974 PMID:21870829
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
PPBP
pro-platelet basic protein
multiple interactions increases expression
EXP
Eugenol results in increased expression of and results in increased secretion of PPBP protein Eugenol results in increased expression of PPBP mRNA
CTD
PMID:23624239
NCBI chr 4:73,986,439...73,988,190
Ensembl chr 4:73,986,439...73,988,190
G
PRDX3
peroxiredoxin 3
decreases expression
EXP
Eugenol results in decreased expression of PRDX3 mRNA
CTD
PMID:17374397
NCBI chr10:119,167,720...119,178,812
Ensembl chr10:119,167,720...119,178,812
G
PTGER3
prostaglandin E receptor 3
decreases expression
EXP
Eugenol results in decreased expression of PTGER3 mRNA
CTD
PMID:17374397
NCBI chr 1:70,852,358...71,047,816
Ensembl chr 1:70,852,353...71,047,816
G
PTGR1
prostaglandin reductase 1
increases expression
EXP
Eugenol results in increased expression of PTGR1 mRNA
CTD
PMID:20566472
NCBI chr 9:111,549,722...111,599,647
Ensembl chr 9:111,549,722...111,599,893
G
PTGS2
prostaglandin-endoperoxide synthase 2
multiple interactions increases expression decreases expression
EXP ISO
Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 mRNA]; Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] Eugenol results in increased expression of PTGS2 mRNA Eugenol results in decreased expression of PTGS2 mRNA Eugenol inhibits the reaction [Thioacetamide results in increased expression of PTGS2 protein]; Eugenol inhibits the reaction [Thioacetamide results in increased expression of PTGS2] Eugenol inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased abundance of Dinoprostone]; Eugenol inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased metabolism of Arachidonic Acid]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Eugenol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]
CTD
PMID:12757841 PMID:16101137 PMID:17509409 PMID:20036707 PMID:20043298 PMID:21807015 PMID:21939359 PMID:30806763 More...
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
RB1
RB transcriptional corepressor 1
decreases expression
EXP
Eugenol results in decreased expression of RB1 protein
CTD
PMID:22686307
NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
G
RECK
reversion inducing cysteine rich protein with kazal motifs
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of RECK mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of RECK protein]
CTD
PMID:20434464
NCBI chr 9:36,036,913...36,124,455
Ensembl chr 9:36,036,913...36,124,455
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP ISO
Eugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RELA protein] Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RELA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RELA protein]
CTD
PMID:10871845 PMID:19851710 PMID:20043298
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
RGS1
regulator of G protein signaling 1
increases expression
EXP
Eugenol results in increased expression of RGS1 mRNA
CTD
PMID:17374397 PMID:20713136
NCBI chr 1:192,575,773...192,580,024
Ensembl chr 1:192,575,763...192,580,024
G
RPL27A
ribosomal protein L27a
increases expression
EXP
Eugenol results in increased expression of RPL27A mRNA
CTD
PMID:17374397
NCBI chr11:8,682,792...8,689,872
Ensembl chr11:8,682,788...8,714,759
G
RRM2B
ribonucleotide reductase regulatory TP53 inducible subunit M2B
increases expression
EXP
Eugenol results in increased expression of RRM2B mRNA
CTD
PMID:21704725
NCBI chr 8:102,204,501...102,238,961
Ensembl chr 8:102,204,502...102,238,961
G
SAT1
spermidine/spermine N1-acetyltransferase 1
increases expression
EXP
Eugenol results in increased expression of SAT1 mRNA
CTD
PMID:17374397
NCBI chr X:23,783,173...23,786,210
Ensembl chr X:23,783,173...23,786,210
G
SDC2
syndecan 2
increases expression
EXP
Eugenol results in increased expression of SDC2 mRNA
CTD
PMID:17374397
NCBI chr 8:96,493,813...96,611,790
Ensembl chr 8:96,493,813...96,611,790
G
SEPTIN11
septin 11
decreases expression
EXP
Eugenol results in decreased expression of SEPTIN11 mRNA
CTD
PMID:17374397
NCBI chr 4:76,949,752...77,040,154
Ensembl chr 4:76,949,751...77,040,384
G
SERPINB3
serpin family B member 3
increases expression
EXP
Eugenol results in increased expression of SERPINB3 mRNA
CTD
PMID:30806763
NCBI chr18:63,655,197...63,661,893
Ensembl chr18:63,655,197...63,661,893
G
SLAMF1
signaling lymphocytic activation molecule family member 1
decreases expression
EXP
Eugenol results in decreased expression of SLAMF1 mRNA
CTD
PMID:20713136
NCBI chr 1:160,608,106...160,647,044
Ensembl chr 1:160,608,106...160,647,044
G
SLC16A10
solute carrier family 16 member 10
increases expression
EXP
Eugenol results in increased expression of SLC16A10 mRNA
CTD
PMID:17374397
NCBI chr 6:111,087,503...111,231,194
Ensembl chr 6:111,087,503...111,231,194
G
SLC2A3
solute carrier family 2 member 3
increases expression
EXP
Eugenol results in increased expression of SLC2A3 mRNA
CTD
PMID:17374397
NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007
G
SLC2A4
solute carrier family 2 member 4
increases expression
ISO
Eugenol results in increased expression of SLC2A4 mRNA
CTD
PMID:20724125 PMID:21870829
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
G
SLC7A11
solute carrier family 7 member 11
increases expression
EXP
Eugenol results in increased expression of SLC7A11 mRNA
CTD
PMID:26198647 PMID:30806763
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
SOD1
superoxide dismutase 1
increases expression decreases expression multiple interactions
EXP
Eugenol results in increased expression of SOD1 mRNA Eugenol results in decreased expression of SOD1 mRNA; Eugenol results in decreased expression of SOD1 protein Acetylcysteine promotes the reaction [Eugenol results in decreased expression of SOD1 mRNA]; Glutathione promotes the reaction [Eugenol results in decreased expression of SOD1 mRNA]
CTD
PMID:16101137 PMID:20566472
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOD2
superoxide dismutase 2
increases expression decreases expression multiple interactions
EXP
Eugenol results in increased expression of SOD2 mRNA Eugenol results in decreased expression of SOD2 mRNA; Eugenol results in decreased expression of SOD2 protein Acetylcysteine promotes the reaction [Eugenol results in decreased expression of SOD2 mRNA]; Glutathione promotes the reaction [Eugenol results in decreased expression of SOD2 mRNA]
CTD
PMID:16101137 PMID:20566472
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SOD3
superoxide dismutase 3
increases expression
EXP
Eugenol results in increased expression of SOD3 mRNA
CTD
PMID:20566472
NCBI chr 4:24,795,573...24,800,842
Ensembl chr 4:24,789,912...24,800,842
G
SQSTM1
sequestosome 1
increases expression
EXP
Eugenol results in increased expression of SQSTM1 mRNA
CTD
PMID:26198647
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
G
SRXN1
sulfiredoxin 1
increases expression
EXP
Eugenol results in increased expression of SRXN1 mRNA
CTD
PMID:20566472 PMID:26198647
NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200
G
STAT1
signal transducer and activator of transcription 1
decreases expression
EXP
Eugenol results in decreased expression of STAT1 mRNA
CTD
PMID:17374397
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
G
STAT4
signal transducer and activator of transcription 4
increases expression
EXP
Eugenol results in increased expression of STAT4 mRNA
CTD
PMID:17374397
NCBI chr 2:191,029,576...191,151,596
Ensembl chr 2:191,029,576...191,178,435
G
STAT5B
signal transducer and activator of transcription 5B
increases expression
EXP
Eugenol results in increased expression of STAT5B mRNA
CTD
PMID:17374397
NCBI chr17:42,199,177...42,288,370
Ensembl chr17:42,199,176...42,288,633
G
SULT1C3
sulfotransferase family 1C member 3
increases sulfation
ISO
SULT1C1 protein results in increased sulfation of Eugenol
CTD
PMID:9560327
NCBI chr 2:108,239,968...108,265,351
Ensembl chr 2:108,239,968...108,265,351
G
TIMP2
TIMP metallopeptidase inhibitor 2
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TIMP2 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TIMP2 protein]
CTD
PMID:20434464
NCBI chr17:78,852,977...78,925,387
Ensembl chr17:78,852,977...78,925,387
G
TLR4
toll like receptor 4
increases expression
EXP
Eugenol results in increased expression of TLR4 mRNA
CTD
PMID:17936526
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TNF
tumor necrosis factor
multiple interactions increases expression affects expression
EXP ISO
Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of TNF protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Eugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] Eugenol results in increased expression of TNF mRNA Eugenol affects the expression of TNF mRNA Eugenol inhibits the reaction [Chlorpyrifos results in increased expression of TNF protein]; Eugenol inhibits the reaction [Thioacetamide results in increased activity of TNF protein] [Methoxychlor co-treated with Eugenol] results in increased expression of TNF protein; [Parathion co-treated with Eugenol] results in increased expression of TNF protein; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of TNF protein]; Eugenol inhibits the reaction [Bacterial Toxins results in increased secretion of TNF protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Eugenol inhibits the reaction [Nicotine results in increased expression of TNF mRNA]; Eugenol inhibits the reaction [Nicotine results in increased secretion of TNF protein]
CTD
PMID:10871845 PMID:12963494 PMID:17509409 PMID:20036707 PMID:20043298 PMID:20385217 PMID:20639367 PMID:20920556 PMID:21237301 PMID:21807015 PMID:21870829 PMID:30806763 PMID:32096903 More...
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFAIP3
TNF alpha induced protein 3
increases expression
EXP
Eugenol results in increased expression of TNFAIP3 mRNA
CTD
PMID:20713136
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
G
TNFAIP6
TNF alpha induced protein 6
increases expression
EXP
Eugenol results in increased expression of TNFAIP6 mRNA
CTD
PMID:17374397 PMID:20713136
NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046
G
TP53
tumor protein p53
multiple interactions increases mutagenesis increases expression
ISO EXP
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TP53 protein] Eugenol results in increased mutagenesis of TP53 gene Eugenol results in increased expression of TRP53 mRNA; Eugenol results in increased expression of TRP53 protein Eugenol promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]
CTD
PMID:15576237 PMID:19851710 PMID:20043298 PMID:20537511
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
TP63
tumor protein p63
decreases expression
EXP
Eugenol results in decreased expression of TP63 mRNA
CTD
PMID:17936526
NCBI chr 3:189,596,746...189,897,276
Ensembl chr 3:189,631,389...189,897,276
G
TRPA1
transient receptor potential cation channel subfamily A member 1
multiple interactions increases activity
ISO
[2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide binds to and results in decreased activity of TRPA1 protein] which results in decreased susceptibility to Eugenol Eugenol results in increased activity of TRPA1 protein
CTD
PMID:22426238
NCBI chr 8:72,021,250...72,090,010
Ensembl chr 8:72,019,917...72,075,584
G
TRPV3
transient receptor potential cation channel subfamily V member 3
multiple interactions increases activity
EXP ISO
Eugenol binds to and results in increased activity of TRPV3 protein [Eugenol binds to and results in increased activity of TRPV3 protein] which results in increased transport of Calcium; Eugenol binds to and results in increased activity of TRPV3 protein [Eugenol results in increased activity of TRPV3 protein] which results in increased transport of Calcium
CTD
PMID:16617338 PMID:20086034 PMID:21593771
NCBI chr17:3,510,502...3,557,812
Ensembl chr17:3,510,502...3,557,812
G
TXN2
thioredoxin 2
increases expression
EXP
Eugenol results in increased expression of TXN2 mRNA
CTD
PMID:20566472
NCBI chr22:36,467,046...36,481,640
Ensembl chr22:36,467,046...36,481,640
G
TXNRD1
thioredoxin reductase 1
increases expression
EXP ISO
Eugenol results in increased expression of TXNRD1 mRNA
CTD
PMID:20566472 PMID:23445166
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
TXNRD2
thioredoxin reductase 2
increases expression
EXP
Eugenol results in increased expression of TXNRD2 mRNA
CTD
PMID:20566472
NCBI chr22:19,875,522...19,941,818
Ensembl chr22:19,875,517...19,941,820
G
UGDH
UDP-glucose 6-dehydrogenase
increases expression
EXP
Eugenol results in increased expression of UGDH mRNA
CTD
PMID:16292757
NCBI chr 4:39,498,755...39,527,439
Ensembl chr 4:39,498,755...39,528,311
G
UGT1A1
UDP glucuronosyltransferase family 1 member A1
increases glucuronidation
EXP
UGT1A1 protein results in increased glucuronidation of Eugenol
CTD
PMID:14557274
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
G
UGT1A10
UDP glucuronosyltransferase family 1 member A10
increases glucuronidation
EXP
UGT1A10 protein results in increased glucuronidation of Eugenol
CTD
PMID:14557274
NCBI chr 2:233,636,448...233,773,300
Ensembl chr 2:233,636,448...233,773,300
G
UGT1A6
UDP glucuronosyltransferase family 1 member A6
increases expression
EXP
Eugenol results in increased expression of UGT1A6 mRNA
CTD
PMID:20566472
NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
G
UGT1A7
UDP glucuronosyltransferase family 1 member A7
increases glucuronidation
EXP
UGT1A7 protein results in increased glucuronidation of Eugenol
CTD
PMID:14557274
NCBI chr 2:233,681,901...233,773,300
Ensembl chr 2:233,681,901...233,773,300
G
UGT1A8
UDP glucuronosyltransferase family 1 member A8
increases glucuronidation
EXP
UGT1A8 protein results in increased glucuronidation of Eugenol
CTD
PMID:14557274
NCBI chr 2:233,617,633...233,773,300
Ensembl chr 2:233,617,633...233,773,300
G
UGT1A9
UDP glucuronosyltransferase family 1 member A9
increases glucuronidation
EXP
UGT1A9 protein results in increased glucuronidation of Eugenol
CTD
PMID:14557274
NCBI chr 2:233,671,898...233,773,300
Ensembl chr 2:233,671,898...233,773,300
G
UGT2B15
UDP glucuronosyltransferase family 2 member B15
increases metabolic processing
EXP
UGT2B15 protein results in increased metabolism of Eugenol; UGT2B15 protein SNP results in increased metabolism of Eugenol
CTD
PMID:7835232 PMID:12386133
NCBI chr 4:68,646,597...68,670,652
Ensembl chr 4:68,646,597...68,670,652
G
UGT2B17
UDP glucuronosyltransferase family 2 member B17
increases metabolic processing
EXP
UGT2B17 protein results in increased metabolism of Eugenol
CTD
PMID:8798464
NCBI chr 4:68,537,173...68,576,322
Ensembl chr 4:68,537,173...68,576,413
G
VDR
vitamin D receptor
increases expression
EXP
Eugenol results in increased expression of VDR mRNA
CTD
PMID:17374397
NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
G
ZBTB17
zinc finger and BTB domain containing 17
decreases expression
EXP
Eugenol results in decreased expression of ZBTB17 mRNA
CTD
PMID:17374397
NCBI chr 1:15,941,869...15,976,101
Ensembl chr 1:15,941,869...15,976,132
G
AASS
aminoadipate-semialdehyde synthase
decreases expression
EXP
methyleugenol results in decreased expression of AASS mRNA
CTD
PMID:32234424
NCBI chr 7:122,073,549...122,144,249
Ensembl chr 7:122,064,583...122,144,308
G
ABAT
4-aminobutyrate aminotransferase
decreases expression
EXP
methyleugenol results in decreased expression of ABAT mRNA
CTD
PMID:32234424
NCBI chr16:8,674,617...8,784,570
Ensembl chr16:8,674,596...8,784,575
G
ABCA1
ATP binding cassette subfamily A member 1
decreases expression
EXP
methyleugenol results in decreased expression of ABCA1 mRNA
CTD
PMID:32234424
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
G
ABCA6
ATP binding cassette subfamily A member 6
decreases expression
EXP
methyleugenol results in decreased expression of ABCA6 mRNA
CTD
PMID:32234424
NCBI chr17:69,078,702...69,141,895
Ensembl chr17:69,078,702...69,141,895
G
ABCB11
ATP binding cassette subfamily B member 11
decreases expression
EXP
methyleugenol results in decreased expression of ABCB11 mRNA
CTD
PMID:32234424
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
ABCB4
ATP binding cassette subfamily B member 4
decreases expression
EXP
methyleugenol results in decreased expression of ABCB4 mRNA
CTD
PMID:32234424
NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
G
ABCC11
ATP binding cassette subfamily C member 11
decreases expression
EXP
methyleugenol results in decreased expression of ABCC11 mRNA
CTD
PMID:32234424
NCBI chr16:48,164,819...48,247,539
Ensembl chr16:48,165,773...48,247,568
G
ABCC6
ATP binding cassette subfamily C member 6
decreases expression
EXP
methyleugenol results in decreased expression of ABCC6 mRNA
CTD
PMID:32234424
NCBI chr16:16,149,565...16,223,494
Ensembl chr16:16,149,565...16,223,522
G
ABCC6P1
ATP binding cassette subfamily C member 6 pseudogene 1
decreases expression
EXP
methyleugenol results in decreased expression of ABCC6P1 mRNA
CTD
PMID:32234424
NCBI chr16:18,571,248...18,598,289
Ensembl chr16:18,571,162...18,598,328 Ensembl chr16:18,571,162...18,598,328
G
ABCC9
ATP binding cassette subfamily C member 9
decreases expression
EXP
methyleugenol results in decreased expression of ABCC9 mRNA
CTD
PMID:32234424
NCBI chr12:21,797,389...21,941,426
Ensembl chr12:21,797,389...21,942,543
G
ABCG5
ATP binding cassette subfamily G member 5
decreases expression
EXP
methyleugenol results in decreased expression of ABCG5 mRNA
CTD
PMID:32234424
NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865
G
ABCG8
ATP binding cassette subfamily G member 8
decreases expression
EXP
methyleugenol results in decreased expression of ABCG8 mRNA
CTD
PMID:32234424
NCBI chr 2:43,838,971...43,882,988
Ensembl chr 2:43,831,942...43,882,988
G
ABHD2
abhydrolase domain containing 2, acylglycerol lipase
decreases expression
EXP
methyleugenol results in decreased expression of ABHD2 mRNA
CTD
PMID:32234424
NCBI chr15:89,040,998...89,202,355
Ensembl chr15:89,087,459...89,202,355
G
ACAA1
acetyl-CoA acyltransferase 1
decreases expression
EXP
methyleugenol results in decreased expression of ACAA1 mRNA
CTD
PMID:32234424
NCBI chr 3:38,122,715...38,137,127
Ensembl chr 3:38,103,129...38,137,242
G
ACACB
acetyl-CoA carboxylase beta
decreases expression
EXP
methyleugenol results in decreased expression of ACACB mRNA
CTD
PMID:32234424
NCBI chr12:109,111,189...109,268,226
Ensembl chr12:109,116,587...109,268,226
G
ACAT2
acetyl-CoA acetyltransferase 2
decreases expression
EXP
methyleugenol results in decreased expression of ACAT2 mRNA
CTD
PMID:32234424
NCBI chr 6:159,762,045...159,779,112
Ensembl chr 6:159,762,045...159,779,112
G
ACHE
acetylcholinesterase (Yt blood group)
increases expression
EXP
methyleugenol results in increased expression of ACHE mRNA
CTD
PMID:32234424
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
G
ACMSD
aminocarboxymuconate semialdehyde decarboxylase
decreases expression
EXP
methyleugenol results in decreased expression of ACMSD mRNA
CTD
PMID:32234424
NCBI chr 2:134,838,616...134,902,034
Ensembl chr 2:134,838,616...134,902,034
G
ACNATP
acyl-CoA:amino acid N-acyltransferase, pseudogene
decreases expression
EXP
methyleugenol results in decreased expression of ACNATP mRNA
CTD
PMID:32234424
NCBI chr 9:101,334,092...101,339,347
Ensembl chr 9:101,334,084...101,339,347
G
ACOT1
acyl-CoA thioesterase 1
decreases expression
EXP
methyleugenol results in decreased expression of ACOT1 mRNA
CTD
PMID:32234424
NCBI chr14:73,490,933...73,543,796
Ensembl chr14:73,537,143...73,543,796
G
ACOT11
acyl-CoA thioesterase 11
decreases expression
EXP
methyleugenol results in decreased expression of ACOT11 mRNA
CTD
PMID:32234424
NCBI chr 1:54,548,228...54,639,192
Ensembl chr 1:54,542,257...54,639,192
G
ACOT12
acyl-CoA thioesterase 12
decreases expression
EXP
methyleugenol results in decreased expression of ACOT12 mRNA
CTD
PMID:32234424
NCBI chr 5:81,308,609...81,394,134
Ensembl chr 5:81,329,996...81,394,179
G
ACOX2
acyl-CoA oxidase 2
decreases expression
EXP
methyleugenol results in decreased expression of ACOX2 mRNA
CTD
PMID:32234424
NCBI chr 3:58,505,136...58,537,190
Ensembl chr 3:58,505,136...58,537,283
G
ACSL1
acyl-CoA synthetase long chain family member 1
decreases expression
EXP
methyleugenol results in decreased expression of ACSL1 mRNA
CTD
PMID:32234424
NCBI chr 4:184,755,595...184,826,594
Ensembl chr 4:184,755,595...184,826,818
G
ACSL4
acyl-CoA synthetase long chain family member 4
decreases expression
EXP
methyleugenol results in decreased expression of ACSL4 mRNA
CTD
PMID:32234424
NCBI chr X:109,641,335...109,733,257
Ensembl chr X:109,624,244...109,733,403
G
ACSL5
acyl-CoA synthetase long chain family member 5
decreases expression
EXP
methyleugenol results in decreased expression of ACSL5 mRNA
CTD
PMID:32234424
NCBI chr10:112,374,116...112,428,376
Ensembl chr10:112,374,116...112,428,379
G
ACSM2A
acyl-CoA synthetase medium chain family member 2A
decreases expression
EXP
methyleugenol results in decreased expression of ACSM2A mRNA
CTD
PMID:32234424
NCBI chr16:20,451,521...20,487,669
Ensembl chr16:20,451,461...20,487,669
G
ACSM2B
acyl-CoA synthetase medium chain family member 2B
decreases expression
EXP
methyleugenol results in decreased expression of ACSM2B mRNA
CTD
PMID:32234424
NCBI chr16:20,536,226...20,576,367
Ensembl chr16:20,536,226...20,576,427
G
ACSM3
acyl-CoA synthetase medium chain family member 3
decreases expression
EXP
methyleugenol results in decreased expression of ACSM3 mRNA
CTD
PMID:32234424
NCBI chr16:20,674,405...20,797,581
Ensembl chr16:20,610,243...20,797,581
G
ACSM5
acyl-CoA synthetase medium chain family member 5
decreases expression
EXP
methyleugenol results in decreased expression of ACSM5 mRNA
CTD
PMID:32234424
NCBI chr16:20,409,534...20,441,336
Ensembl chr16:20,409,534...20,441,336
G
ACSS1
acyl-CoA synthetase short chain family member 1
decreases expression
EXP
methyleugenol results in decreased expression of ACSS1 mRNA
CTD
PMID:32234424
NCBI chr20:25,006,237...25,058,139
Ensembl chr20:25,006,230...25,058,980
G
ACSS2
acyl-CoA synthetase short chain family member 2
decreases expression
EXP
methyleugenol results in decreased expression of ACSS2 mRNA
CTD
PMID:32234424
NCBI chr20:34,874,989...34,927,959
Ensembl chr20:34,872,146...34,927,962
G
ACTL10
actin like 10
increases expression
EXP
methyleugenol results in increased expression of ACTL10 mRNA
CTD
PMID:32234424
NCBI chr20:33,666,943...33,668,525
Ensembl chr20:33,666,943...33,668,525
G
ACYP2
acylphosphatase 2
decreases expression
EXP
methyleugenol results in decreased expression of ACYP2 mRNA
CTD
PMID:32234424
NCBI chr 2:53,971,113...54,305,300
Ensembl chr 2:53,970,838...54,305,300
G
ADAM19
ADAM metallopeptidase domain 19
increases expression
EXP
methyleugenol results in increased expression of ADAM19 mRNA
CTD
PMID:32234424
NCBI chr 5:157,477,304...157,575,775
Ensembl chr 5:157,395,534...157,575,775
G
ADAMTS17
ADAM metallopeptidase with thrombospondin type 1 motif 17
decreases expression
EXP
methyleugenol results in decreased expression of ADAMTS17 mRNA
CTD
PMID:32234424
NCBI chr15:99,971,437...100,341,975
Ensembl chr15:99,971,437...100,342,005
G
ADAMTS3
ADAM metallopeptidase with thrombospondin type 1 motif 3
decreases expression
EXP
methyleugenol results in decreased expression of ADAMTS3 mRNA
CTD
PMID:32234424
NCBI chr 4:72,280,969...72,569,221
Ensembl chr 4:72,280,969...72,569,221
G
ADAMTS6
ADAM metallopeptidase with thrombospondin type 1 motif 6
decreases expression
EXP
methyleugenol results in decreased expression of ADAMTS6 mRNA
CTD
PMID:32234424
NCBI chr 5:65,148,738...65,481,920
Ensembl chr 5:65,148,738...65,481,920
G
ADAMTSL3
ADAMTS like 3
decreases expression
EXP
methyleugenol results in decreased expression of ADAMTSL3 mRNA
CTD
PMID:32234424
NCBI chr15:83,654,123...84,039,842
Ensembl chr15:83,654,088...84,039,842
G
ADARB2
adenosine deaminase RNA specific B2 (inactive)
decreases expression
EXP
methyleugenol results in decreased expression of ADARB2 mRNA
CTD
PMID:32234424
NCBI chr10:1,177,313...1,737,525
Ensembl chr10:1,177,313...1,737,525
G
ADCY5
adenylate cyclase 5
decreases expression
EXP
methyleugenol results in decreased expression of ADCY5 mRNA
CTD
PMID:32234424
NCBI chr 3:123,282,296...123,449,090
Ensembl chr 3:123,282,296...123,449,090
G
ADCY8
adenylate cyclase 8
decreases expression
EXP
methyleugenol results in decreased expression of ADCY8 mRNA
CTD
PMID:32234424
NCBI chr 8:130,780,301...131,040,909
Ensembl chr 8:130,780,301...131,040,909
G
ADGRF4
adhesion G protein-coupled receptor F4
increases expression
EXP
methyleugenol results in increased expression of ADGRF4 mRNA
CTD
PMID:32234424
NCBI chr 6:47,698,580...47,722,014
Ensembl chr 6:47,685,864...47,722,021
G
ADGRG1
adhesion G protein-coupled receptor G1
increases expression
EXP
methyleugenol results in increased expression of ADGRG1 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr16:57,619,738...57,665,567
Ensembl chr16:57,610,652...57,665,580
G
ADGRG7
adhesion G protein-coupled receptor G7
decreases expression
EXP
methyleugenol results in decreased expression of ADGRG7 mRNA
CTD
PMID:32234424
NCBI chr 3:100,609,601...100,695,479
Ensembl chr 3:100,609,601...100,695,479
G
ADGRV1
adhesion G protein-coupled receptor V1
decreases expression
EXP
methyleugenol results in decreased expression of ADGRV1 mRNA
CTD
PMID:32234424
NCBI chr 5:90,558,797...91,164,437
Ensembl chr 5:90,529,344...91,164,437
G
ADH1B
alcohol dehydrogenase 1B (class I), beta polypeptide
decreases expression
EXP
methyleugenol results in decreased expression of ADH1B mRNA
CTD
PMID:32234424
NCBI chr 4:99,304,971...99,321,401
Ensembl chr 4:99,304,971...99,321,401
G
ADH4
alcohol dehydrogenase 4 (class II), pi polypeptide
decreases expression
EXP
methyleugenol results in decreased expression of ADH4 mRNA
CTD
PMID:32234424
NCBI chr 4:99,123,658...99,144,297
Ensembl chr 4:99,123,657...99,157,792
G
ADH6
alcohol dehydrogenase 6 (class V)
decreases expression
EXP
methyleugenol results in decreased expression of ADH6 mRNA
CTD
PMID:32234424
NCBI chr 4:99,202,639...99,219,246
Ensembl chr 4:99,202,638...99,219,537
G
ADK
adenosine kinase
decreases expression
EXP
methyleugenol results in decreased expression of ADK mRNA
CTD
PMID:32234424
NCBI chr10:74,151,221...74,709,290
Ensembl chr10:74,151,202...74,709,963
G
ADRA1A
adrenoceptor alpha 1A
decreases expression
EXP
methyleugenol results in decreased expression of ADRA1A mRNA
CTD
PMID:32234424
NCBI chr 8:26,748,150...26,867,379
Ensembl chr 8:26,748,150...26,867,278
G
AFF2
ALF transcription elongation factor 2
decreases expression
EXP
methyleugenol results in decreased expression of AFF2 mRNA
CTD
PMID:32234424
NCBI chr X:148,500,617...149,000,663
Ensembl chr X:148,500,617...149,000,663
G
AFF3
ALF transcription elongation factor 3
decreases expression
EXP
methyleugenol results in decreased expression of AFF3 mRNA
CTD
PMID:32234424
NCBI chr 2:99,545,419...100,142,590
Ensembl chr 2:99,545,419...100,192,428
G
AFG1L
AFG1 like ATPase
decreases expression
EXP
methyleugenol results in decreased expression of AFG1L mRNA
CTD
PMID:32234424
NCBI chr 6:108,295,054...108,526,001
Ensembl chr 6:108,294,991...108,526,796
G
AFM
afamin
decreases expression
EXP
methyleugenol results in decreased expression of AFM mRNA
CTD
PMID:32234424
NCBI chr 4:73,481,745...73,504,001
Ensembl chr 4:73,481,745...73,504,001
G
AGBL5-AS1
AGBL5 antisense RNA 1
increases expression
EXP
methyleugenol results in increased expression of AGBL5-AS1 mRNA
CTD
PMID:32234424
NCBI chr 2:27,049,683...27,050,264
Ensembl chr 2:27,049,683...27,050,264
G
AGMO
alkylglycerol monooxygenase
decreases expression
EXP
methyleugenol results in decreased expression of AGMO mRNA
CTD
PMID:32234424
NCBI chr 7:15,117,223...15,562,015
Ensembl chr 7:15,200,317...15,562,015
G
AGPAT2
1-acylglycerol-3-phosphate O-acyltransferase 2
decreases expression
EXP
methyleugenol results in decreased expression of AGPAT2 mRNA
CTD
PMID:32234424
NCBI chr 9:136,673,143...136,687,457
Ensembl chr 9:136,673,143...136,687,457
G
AGR2
anterior gradient 2, protein disulphide isomerase family member
increases expression
EXP
methyleugenol results in increased expression of AGR2 mRNA
CTD
PMID:32234424
NCBI chr 7:16,791,811...16,804,999
Ensembl chr 7:16,791,811...16,833,433
G
AGT
angiotensinogen
decreases expression
EXP
methyleugenol results in decreased expression of AGT mRNA
CTD
PMID:32234424
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AGXT
alanine--glyoxylate aminotransferase
decreases expression
EXP
methyleugenol results in decreased expression of AGXT mRNA
CTD
PMID:32234424
NCBI chr 2:240,868,824...240,880,500
Ensembl chr 2:240,868,824...240,880,502
G
AGXT2
alanine--glyoxylate aminotransferase 2
decreases expression
EXP
methyleugenol results in decreased expression of AGXT2 mRNA
CTD
PMID:32234424
NCBI chr 5:34,998,102...35,047,949
Ensembl chr 5:34,998,101...35,048,135
G
AHSG
alpha 2-HS glycoprotein
decreases expression
EXP
methyleugenol results in decreased expression of AHSG mRNA
CTD
PMID:32234424
NCBI chr 3:186,613,060...186,621,318
Ensembl chr 3:186,613,060...186,621,318
G
AIG1
androgen induced 1
decreases expression
EXP
methyleugenol results in decreased expression of AIG1 mRNA
CTD
PMID:32234424
NCBI chr 6:143,059,213...143,343,883
Ensembl chr 6:143,060,496...143,341,058
G
AKAP12
A-kinase anchoring protein 12
increases expression
EXP
methyleugenol results in increased expression of AKAP12 mRNA
CTD
PMID:32234424
NCBI chr 6:151,239,967...151,358,559
Ensembl chr 6:151,239,967...151,358,559
G
AKAP6
A-kinase anchoring protein 6
decreases expression
EXP
methyleugenol results in decreased expression of AKAP6 mRNA
CTD
PMID:32234424
NCBI chr14:32,329,298...32,837,684
Ensembl chr14:32,329,298...32,837,684
G
AKR1B1
aldo-keto reductase family 1 member B
increases expression
EXP
methyleugenol results in increased expression of AKR1B1 mRNA
CTD
PMID:32234424
NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284
G
AKR1B10
aldo-keto reductase family 1 member B10
increases expression
EXP
methyleugenol results in increased expression of AKR1B10 mRNA
CTD
PMID:32234424
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
G
AKR1B15
aldo-keto reductase family 1 member B15
increases expression
EXP
methyleugenol results in increased expression of AKR1B15 mRNA
CTD
PMID:32234424
NCBI chr 7:134,549,110...134,579,869
Ensembl chr 7:134,549,110...134,579,875
G
AKR1C4
aldo-keto reductase family 1 member C4
decreases expression
EXP
methyleugenol results in decreased expression of AKR1C4 mRNA
CTD
PMID:32234424
NCBI chr10:5,196,837...5,218,949
Ensembl chr10:5,195,462...5,218,949
G
AKR1C6P
aldo-keto reductase family 1 member C6, pseudogene
decreases expression
EXP
methyleugenol results in decreased expression of AKR1C6P mRNA
CTD
PMID:32234424
NCBI chr10:4,871,667...4,916,273
Ensembl chr10:4,871,901...4,891,975
G
AKR1D1
aldo-keto reductase family 1 member D1
decreases expression
EXP
methyleugenol results in decreased expression of AKR1D1 mRNA
CTD
PMID:32234424
NCBI chr 7:138,076,459...138,118,305
Ensembl chr 7:138,002,324...138,118,305
G
AKR7A3
aldo-keto reductase family 7 member A3
decreases expression
EXP
methyleugenol results in decreased expression of AKR7A3 mRNA
CTD
PMID:32234424
NCBI chr 1:19,274,229...19,288,770
Ensembl chr 1:19,282,573...19,288,770
G
ALB
albumin
decreases expression
EXP
methyleugenol results in decreased expression of ALB mRNA
CTD
PMID:32234424
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
ALDH3A1
aldehyde dehydrogenase 3 family member A1
increases expression
EXP
methyleugenol results in increased expression of ALDH3A1 mRNA
CTD
PMID:32234424
NCBI chr17:19,737,984...19,748,298
Ensembl chr17:19,737,984...19,748,943
G
ALDH4A1
aldehyde dehydrogenase 4 family member A1
decreases expression
EXP
methyleugenol results in decreased expression of ALDH4A1 mRNA
CTD
PMID:32234424
NCBI chr 1:18,871,430...18,902,555
Ensembl chr 1:18,871,430...18,902,724
G
ALDH6A1
aldehyde dehydrogenase 6 family member A1
decreases expression
EXP
methyleugenol results in decreased expression of ALDH6A1 mRNA
CTD
PMID:32234424
NCBI chr14:74,056,847...74,084,453
Ensembl chr14:74,056,847...74,084,492
G
ALDH8A1
aldehyde dehydrogenase 8 family member A1
decreases expression
EXP
methyleugenol results in decreased expression of ALDH8A1 mRNA
CTD
PMID:32234424
NCBI chr 6:134,917,393...134,950,101
Ensembl chr 6:134,917,393...134,950,115
G
ALDOB
aldolase, fructose-bisphosphate B
decreases expression
EXP
methyleugenol results in decreased expression of ALDOB mRNA
CTD
PMID:32234424
NCBI chr 9:101,420,560...101,435,774
Ensembl chr 9:101,420,560...101,449,664
G
ALOX5
arachidonate 5-lipoxygenase
increases expression
EXP
methyleugenol results in increased expression of ALOX5 mRNA
CTD
PMID:32234424
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
G
ALPK2
alpha kinase 2
increases expression
EXP
methyleugenol results in increased expression of ALPK2 mRNA
CTD
PMID:32234424
NCBI chr18:58,481,247...58,629,091
Ensembl chr18:58,481,247...58,629,091
G
AMBP
alpha-1-microglobulin/bikunin precursor
decreases expression
EXP
methyleugenol results in decreased expression of AMBP mRNA
CTD
PMID:32234424
NCBI chr 9:114,060,127...114,078,300
Ensembl chr 9:114,060,127...114,078,328
G
AMOTL1
angiomotin like 1
decreases expression
EXP
methyleugenol results in decreased expression of AMOTL1 mRNA
CTD
PMID:32234424
NCBI chr11:94,706,460...94,876,748
Ensembl chr11:94,706,431...94,876,748
G
ANG
angiogenin
decreases expression
EXP
methyleugenol results in decreased expression of ANG mRNA
CTD
PMID:32234424
NCBI chr14:20,684,177...20,694,186
Ensembl chr14:20,684,177...20,698,971
G
ANGPTL3
angiopoietin like 3
decreases expression
EXP
methyleugenol results in decreased expression of ANGPTL3 mRNA
CTD
PMID:32234424
NCBI chr 1:62,597,520...62,606,313
Ensembl chr 1:62,597,520...62,606,313
G
ANGPTL8
angiopoietin like 8
decreases expression
EXP
methyleugenol results in decreased expression of ANGPTL8 mRNA
CTD
PMID:32234424
NCBI chr19:11,239,619...11,241,943
Ensembl chr19:11,237,502...11,241,943
G
ANK1
ankyrin 1
increases expression
EXP
methyleugenol results in increased expression of ANK1 mRNA
CTD
PMID:32234424
NCBI chr 8:41,653,225...41,896,741
Ensembl chr 8:41,653,220...41,896,741
G
ANK2
ankyrin 2
decreases expression
EXP
methyleugenol results in decreased expression of ANK2 mRNA
CTD
PMID:32234424
NCBI chr 4:112,705,622...113,383,736
Ensembl chr 4:112,818,032...113,384,221
G
ANKHD1-EIF4EBP3
ANKHD1-EIF4EBP3 readthrough
decreases expression
EXP
methyleugenol results in decreased expression of ANKHD1-EIF4EBP3 mRNA
CTD
PMID:32234424
NCBI chr 5:140,401,833...140,549,576
Ensembl chr 5:140,401,908...140,549,569
G
ANKRD1
ankyrin repeat domain 1
decreases expression
EXP
methyleugenol results in decreased expression of ANKRD1 mRNA
CTD
PMID:32234424
NCBI chr10:90,912,096...90,921,087
Ensembl chr10:90,912,096...90,921,087
G
ANKRD2
ankyrin repeat domain 2
decreases expression
EXP
methyleugenol results in decreased expression of ANKRD2 mRNA
CTD
PMID:32234424
NCBI chr10:97,572,441...97,583,884
Ensembl chr10:97,572,499...97,583,884
G
ANKS1B
ankyrin repeat and sterile alpha motif domain containing 1B
decreases expression
EXP
methyleugenol results in decreased expression of ANKS1B mRNA
CTD
PMID:32234424
NCBI chr12:98,734,786...99,984,936
Ensembl chr12:98,726,457...99,984,936
G
ANO1
anoctamin 1
decreases expression
EXP
methyleugenol results in decreased expression of ANO1 mRNA
CTD
PMID:32234424
NCBI chr11:69,965,997...70,189,530
Ensembl chr11:69,985,907...70,189,530
G
ANO4
anoctamin 4
decreases expression
EXP
methyleugenol results in decreased expression of ANO4 mRNA
CTD
PMID:32234424
NCBI chr12:100,717,261...101,128,641
Ensembl chr12:100,717,526...101,128,641
G
ANXA10
annexin A10
decreases expression
EXP
methyleugenol results in decreased expression of ANXA10 mRNA
CTD
PMID:32234424
NCBI chr 4:168,092,537...168,187,736
Ensembl chr 4:168,092,537...168,187,736
G
ANXA3
annexin A3
increases expression
EXP
methyleugenol results in increased expression of ANXA3 mRNA
CTD
PMID:32234424
NCBI chr 4:78,551,770...78,610,447
Ensembl chr 4:78,551,747...78,610,451
G
AOC1
amine oxidase copper containing 1
decreases expression
EXP
methyleugenol results in decreased expression of AOC1 mRNA
CTD
PMID:32234424
NCBI chr 7:150,852,120...150,861,504
Ensembl chr 7:150,824,627...150,861,504
G
AOC4P
amine oxidase copper containing 4, pseudogene
decreases expression
EXP
methyleugenol results in decreased expression of AOC4P mRNA
CTD
PMID:32234424
NCBI chr17:42,867,145...42,869,217
Ensembl chr17:42,865,922...42,874,246 Ensembl chr17:42,865,922...42,874,246
G
APBA1
amyloid beta precursor protein binding family A member 1
decreases expression
EXP
methyleugenol results in decreased expression of APBA1 mRNA
CTD
PMID:32234424
NCBI chr 9:69,427,532...69,673,013
Ensembl chr 9:69,427,532...69,672,371
G
APBB1IP
amyloid beta precursor protein binding family B member 1 interacting protein
decreases expression
EXP
methyleugenol results in decreased expression of APBB1IP mRNA
CTD
PMID:32234424
NCBI chr10:26,438,341...26,567,803
Ensembl chr10:26,438,341...26,567,803
G
APCDD1L
APC down-regulated 1 like
increases expression
EXP
methyleugenol results in increased expression of APCDD1L mRNA
CTD
PMID:32234424
NCBI chr20:58,459,101...58,515,399
Ensembl chr20:58,459,101...58,515,399
G
APCDD1L-DT
APCDD1L divergent transcript
increases expression
EXP
methyleugenol results in increased expression of APCDD1L-DT mRNA
CTD
PMID:32234424
NCBI chr20:58,515,379...58,619,892
Ensembl chr20:58,515,379...58,619,888
G
APCS
amyloid P component, serum
decreases expression
EXP
methyleugenol results in decreased expression of APCS mRNA
CTD
PMID:32234424
NCBI chr 1:159,587,826...159,588,865
Ensembl chr 1:159,587,826...159,588,865
G
APMAP
adipocyte plasma membrane associated protein
decreases expression
EXP
methyleugenol results in decreased expression of APMAP mRNA
CTD
PMID:32234424
NCBI chr20:24,962,925...24,992,751
Ensembl chr20:24,962,925...24,992,751
G
APOA1
apolipoprotein A1
decreases expression
EXP
methyleugenol results in decreased expression of APOA1 mRNA
CTD
PMID:32234424
NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622
G
APOA4
apolipoprotein A4
decreases expression
EXP
methyleugenol results in decreased expression of APOA4 mRNA
CTD
PMID:32234424
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
G
APOA5
apolipoprotein A5
decreases expression
EXP
methyleugenol results in decreased expression of APOA5 mRNA
CTD
PMID:32234424
NCBI chr11:116,789,367...116,792,420
Ensembl chr11:116,789,367...116,792,420
G
APOC3
apolipoprotein C3
decreases expression
EXP
methyleugenol results in decreased expression of APOC3 mRNA
CTD
PMID:32234424
NCBI chr11:116,829,907...116,833,072
Ensembl chr11:116,829,706...116,833,072
G
APOH
apolipoprotein H
decreases expression
EXP
methyleugenol results in decreased expression of APOH mRNA
CTD
PMID:32234424
NCBI chr17:66,212,033...66,229,415
Ensembl chr17:66,212,033...66,256,525
G
APOM
apolipoprotein M
decreases expression
EXP
methyleugenol results in decreased expression of APOM mRNA
CTD
PMID:32234424
NCBI chr 6:31,652,404...31,658,210
Ensembl chr 6:31,652,416...31,658,210
G
AQP4
aquaporin 4
decreases expression
EXP
methyleugenol results in decreased expression of AQP4 mRNA
CTD
PMID:32234424
NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771
G
AQP4-AS1
AQP4 antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of AQP4-AS1 mRNA
CTD
PMID:32234424
NCBI chr18:26,865,308...26,935,946
Ensembl chr18:26,655,737...27,190,698
G
AQP7P1
aquaporin 7 pseudogene 1
decreases expression
EXP
methyleugenol results in decreased expression of AQP7P1 mRNA
CTD
PMID:32234424
NCBI chr 9:63,315,243...63,334,520
Ensembl chr 9:63,317,067...63,333,091
G
AQP7P2
aquaporin 7 pseudogene 2
decreases expression
EXP
methyleugenol results in decreased expression of AQP7P2 mRNA
CTD
PMID:32234424
NCBI chr 9:64,621,504...64,639,027
Ensembl chr 9:64,621,560...64,637,586
G
AQP7P4
aquaporin 7 pseudogene 4
decreases expression
EXP
methyleugenol results in decreased expression of AQP7P4 mRNA
CTD
PMID:32234424
NCBI chr 9:63,133,597...63,143,456
Ensembl chr 9:63,127,359...63,143,401
G
AQP9
aquaporin 9
decreases expression
EXP
methyleugenol results in decreased expression of AQP9 mRNA
CTD
PMID:32234424
NCBI chr15:58,138,169...58,185,911
Ensembl chr15:58,138,169...58,185,911
G
ARB2A
ARB2 cotranscriptional regulator A
decreases expression
EXP
methyleugenol results in decreased expression of ARB2A mRNA
CTD
PMID:32234424
NCBI chr 5:93,617,725...94,111,699
Ensembl chr 5:93,617,725...94,111,699
G
ARG1
arginase 1
decreases expression
EXP
methyleugenol results in decreased expression of ARG1 mRNA
CTD
PMID:32234424
NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
G
ARHGAP6
Rho GTPase activating protein 6
decreases expression
EXP
methyleugenol results in decreased expression of ARHGAP6 mRNA
CTD
PMID:32234424
NCBI chr X:11,137,544...11,665,920
Ensembl chr X:11,117,651...11,665,920
G
ARHGEF37
Rho guanine nucleotide exchange factor 37
increases expression
EXP
methyleugenol results in increased expression of ARHGEF37 mRNA
CTD
PMID:32234424
NCBI chr 5:149,551,625...149,634,968
Ensembl chr 5:149,551,947...149,634,968
G
ARL14
ADP ribosylation factor like GTPase 14
increases expression
EXP
methyleugenol results in increased expression of ARL14 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 3:160,677,160...160,678,448
Ensembl chr 3:160,677,160...160,678,448
G
ARRB1
arrestin beta 1
increases expression
EXP
methyleugenol results in increased expression of ARRB1 mRNA
CTD
PMID:32234424
NCBI chr11:75,260,122...75,351,661
Ensembl chr11:75,260,122...75,351,705
G
ARSB
arylsulfatase B
decreases expression
EXP
methyleugenol results in decreased expression of ARSB mRNA
CTD
PMID:32234424
NCBI chr 5:78,777,209...78,985,958
Ensembl chr 5:78,777,209...78,986,087
G
ARSF
arylsulfatase F
decreases expression
EXP
methyleugenol results in decreased expression of ARSF mRNA
CTD
PMID:32234424
NCBI chr X:3,040,234...3,112,727
Ensembl chr X:3,041,471...3,112,727
G
ART3
ADP-ribosyltransferase 3 (inactive)
decreases expression
EXP
methyleugenol results in decreased expression of ART3 mRNA
CTD
PMID:32234424
NCBI chr 4:76,011,190...76,112,786
Ensembl chr 4:76,011,184...76,114,048
G
ARVCF
ARVCF delta catenin family member
increases expression
EXP
methyleugenol results in increased expression of ARVCF mRNA
CTD
PMID:32234424
NCBI chr22:19,965,134...20,016,823
Ensembl chr22:19,969,896...20,016,823
G
ASB4
ankyrin repeat and SOCS box containing 4
decreases expression
EXP
methyleugenol results in decreased expression of ASB4 mRNA
CTD
PMID:32234424
NCBI chr 7:95,470,656...95,551,317
Ensembl chr 7:95,478,444...95,540,233
G
ASGR1
asialoglycoprotein receptor 1
decreases expression
EXP
methyleugenol results in decreased expression of ASGR1 mRNA
CTD
PMID:32234424
NCBI chr17:7,173,431...7,179,370
Ensembl chr17:7,173,431...7,179,564
G
ASPDH
aspartate dehydrogenase domain containing
decreases expression
EXP
methyleugenol results in decreased expression of ASPDH mRNA
CTD
PMID:32234424
NCBI chr19:50,511,603...50,515,101
Ensembl chr19:50,511,600...50,514,690
G
ATL1
atlastin GTPase 1
decreases expression
EXP
methyleugenol results in decreased expression of ATL1 mRNA
CTD
PMID:32234424
NCBI chr14:50,533,082...50,633,068
Ensembl chr14:50,532,509...50,634,017
G
ATM
ATM serine/threonine kinase
increases phosphorylation decreases expression
EXP ISO
methyleugenol results in increased phosphorylation of ATM protein methyleugenol results in decreased expression of ATM mRNA
CTD
PMID:26011634 PMID:28818686
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,804...108,369,102
G
ATP13A4
ATPase 13A4
decreases expression
EXP
methyleugenol results in decreased expression of ATP13A4 mRNA
CTD
PMID:32234424
NCBI chr 3:193,398,967...193,593,119
Ensembl chr 3:193,398,967...193,593,111
G
ATP2B2
ATPase plasma membrane Ca2+ transporting 2
decreases expression
EXP
methyleugenol results in decreased expression of ATP2B2 mRNA
CTD
PMID:32234424
NCBI chr 3:10,324,023...10,708,007
Ensembl chr 3:10,324,023...10,708,007
G
ATP8B4
ATPase phospholipid transporting 8B4 (putative)
decreases expression
EXP
methyleugenol results in decreased expression of ATP8B4 mRNA
CTD
PMID:32234424
NCBI chr15:49,858,238...50,181,854
Ensembl chr15:49,858,238...50,182,817
G
ATR
ATR serine/threonine kinase
increases phosphorylation
EXP
methyleugenol results in increased phosphorylation of ATR protein
CTD
PMID:28818686
NCBI chr 3:142,449,235...142,578,733
Ensembl chr 3:142,449,007...142,578,733
G
ATRNL1
attractin like 1
decreases expression
EXP
methyleugenol results in decreased expression of ATRNL1 mRNA
CTD
PMID:32234424
NCBI chr10:115,093,365...115,948,999
Ensembl chr10:115,093,365...115,948,999
G
ATXN1
ataxin 1
decreases expression
EXP
methyleugenol results in decreased expression of ATXN1 mRNA
CTD
PMID:32234424
NCBI chr 6:16,299,112...16,761,460
Ensembl chr 6:16,299,112...16,761,491
G
AURKA
aurora kinase A
decreases expression
ISO EXP
methyleugenol results in decreased expression of AURKA mRNA
CTD
PMID:26011634 PMID:32234424
NCBI chr20:56,369,390...56,392,215
Ensembl chr20:56,369,389...56,392,337
G
AURKB
aurora kinase B
increases expression affects expression
ISO
methyleugenol results in increased expression of AURKB protein methyleugenol affects the expression of AURKB mRNA
CTD
PMID:23411599 PMID:26011634
NCBI chr17:8,204,731...8,210,575
Ensembl chr17:8,204,733...8,210,600
G
AZGP1
alpha-2-glycoprotein 1, zinc-binding
decreases expression
EXP
methyleugenol results in decreased expression of AZGP1 mRNA
CTD
PMID:32234424
NCBI chr 7:99,966,730...99,976,031
Ensembl chr 7:99,966,720...99,976,042
G
AZGP1P1
AZGP1 pseudogene 1
decreases expression
EXP
methyleugenol results in decreased expression of AZGP1P1 mRNA
CTD
PMID:32234424
NCBI chr 7:99,980,762...99,984,237
Ensembl chr 7:99,980,741...99,987,838 Ensembl chr 7:99,980,741...99,987,838
G
AZGP1P2
AZGP1 pseudogene 2
decreases expression
EXP
methyleugenol results in decreased expression of AZGP1P2 mRNA
CTD
PMID:32234424
NCBI chr 7:101,287,479...101,289,775
Ensembl chr 7:101,287,482...101,289,771
G
B3GALT1
beta-1,3-galactosyltransferase 1
decreases expression
EXP
methyleugenol results in decreased expression of B3GALT1 mRNA
CTD
PMID:32234424
NCBI chr 2:167,293,001...167,874,045
Ensembl chr 2:167,293,001...167,874,045
G
B3GNT3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
increases expression
EXP
methyleugenol results in increased expression of B3GNT3 mRNA
CTD
PMID:32234424
NCBI chr19:17,794,791...17,813,576
Ensembl chr19:17,794,828...17,813,576
G
B4GALNT1
beta-1,4-N-acetyl-galactosaminyltransferase 1
increases expression
EXP
methyleugenol results in increased expression of B4GALNT1 mRNA
CTD
PMID:32234424
NCBI chr12:57,623,409...57,633,201
Ensembl chr12:57,623,409...57,633,239
G
BAAT
bile acid-CoA:amino acid N-acyltransferase
decreases expression
EXP
methyleugenol results in decreased expression of BAAT mRNA
CTD
PMID:32234424
NCBI chr 9:101,360,417...101,385,006
Ensembl chr 9:101,354,182...101,385,400
G
BABAM2
BRISC and BRCA1 A complex member 2
decreases expression
EXP
methyleugenol results in decreased expression of BABAM2 mRNA
CTD
PMID:32234424
NCBI chr 2:27,888,709...28,338,901
Ensembl chr 2:27,889,941...28,338,901
G
BAIAP2L2
BAR/IMD domain containing adaptor protein 2 like 2
increases expression
EXP
methyleugenol results in increased expression of BAIAP2L2 mRNA
CTD
PMID:32234424
NCBI chr22:38,084,900...38,110,967
Ensembl chr22:38,084,652...38,111,015
G
BANF1P2
BANF1 pseudogene 2
decreases expression
EXP
methyleugenol results in decreased expression of BANF1P2 mRNA
CTD
PMID:32234424
NCBI chr10:133,344,275...133,344,990
Ensembl chr10:133,344,643...133,344,906
G
BANK1
B cell scaffold protein with ankyrin repeats 1
decreases expression
EXP
methyleugenol results in decreased expression of BANK1 mRNA
CTD
PMID:32234424
NCBI chr 4:101,790,730...102,074,812
Ensembl chr 4:101,411,286...102,074,812
G
BATF3
basic leucine zipper ATF-like transcription factor 3
increases expression
EXP
methyleugenol results in increased expression of BATF3 mRNA
CTD
PMID:32234424
NCBI chr 1:212,686,417...212,699,840
Ensembl chr 1:212,686,417...212,699,840
G
BAX
BCL2 associated X, apoptosis regulator
increases expression
EXP
methyleugenol results in increased expression of BAX mRNA
CTD
PMID:32234424
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BBOX1
gamma-butyrobetaine hydroxylase 1
decreases expression
EXP
methyleugenol results in decreased expression of BBOX1 mRNA
CTD
PMID:32234424
NCBI chr11:27,040,815...27,127,809
Ensembl chr11:27,040,725...27,127,809
G
BBS9
Bardet-Biedl syndrome 9
decreases expression
EXP
methyleugenol results in decreased expression of BBS9 mRNA
CTD
PMID:32234424
NCBI chr 7:33,129,285...33,635,767
Ensembl chr 7:33,109,557...33,877,180
G
BCAS3
BCAS3 microtubule associated cell migration factor
decreases expression
EXP
methyleugenol results in decreased expression of BCAS3 mRNA
CTD
PMID:32234424
NCBI chr17:60,677,851...61,392,831
Ensembl chr17:60,677,453...61,392,838
G
BCKDHB
branched chain keto acid dehydrogenase E1 subunit beta
decreases expression
EXP
methyleugenol results in decreased expression of BCKDHB mRNA
CTD
PMID:32234424
NCBI chr 6:80,106,610...80,466,676
Ensembl chr 6:80,106,647...80,346,270
G
BCL2L15
BCL2 like 15
increases expression
EXP
methyleugenol results in increased expression of BCL2L15 mRNA
CTD
PMID:32234424
NCBI chr 1:113,876,816...113,887,581
Ensembl chr 1:113,876,816...113,887,581
G
BDH1
3-hydroxybutyrate dehydrogenase 1
decreases expression
EXP
methyleugenol results in decreased expression of BDH1 mRNA
CTD
PMID:32234424
NCBI chr 3:197,509,783...197,573,343
Ensembl chr 3:197,509,783...197,573,323
G
BDKRB2
bradykinin receptor B2
increases expression
EXP
methyleugenol results in increased expression of BDKRB2 mRNA
CTD
PMID:32234424
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
G
BHLHE40-AS1
BHLHE40 antisense RNA 1
increases expression
EXP
methyleugenol results in increased expression of BHLHE40-AS1 mRNA
CTD
PMID:32234424
NCBI chr 3:4,896,809...4,979,961
Ensembl chr 3:4,896,806...4,980,414
G
BHLHE41
basic helix-loop-helix family member e41
increases expression
EXP
methyleugenol results in increased expression of BHLHE41 mRNA
CTD
PMID:32234424
NCBI chr12:26,120,030...26,125,037
Ensembl chr12:26,120,030...26,125,037
G
BHMT
betaine--homocysteine S-methyltransferase
decreases expression
EXP
methyleugenol results in decreased expression of BHMT mRNA
CTD
PMID:32234424
NCBI chr 5:79,111,809...79,132,288
Ensembl chr 5:79,111,809...79,132,288
G
BMERB1
bMERB domain containing 1
decreases expression
EXP
methyleugenol results in decreased expression of BMERB1 mRNA
CTD
PMID:32234424
NCBI chr16:15,434,588...15,588,259
Ensembl chr16:15,434,475...15,625,028
G
BMF
Bcl2 modifying factor
increases expression
EXP
methyleugenol results in increased expression of BMF mRNA
CTD
PMID:32234424
NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892
G
BMPR1B
bone morphogenetic protein receptor type 1B
decreases expression
EXP
methyleugenol results in decreased expression of BMPR1B mRNA
CTD
PMID:32234424
NCBI chr 4:94,757,955...95,158,450
Ensembl chr 4:94,757,955...95,158,448
G
BRCA1
BRCA1 DNA repair associated
decreases expression
ISO
methyleugenol results in decreased expression of BRCA1 mRNA
CTD
PMID:21659616 PMID:26011634
NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245
G
BRCA2
BRCA2 DNA repair associated
decreases expression
ISO
methyleugenol results in decreased expression of BRCA2 mRNA
CTD
PMID:26011634
NCBI chr13:32,315,508...32,400,268
Ensembl chr13:32,315,086...32,400,268
G
BRCC3
BRCA1/BRCA2-containing complex subunit 3
affects expression
ISO
methyleugenol affects the expression of BRCC3 mRNA
CTD
PMID:26011634
NCBI chr X:155,071,508...155,123,077
Ensembl chr X:155,071,420...155,123,077
G
BRINP1
BMP/retinoic acid inducible neural specific 1
decreases expression
EXP
methyleugenol results in decreased expression of BRINP1 mRNA
CTD
PMID:32234424
NCBI chr 9:119,166,629...119,369,435
Ensembl chr 9:119,153,458...119,369,435
G
BSN
bassoon presynaptic cytomatrix protein
decreases expression
EXP
methyleugenol results in decreased expression of BSN mRNA
CTD
PMID:32234424
NCBI chr 3:49,554,477...49,673,130
Ensembl chr 3:49,554,477...49,671,549
G
BTBD16
BTB domain containing 16
decreases expression
EXP
methyleugenol results in decreased expression of BTBD16 mRNA
CTD
PMID:32234424
NCBI chr10:122,271,296...122,338,159
Ensembl chr10:122,271,296...122,338,159
G
BTBD9
BTB domain containing 9
decreases expression
EXP
methyleugenol results in decreased expression of BTBD9 mRNA
CTD
PMID:32234424
NCBI chr 6:38,168,451...38,639,929
Ensembl chr 6:38,168,451...38,640,148
G
BUB1
BUB1 mitotic checkpoint serine/threonine kinase
increases expression
ISO
methyleugenol results in increased expression of BUB1 mRNA
CTD
PMID:26011634
NCBI chr 2:110,637,528...110,678,063
Ensembl chr 2:110,637,528...110,678,063
G
C11orf54
chromosome 11 open reading frame 54
decreases expression
EXP
methyleugenol results in decreased expression of C11ORF54 mRNA
CTD
PMID:32234424
NCBI chr11:93,741,672...93,764,749
Ensembl chr11:93,741,591...93,764,749
G
C11orf65
chromosome 11 open reading frame 65
decreases expression
EXP
methyleugenol results in decreased expression of C11ORF65 mRNA
CTD
PMID:32234424
NCBI chr11:108,308,519...108,469,881
Ensembl chr11:108,308,519...108,467,531
G
C11orf86
chromosome 11 open reading frame 86
decreases expression
EXP
methyleugenol results in decreased expression of C11ORF86 mRNA
CTD
PMID:32234424
NCBI chr11:66,975,304...66,977,009
Ensembl chr11:66,975,277...66,977,009
G
C1orf226
chromosome 1 open reading frame 226
decreases expression
EXP
methyleugenol results in decreased expression of C1ORF226 mRNA
CTD
PMID:32234424
NCBI chr 1:162,378,841...162,386,812
Ensembl chr 1:162,378,841...162,386,812
G
C2CD4A
C2 calcium dependent domain containing 4A
increases expression
EXP
methyleugenol results in increased expression of C2CD4A mRNA
CTD
PMID:32234424
NCBI chr15:62,066,977...62,070,917
Ensembl chr15:62,066,977...62,070,917
G
C3P1
complement component 3 precursor pseudogene
decreases expression
EXP
methyleugenol results in decreased expression of C3P1 mRNA
CTD
PMID:32234424
NCBI chr19:10,041,356...10,074,138
Ensembl chr19:10,037,803...10,074,135 Ensembl chr19:10,037,803...10,074,135
G
C4BPA
complement component 4 binding protein alpha
decreases expression
EXP
methyleugenol results in decreased expression of C4BPA mRNA
CTD
PMID:32234424
NCBI chr 1:207,104,233...207,144,972
Ensembl chr 1:207,104,233...207,144,972
G
C4BPB
complement component 4 binding protein beta
decreases expression
EXP
methyleugenol results in decreased expression of C4BPB mRNA
CTD
PMID:32234424
NCBI chr 1:207,088,860...207,099,993
Ensembl chr 1:207,088,860...207,099,993
G
C5
complement C5
decreases expression
EXP
methyleugenol results in decreased expression of C5 mRNA
CTD
PMID:32234424
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
G
C6
complement C6
decreases expression
EXP
methyleugenol results in decreased expression of C6 mRNA
CTD
PMID:32234424
NCBI chr 5:41,142,116...41,261,469
Ensembl chr 5:41,142,116...41,261,438
G
C6orf141
chromosome 6 open reading frame 141
increases expression
EXP
methyleugenol results in increased expression of C6ORF141 mRNA
CTD
PMID:32234424
NCBI chr 6:49,550,668...49,561,916
Ensembl chr 6:49,550,666...49,561,907
G
C8A
complement C8 alpha chain
decreases expression
EXP
methyleugenol results in decreased expression of C8A mRNA
CTD
PMID:32234424
NCBI chr 1:56,854,797...56,918,223
Ensembl chr 1:56,854,768...56,918,223
G
C8B
complement C8 beta chain
decreases expression
EXP
methyleugenol results in decreased expression of C8B mRNA
CTD
PMID:32234424
NCBI chr 1:56,929,207...56,966,015
Ensembl chr 1:56,929,207...56,974,383
G
C8G
complement C8 gamma chain
decreases expression
EXP
methyleugenol results in decreased expression of C8G mRNA
CTD
PMID:32234424
NCBI chr 9:136,945,243...136,946,975
Ensembl chr 9:136,945,185...136,946,975
G
C9
complement C9
decreases expression
EXP
methyleugenol results in decreased expression of C9 mRNA
CTD
PMID:32234424
NCBI chr 5:39,284,140...39,364,495
Ensembl chr 5:39,284,140...39,371,324
G
CA12
carbonic anhydrase 12
increases expression
EXP
methyleugenol results in increased expression of CA12 mRNA
CTD
PMID:32234424
NCBI chr15:63,321,378...63,381,846
Ensembl chr15:63,321,378...63,381,846
G
CA3
carbonic anhydrase 3
decreases expression
EXP
methyleugenol results in decreased expression of CA3 mRNA
CTD
PMID:32234424
NCBI chr 8:85,438,859...85,449,040
Ensembl chr 8:85,373,436...85,449,040
G
CA9
carbonic anhydrase 9
decreases expression
EXP
methyleugenol results in decreased expression of CA9 mRNA
CTD
PMID:32234424
NCBI chr 9:35,673,928...35,681,159
Ensembl chr 9:35,673,928...35,681,159
G
CACNA1D
calcium voltage-gated channel subunit alpha1 D
decreases expression
EXP
methyleugenol results in decreased expression of CACNA1D mRNA
CTD
PMID:32234424
NCBI chr 3:53,494,611...53,813,733
Ensembl chr 3:53,328,963...53,813,733
G
CACNA2D1
calcium voltage-gated channel auxiliary subunit alpha2delta 1
decreases expression
EXP
methyleugenol results in decreased expression of CACNA2D1 mRNA
CTD
PMID:32234424
NCBI chr 7:81,946,444...82,443,956
Ensembl chr 7:81,946,444...82,443,956
G
CACNA2D3
calcium voltage-gated channel auxiliary subunit alpha2delta 3
decreases expression
EXP
methyleugenol results in decreased expression of CACNA2D3 mRNA
CTD
PMID:32234424
NCBI chr 3:54,122,552...55,074,557
Ensembl chr 3:54,122,552...55,074,557
G
CACNB3
calcium voltage-gated channel auxiliary subunit beta 3
increases expression
EXP
methyleugenol results in increased expression of CACNB3 mRNA
CTD
PMID:32234424
NCBI chr12:48,814,480...48,828,941
Ensembl chr12:48,813,794...48,828,941
G
CADM2
cell adhesion molecule 2
decreases expression
EXP
methyleugenol results in decreased expression of CADM2 mRNA
CTD
PMID:32234424
NCBI chr 3:84,958,989...86,074,429
Ensembl chr 3:84,958,989...86,074,429
G
CADPS2
calcium dependent secretion activator 2
decreases expression
EXP
methyleugenol results in decreased expression of CADPS2 mRNA
CTD
PMID:32234424
NCBI chr 7:122,318,411...122,886,460
Ensembl chr 7:122,318,411...122,886,759
G
CALB2
calbindin 2
increases expression
EXP
methyleugenol results in increased expression of CALB2 mRNA
CTD
PMID:32234424
NCBI chr16:71,358,723...71,390,433
Ensembl chr16:71,358,713...71,390,436
G
CALML4
calmodulin like 4
decreases expression
EXP
methyleugenol results in decreased expression of CALML4 mRNA
CTD
PMID:32234424
NCBI chr15:68,190,705...68,206,110
Ensembl chr15:68,190,705...68,206,079
G
CALN1
calneuron 1
decreases expression
EXP
methyleugenol results in decreased expression of CALN1 mRNA
CTD
PMID:32234424
NCBI chr 7:71,779,491...72,504,279
Ensembl chr 7:71,779,491...72,447,151
G
CAMK1D
calcium/calmodulin dependent protein kinase ID
decreases expression
EXP
methyleugenol results in decreased expression of CAMK1D mRNA
CTD
PMID:32234424
NCBI chr10:12,349,547...12,835,545
Ensembl chr10:12,349,547...12,835,545
G
CAMK4
calcium/calmodulin dependent protein kinase IV
decreases expression
EXP
methyleugenol results in decreased expression of CAMK4 mRNA
CTD
PMID:32234424
NCBI chr 5:111,223,583...111,494,886
Ensembl chr 5:111,223,653...111,494,886
G
CARMIL3
capping protein regulator and myosin 1 linker 3
decreases expression
EXP
methyleugenol results in decreased expression of CARMIL3 mRNA
CTD
PMID:32234424
NCBI chr14:24,052,009...24,069,729
Ensembl chr14:24,052,009...24,069,729
G
CASP16P
caspase 16, pseudogene
decreases expression
EXP
methyleugenol results in decreased expression of CASP16P mRNA
CTD
PMID:32234424
NCBI chr16:3,144,291...3,149,946
Ensembl chr16:3,144,219...3,149,963 Ensembl chr16:3,144,219...3,149,963
G
CASP3
caspase 3
increases activity increases cleavage
EXP ISO
methyleugenol results in increased activity of CASP3 protein methyleugenol results in increased cleavage of CASP3 protein
CTD
PMID:26011634 PMID:28818686
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CAT
catalase
decreases expression
EXP
methyleugenol results in decreased expression of CAT mRNA
CTD
PMID:32234424
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CATSPER3
cation channel sperm associated 3
decreases expression
EXP
methyleugenol results in decreased expression of CATSPER3 mRNA
CTD
PMID:32234424
NCBI chr 5:134,967,907...135,011,696
Ensembl chr 5:134,967,907...135,011,696
G
CATSPERE
catsper channel auxiliary subunit epsilon
decreases expression
EXP
methyleugenol results in decreased expression of CATSPERE mRNA
CTD
PMID:32234424
NCBI chr 1:244,451,242...244,640,504
Ensembl chr 1:244,454,377...244,641,177
G
CBARP
CACN subunit beta associated regulatory protein
decreases expression
EXP
methyleugenol results in decreased expression of CBARP mRNA
CTD
PMID:32234424
NCBI chr19:1,228,287...1,238,502
Ensembl chr19:1,228,287...1,238,027
G
CBR3
carbonyl reductase 3
increases expression
EXP
methyleugenol results in increased expression of CBR3 mRNA
CTD
PMID:32234424
NCBI chr21:36,135,079...36,146,562
Ensembl chr21:36,135,079...36,146,562
G
CBX5
chromobox 5
increases expression
ISO
methyleugenol results in increased expression of CBX5 protein
CTD
PMID:23411599
NCBI chr12:54,230,942...54,280,122
Ensembl chr12:54,230,942...54,280,133
G
CCBE1
collagen and calcium binding EGF domains 1
decreases expression
EXP
methyleugenol results in decreased expression of CCBE1 mRNA
CTD
PMID:32234424
NCBI chr18:59,430,939...59,697,721
Ensembl chr18:59,430,939...59,697,662
G
CCDC13-AS2
CCDC13 antisense RNA 2
decreases expression
EXP
methyleugenol results in decreased expression of CCDC13-AS2 mRNA
CTD
PMID:32234424
NCBI chr 3:42,770,612...42,773,635
Ensembl chr 3:42,770,600...42,773,785
G
CCDC141
coiled-coil domain containing 141
decreases expression
EXP
methyleugenol results in decreased expression of CCDC141 mRNA
CTD
PMID:32234424
NCBI chr 2:178,814,978...179,050,137
Ensembl chr 2:178,829,757...179,050,137
G
CCDC146
coiled-coil domain containing 146
decreases expression
EXP
methyleugenol results in decreased expression of CCDC146 mRNA
CTD
PMID:32234424
NCBI chr 7:77,122,615...77,295,204
Ensembl chr 7:77,122,434...77,329,533
G
CCDC170
coiled-coil domain containing 170
decreases expression
EXP
methyleugenol results in decreased expression of CCDC170 mRNA
CTD
PMID:32234424
NCBI chr 6:151,494,017...151,621,193
Ensembl chr 6:151,494,017...151,621,193
G
CCDC171
coiled-coil domain containing 171
decreases expression
EXP
methyleugenol results in decreased expression of CCDC171 mRNA
CTD
PMID:32234424
NCBI chr 9:15,552,885...16,108,926
Ensembl chr 9:15,553,043...16,061,663
G
CCL16
C-C motif chemokine ligand 16
decreases expression
EXP
methyleugenol results in decreased expression of CCL16 mRNA
CTD
PMID:32234424
NCBI chr17:35,976,499...35,981,497
Ensembl chr17:35,976,493...35,981,497
G
CCN2
cellular communication network factor 2
decreases expression
EXP
methyleugenol results in decreased expression of CCN2 mRNA
CTD
PMID:32234424
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
G
CCNB1
cyclin B1
decreases expression
EXP
methyleugenol results in decreased expression of CCNB1 mRNA
CTD
PMID:32234424
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
G
CCNG1
cyclin G1
increases expression
ISO
methyleugenol results in increased expression of CCNG1 mRNA
CTD
PMID:15618236
NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,446,151
G
CCRL2
C-C motif chemokine receptor like 2
increases expression
EXP
methyleugenol results in increased expression of CCRL2 mRNA
CTD
PMID:32234424
NCBI chr 3:46,407,259...46,409,523
Ensembl chr 3:46,407,166...46,412,997
G
CCSER1
coiled-coil serine rich protein 1
decreases expression
EXP
methyleugenol results in decreased expression of CCSER1 mRNA
CTD
PMID:32234424
NCBI chr 4:90,127,394...91,605,295
Ensembl chr 4:90,127,394...91,605,295
G
CD22
CD22 molecule
increases expression
EXP
methyleugenol results in increased expression of CD22 mRNA
CTD
PMID:32234424
NCBI chr19:35,329,187...35,347,361
Ensembl chr19:35,319,261...35,347,361
G
CD44
CD44 molecule (IN blood group)
increases expression
EXP
methyleugenol results in increased expression of CD44 mRNA
CTD
PMID:32234424
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
G
CD9
CD9 molecule
increases expression
EXP
methyleugenol results in increased expression of CD9 mRNA
CTD
PMID:32234424
NCBI chr12:6,199,946...6,238,266
Ensembl chr12:6,199,715...6,238,271
G
CDC14A
cell division cycle 14A
decreases expression
EXP
methyleugenol results in decreased expression of CDC14A mRNA
CTD
PMID:32234424
NCBI chr 1:100,345,001...100,520,277
Ensembl chr 1:100,345,001...100,520,277
G
CDC20B
cell division cycle 20B
decreases expression
EXP
methyleugenol results in decreased expression of CDC20B mRNA
CTD
PMID:32234424
NCBI chr 5:55,112,971...55,173,177
Ensembl chr 5:55,112,971...55,173,177
G
CDCA3
cell division cycle associated 3
decreases expression
EXP
methyleugenol results in decreased expression of CDCA3 mRNA
CTD
PMID:32234424
NCBI chr12:6,844,798...6,851,286
Ensembl chr12:6,844,793...6,851,292
G
CDH1
cadherin 1
decreases expression
EXP
methyleugenol results in decreased expression of CDH1 mRNA
CTD
PMID:32234424
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
G
CDH12
cadherin 12
decreases expression
EXP
methyleugenol results in decreased expression of CDH12 mRNA
CTD
PMID:32234424
NCBI chr 5:21,750,673...22,853,344
Ensembl chr 5:21,750,673...22,853,344
G
CDK1
cyclin dependent kinase 1
increases expression
ISO
methyleugenol results in increased expression of CDK1 protein
CTD
PMID:23411599
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
G
CDK14
cyclin dependent kinase 14
decreases expression
EXP
methyleugenol results in decreased expression of CDK14 mRNA
CTD
PMID:32234424
NCBI chr 7:90,596,321...91,210,590
Ensembl chr 7:90,466,424...91,210,590
G
CDK2AP2
cyclin dependent kinase 2 associated protein 2
decreases expression
EXP
methyleugenol results in decreased expression of CDK2AP2 mRNA
CTD
PMID:32234424
NCBI chr11:67,506,497...67,508,162
Ensembl chr11:67,506,497...67,508,649
G
CDKAL1
CDK5 regulatory subunit associated protein 1 like 1
decreases expression
EXP
methyleugenol results in decreased expression of CDKAL1 mRNA
CTD
PMID:32234424
NCBI chr 6:20,534,457...21,232,404
Ensembl chr 6:20,534,457...21,232,404
G
CDKN1A
cyclin dependent kinase inhibitor 1A
increases expression increases phosphorylation
ISO
methyleugenol results in increased expression of CDKN1A mRNA methyleugenol results in increased phosphorylation of CDKN1A protein methyleugenol results in increased expression of CDKN1A mRNA; methyleugenol results in increased expression of CDKN1A protein
CTD
PMID:15618236 PMID:23411599 PMID:26011634
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDKN2A
cyclin dependent kinase inhibitor 2A
increases expression decreases expression
ISO
methyleugenol results in increased expression of CDKN2A protein methyleugenol results in decreased expression of CDKN2A mRNA
CTD
PMID:23411599 PMID:26011634
NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
G
CDO1
cysteine dioxygenase type 1
decreases expression
EXP
methyleugenol results in decreased expression of CDO1 mRNA
CTD
PMID:32234424
NCBI chr 5:115,804,733...115,816,659
Ensembl chr 5:115,804,733...115,816,659
G
CDR2L
cerebellar degeneration related protein 2 like
increases expression
EXP
methyleugenol results in increased expression of CDR2L mRNA
CTD
PMID:32234424
NCBI chr17:74,987,632...75,005,800
Ensembl chr17:74,987,632...75,005,800
G
CEACAM1
CEA cell adhesion molecule 1
increases expression
EXP
methyleugenol results in increased expression of CEACAM1 mRNA
CTD
PMID:32234424
NCBI chr19:42,507,306...42,528,481
Ensembl chr19:42,507,304...42,561,234
G
CEACAM20
CEA cell adhesion molecule 20
decreases expression
EXP
methyleugenol results in decreased expression of CEACAM20 mRNA
CTD
PMID:32234424
NCBI chr19:44,506,159...44,529,675
Ensembl chr19:44,501,677...44,529,788
G
CEMIP
cell migration inducing hyaluronidase 1
decreases expression
EXP
methyleugenol results in decreased expression of CEMIP mRNA
CTD
PMID:32234424
NCBI chr15:80,779,370...80,951,771
Ensembl chr15:80,779,343...80,951,776
G
CENPA
centromere protein A
decreases expression
EXP
methyleugenol results in decreased expression of CENPA mRNA
CTD
PMID:32234424
NCBI chr 2:26,786,056...26,794,589
Ensembl chr 2:26,764,289...26,801,067
G
CENPE
centromere protein E
decreases expression
EXP
methyleugenol results in decreased expression of CENPE mRNA
CTD
PMID:32234424
NCBI chr 4:103,105,811...103,198,343
Ensembl chr 4:103,105,349...103,198,445
G
CEP128
centrosomal protein 128
decreases expression
EXP
methyleugenol results in decreased expression of CEP128 mRNA
CTD
PMID:32234424
NCBI chr14:80,476,969...80,959,502
Ensembl chr14:80,476,983...80,959,517
G
CES3
carboxylesterase 3
decreases expression
EXP
methyleugenol results in decreased expression of CES3 mRNA
CTD
PMID:32234424
NCBI chr16:66,961,266...66,975,149
Ensembl chr16:66,961,245...66,975,149
G
CFAP20DC
CFAP20 domain containing
decreases expression
EXP
methyleugenol results in decreased expression of CFAP20DC mRNA
CTD
PMID:32234424
NCBI chr 3:58,716,173...59,050,025
Ensembl chr 3:58,717,365...59,050,084
G
CFAP418-AS1
CFAP418 antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of CFAP418-AS1 mRNA
CTD
PMID:32234424
NCBI chr 8:95,268,836...95,810,143
Ensembl chr 8:95,204,456...95,811,254
G
CFAP52
cilia and flagella associated protein 52
decreases expression
EXP
methyleugenol results in decreased expression of CFAP52 mRNA
CTD
PMID:32234424
NCBI chr17:9,576,642...9,645,554
Ensembl chr17:9,576,627...9,643,447
G
CFB
complement factor B
decreases expression
EXP
methyleugenol results in decreased expression of CFB mRNA
CTD
PMID:32234424
NCBI chr 6:31,946,095...31,952,084
Ensembl chr 6:31,945,650...31,952,086
G
CFHR1
complement factor H related 1
decreases expression
EXP
methyleugenol results in decreased expression of CFHR1 mRNA
CTD
PMID:32234424
NCBI chr 1:196,819,731...196,832,189
Ensembl chr 1:196,819,731...196,837,159
G
CFHR2
complement factor H related 2
decreases expression
EXP
methyleugenol results in decreased expression of CFHR2 mRNA
CTD
PMID:32234424
NCBI chr 1:196,943,738...196,959,622
Ensembl chr 1:196,943,738...196,959,622
G
CFHR3
complement factor H related 3
decreases expression
EXP
methyleugenol results in decreased expression of CFHR3 mRNA
CTD
PMID:32234424
NCBI chr 1:196,774,840...196,795,407
Ensembl chr 1:196,774,813...196,795,407
G
CFHR4
complement factor H related 4
decreases expression
EXP
methyleugenol results in decreased expression of CFHR4 mRNA
CTD
PMID:32234424
NCBI chr 1:196,888,052...196,918,633
Ensembl chr 1:196,888,014...196,918,795
G
CFHR5
complement factor H related 5
decreases expression
EXP
methyleugenol results in decreased expression of CFHR5 mRNA
CTD
PMID:32234424
NCBI chr 1:196,975,034...197,009,678
Ensembl chr 1:196,975,010...197,009,678
G
CHEK1
checkpoint kinase 1
affects expression
ISO
methyleugenol affects the expression of CHEK1 mRNA
CTD
PMID:26011634
NCBI chr11:125,625,136...125,681,124
Ensembl chr11:125,625,163...125,676,255
G
CHEK2
checkpoint kinase 2
decreases expression
ISO
methyleugenol results in decreased expression of CHEK2 mRNA
CTD
PMID:26011634
NCBI chr22:28,687,743...28,741,834
Ensembl chr22:28,687,743...28,742,422
G
CHN2
chimerin 2
decreases expression
EXP
methyleugenol results in decreased expression of CHN2 mRNA
CTD
PMID:32234424
NCBI chr 7:29,146,591...29,514,328
Ensembl chr 7:29,146,547...29,514,328
G
CIDEB
cell death inducing DFFA like effector b
decreases expression
EXP
methyleugenol results in decreased expression of CIDEB mRNA
CTD
PMID:32234424
NCBI chr14:24,305,187...24,311,435
Ensembl chr14:24,305,187...24,311,430
G
CISH
cytokine inducible SH2 containing protein
decreases expression
ISO
methyleugenol results in decreased expression of CISH mRNA
CTD
PMID:15618236
NCBI chr 3:50,606,489...50,611,774
Ensembl chr 3:50,606,489...50,611,774
G
CLCNKA
chloride voltage-gated channel Ka
decreases expression
EXP
methyleugenol results in decreased expression of CLCNKA mRNA
CTD
PMID:32234424
NCBI chr 1:16,022,036...16,034,050
Ensembl chr 1:16,018,875...16,034,050
G
CLDN14
claudin 14
decreases expression
EXP
methyleugenol results in decreased expression of CLDN14 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr21:36,460,621...36,576,569
Ensembl chr21:36,460,621...36,576,569
G
CLDN16
claudin 16
decreases expression
EXP
methyleugenol results in decreased expression of CLDN16 mRNA
CTD
PMID:32234424
NCBI chr 3:190,290,361...190,412,138
Ensembl chr 3:190,322,541...190,412,138
G
CLRN3
clarin 3
decreases expression
EXP
methyleugenol results in decreased expression of CLRN3 mRNA
CTD
PMID:32234424
NCBI chr10:127,877,841...127,892,941
Ensembl chr10:127,877,841...127,892,941
G
CLYBL
citramalyl-CoA lyase
decreases expression
EXP
methyleugenol results in decreased expression of CLYBL mRNA
CTD
PMID:32234424
NCBI chr13:99,606,690...99,909,444
Ensembl chr13:99,606,669...99,909,459
G
CMSS1
cms1 ribosomal small subunit homolog
decreases expression
EXP
methyleugenol results in decreased expression of CMSS1 mRNA
CTD
PMID:32234424
NCBI chr 3:99,817,862...100,181,732
Ensembl chr 3:99,817,837...100,181,732
G
CNGA1
cyclic nucleotide gated channel subunit alpha 1
decreases expression
EXP
methyleugenol results in decreased expression of CNGA1 mRNA
CTD
PMID:32234424
NCBI chr 4:47,935,977...48,016,681
Ensembl chr 4:47,935,977...48,016,681
G
CNKSR2
connector enhancer of kinase suppressor of Ras 2
decreases expression
EXP
methyleugenol results in decreased expression of CNKSR2 mRNA
CTD
PMID:32234424
NCBI chr X:21,374,418...21,654,689
Ensembl chr X:21,372,801...21,654,695
G
CNN2P3
calponin 2 pseudogene 3
decreases expression
EXP
methyleugenol results in decreased expression of CNN2P3 mRNA
CTD
PMID:32234424
NCBI chr 9:64,485,967...64,487,107
Ensembl chr 9:64,486,164...64,487,069
G
CNTN1
contactin 1
decreases expression
EXP
methyleugenol results in decreased expression of CNTN1 mRNA
CTD
PMID:32234424
NCBI chr12:40,692,439...41,072,415
Ensembl chr12:40,692,439...41,072,415
G
CNTN5
contactin 5
decreases expression
EXP
methyleugenol results in decreased expression of CNTN5 mRNA
CTD
PMID:32234424
NCBI chr11:99,020,949...100,358,885
Ensembl chr11:99,020,949...100,358,885
G
COBL
cordon-bleu WH2 repeat protein
decreases expression
EXP
methyleugenol results in decreased expression of COBL mRNA
CTD
PMID:32234424
NCBI chr 7:51,016,212...51,316,809
Ensembl chr 7:51,016,212...51,316,818
G
COL18A1
collagen type XVIII alpha 1 chain
decreases expression
EXP
methyleugenol results in decreased expression of COL18A1 mRNA
CTD
PMID:32234424
NCBI chr21:45,405,165...45,513,720
Ensembl chr21:45,405,165...45,513,720
G
COL5A2
collagen type V alpha 2 chain
decreases expression
EXP
methyleugenol results in decreased expression of COL5A2 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 2:189,031,898...189,441,111
Ensembl chr 2:189,031,898...189,225,312
G
COL8A1
collagen type VIII alpha 1 chain
decreases expression
EXP
methyleugenol results in decreased expression of COL8A1 mRNA
CTD
PMID:32234424
NCBI chr 3:99,638,594...99,799,217
Ensembl chr 3:99,638,475...99,799,226
G
COMMD1
copper metabolism domain containing 1
decreases expression
EXP
methyleugenol results in decreased expression of COMMD1 mRNA
CTD
PMID:32234424
NCBI chr 2:61,888,391...62,136,058
Ensembl chr 2:61,888,724...62,147,247
G
COMMD10
COMM domain containing 10
decreases expression
EXP
methyleugenol results in decreased expression of COMMD10 mRNA
CTD
PMID:32234424
NCBI chr 5:116,085,025...116,293,287
Ensembl chr 5:116,085,016...116,412,762
G
COX6A2
cytochrome c oxidase subunit 6A2
decreases expression
EXP
methyleugenol results in decreased expression of COX6A2 mRNA
CTD
PMID:32234424
NCBI chr16:31,427,731...31,428,360
Ensembl chr16:31,427,731...31,428,360
G
CPA4
carboxypeptidase A4
increases expression
EXP
methyleugenol results in increased expression of CPA4 mRNA
CTD
PMID:32234424
NCBI chr 7:130,293,161...130,324,180
Ensembl chr 7:130,293,134...130,324,180
G
CPA5
carboxypeptidase A5
increases expression
EXP
methyleugenol results in increased expression of CPA5 mRNA
CTD
PMID:32234424
NCBI chr 7:130,344,816...130,374,599
Ensembl chr 7:130,344,816...130,368,730
G
CPB2
carboxypeptidase B2
decreases expression
EXP
methyleugenol results in decreased expression of CPB2 mRNA
CTD
PMID:32234424
NCBI chr13:46,053,186...46,105,033
Ensembl chr13:46,053,186...46,105,033
G
CPB2-AS1
CPB2 antisense RNA 1
increases expression
EXP
methyleugenol results in increased expression of CPB2-AS1 mRNA
CTD
PMID:32234424
NCBI chr13:46,052,848...46,101,347
Ensembl chr13:46,052,497...46,161,379
G
CPED1
cadherin like and PC-esterase domain containing 1
decreases expression
EXP
methyleugenol results in decreased expression of CPED1 mRNA
CTD
PMID:32234424
NCBI chr 7:120,988,711...121,297,442
Ensembl chr 7:120,988,697...121,297,442
G
CPLX1
complexin 1
decreases expression
EXP
methyleugenol results in decreased expression of CPLX1 mRNA
CTD
PMID:32234424
NCBI chr 4:784,957...826,129
Ensembl chr 4:784,957...826,129
G
CPN1
carboxypeptidase N subunit 1
decreases expression
EXP
methyleugenol results in decreased expression of CPN1 mRNA
CTD
PMID:32234424
NCBI chr10:100,042,193...100,081,869
Ensembl chr10:100,042,193...100,081,869
G
CPNE2
copine 2
increases expression
EXP
methyleugenol results in increased expression of CPNE2 mRNA
CTD
PMID:32234424
NCBI chr16:57,092,583...57,148,369
Ensembl chr16:57,092,583...57,148,369
G
CPNE4
copine 4
decreases expression
EXP
methyleugenol results in decreased expression of CPNE4 mRNA
CTD
PMID:32234424
NCBI chr 3:131,533,569...132,039,606
Ensembl chr 3:131,533,555...132,285,410
G
CPNE6
copine 6
decreases expression
EXP
methyleugenol results in decreased expression of CPNE6 mRNA
CTD
PMID:32234424
NCBI chr14:24,070,949...24,078,087
Ensembl chr14:24,070,837...24,078,100
G
CPQ
carboxypeptidase Q
decreases expression
EXP
methyleugenol results in decreased expression of CPQ mRNA
CTD
PMID:32234424
NCBI chr 8:96,645,242...97,143,501
Ensembl chr 8:96,645,242...97,149,654
G
CPS1
carbamoyl-phosphate synthase 1
decreases expression
EXP
methyleugenol results in decreased expression of CPS1 mRNA
CTD
PMID:32234424
NCBI chr 2:210,477,685...210,679,107
Ensembl chr 2:210,477,682...210,679,107
G
CPVL
carboxypeptidase vitellogenic like
decreases expression
EXP
methyleugenol results in decreased expression of CPVL mRNA
CTD
PMID:32234424
NCBI chr 7:28,994,636...29,195,451
Ensembl chr 7:28,995,235...29,195,451
G
CRB1
crumbs cell polarity complex component 1
decreases expression
EXP
methyleugenol results in decreased expression of CRB1 mRNA
CTD
PMID:32234424
NCBI chr 1:197,201,504...197,478,455
Ensembl chr 1:197,268,204...197,478,455
G
CRELD2
cysteine rich with EGF like domains 2
decreases expression
EXP
methyleugenol results in decreased expression of CRELD2 mRNA
CTD
PMID:32234424
NCBI chr22:49,918,634...49,927,537
Ensembl chr22:49,918,167...49,927,540
G
CRP
C-reactive protein
decreases expression
EXP
methyleugenol results in decreased expression of CRP mRNA
CTD
PMID:32234424
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CRPPA
CDP-L-ribitol pyrophosphorylase A
decreases expression
EXP
methyleugenol results in decreased expression of CRPPA mRNA
CTD
PMID:32234424
NCBI chr 7:16,087,525...16,421,538
Ensembl chr 7:16,087,525...16,502,504
G
CRYBG2
crystallin beta-gamma domain containing 2
increases expression
EXP
methyleugenol results in increased expression of CRYBG2 mRNA
CTD
PMID:32234424
NCBI chr 1:26,321,865...26,354,130
Ensembl chr 1:26,321,698...26,360,080
G
CTH
cystathionine gamma-lyase
decreases expression
EXP
methyleugenol results in decreased expression of CTH mRNA
CTD
PMID:32234424
NCBI chr 1:70,411,268...70,439,851
Ensembl chr 1:70,411,218...70,439,851
G
CTNNA3
catenin alpha 3
decreases expression
EXP
methyleugenol results in decreased expression of CTNNA3 mRNA
CTD
PMID:32234424
NCBI chr10:65,912,523...67,763,594
Ensembl chr10:65,912,457...67,763,637
G
CTNNB1
catenin beta 1
increases mutagenesis
ISO
methyleugenol results in increased mutagenesis of CTNNB1 gene
CTD
PMID:10467420
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
G
CTXN1
cortexin 1
increases expression
EXP
methyleugenol results in increased expression of CTXN1 mRNA
CTD
PMID:32234424
NCBI chr19:7,924,491...7,926,135
Ensembl chr19:7,924,491...7,926,135
G
CUX2
cut like homeobox 2
decreases expression
EXP
methyleugenol results in decreased expression of CUX2 mRNA
CTD
PMID:32234424
NCBI chr12:111,034,165...111,350,554
Ensembl chr12:111,034,165...111,350,554
G
CX3CR1
C-X3-C motif chemokine receptor 1
decreases expression
EXP
methyleugenol results in decreased expression of CX3CR1 mRNA
CTD
PMID:32234424
NCBI chr 3:39,263,494...39,292,966
Ensembl chr 3:39,263,495...39,281,735
G
CXCL13
C-X-C motif chemokine ligand 13
decreases expression
EXP
methyleugenol results in decreased expression of CXCL13 mRNA
CTD
PMID:32234424
NCBI chr 4:77,511,753...77,611,834
Ensembl chr 4:77,511,753...77,611,834
G
CXXC4
CXXC finger protein 4
increases expression
EXP
methyleugenol results in increased expression of CXXC4 mRNA
CTD
PMID:32234424
NCBI chr 4:104,468,308...104,494,894
Ensembl chr 4:104,468,308...104,494,901
G
CYBA
cytochrome b-245 alpha chain
decreases expression
EXP
methyleugenol results in decreased expression of CYBA mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
increases expression
EXP
methyleugenol results in increased expression of CYP1A1 mRNA
CTD
PMID:32234424
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
increases expression
EXP
methyleugenol results in increased expression of CYP1A2 mRNA
CTD
PMID:32234424
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
increases expression
EXP
methyleugenol results in increased expression of CYP1B1 mRNA
CTD
PMID:32234424
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
CYP2A13
cytochrome P450 family 2 subfamily A member 13
decreases expression
EXP
methyleugenol results in decreased expression of CYP2A13 mRNA
CTD
PMID:32234424
NCBI chr19:41,088,451...41,096,195
Ensembl chr19:41,088,451...41,096,195
G
CYP2A6
cytochrome P450 family 2 subfamily A member 6
decreases expression
EXP
methyleugenol results in decreased expression of CYP2A6 mRNA
CTD
PMID:32234424
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
G
CYP2A7
cytochrome P450 family 2 subfamily A member 7
decreases expression
EXP
methyleugenol results in decreased expression of CYP2A7 mRNA
CTD
PMID:32234424
NCBI chr19:40,875,439...40,882,231
Ensembl chr19:40,875,439...40,882,752
G
CYP2B6
cytochrome P450 family 2 subfamily B member 6
decreases expression
EXP
methyleugenol results in decreased expression of CYP2B6 mRNA
CTD
PMID:32234424
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
G
CYP2B7P
cytochrome P450 family 2 subfamily B member 7, pseudogene
decreases expression
EXP
methyleugenol results in decreased expression of CYP2B7P mRNA
CTD
PMID:32234424
NCBI chr19:40,924,265...40,950,660
Ensembl chr19:40,924,273...40,949,234 Ensembl chr19:40,924,273...40,949,234
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
decreases expression
EXP
methyleugenol results in decreased expression of CYP2C19 mRNA
CTD
PMID:32234424
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
G
CYP2C8
cytochrome P450 family 2 subfamily C member 8
decreases expression
EXP
methyleugenol results in decreased expression of CYP2C8 mRNA
CTD
PMID:32234424
NCBI chr10:95,036,772...95,069,497
Ensembl chr10:95,036,772...95,069,497
G
CYP2C9
cytochrome P450 family 2 subfamily C member 9
decreases expression
EXP
methyleugenol results in decreased expression of CYP2C9 mRNA
CTD
PMID:32234424
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6
decreases expression
EXP
methyleugenol results in decreased expression of CYP2D6 mRNA
CTD
PMID:32234424
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
decreases expression
EXP
methyleugenol results in decreased expression of CYP2E1 mRNA
CTD
PMID:32234424
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
CYP2U1-AS1
CYP2U1 and SGMS2 antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of CYP2U1-AS1 mRNA
CTD
PMID:32234424
NCBI chr 4:107,863,479...107,932,119
Ensembl chr 4:107,863,473...107,989,724
G
CYP3A7
cytochrome P450 family 3 subfamily A member 7
decreases expression
EXP
methyleugenol results in decreased expression of CYP3A7 mRNA
CTD
PMID:32234424
NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196
G
CYP46A1
cytochrome P450 family 46 subfamily A member 1
decreases expression
EXP
methyleugenol results in decreased expression of CYP46A1 mRNA
CTD
PMID:32234424
NCBI chr14:99,684,298...99,727,301
Ensembl chr14:99,684,298...99,727,301
G
CYP4A11
cytochrome P450 family 4 subfamily A member 11
decreases expression
EXP
methyleugenol results in decreased expression of CYP4A11 mRNA
CTD
PMID:32234424
NCBI chr 1:46,929,188...46,941,476
Ensembl chr 1:46,929,177...46,941,484
G
CYP4A22
cytochrome P450 family 4 subfamily A member 22
decreases expression
EXP
methyleugenol results in decreased expression of CYP4A22 mRNA
CTD
PMID:32234424
NCBI chr 1:47,137,441...47,149,727
Ensembl chr 1:47,137,435...47,149,727
G
CYP4B1
cytochrome P450 family 4 subfamily B member 1
decreases expression
EXP
methyleugenol results in decreased expression of CYP4B1 mRNA
CTD
PMID:32234424
NCBI chr 1:46,799,046...46,819,413
Ensembl chr 1:46,757,838...46,819,413
G
CYP4F2
cytochrome P450 family 4 subfamily F member 2
decreases expression
EXP
methyleugenol results in decreased expression of CYP4F2 mRNA
CTD
PMID:32234424
NCBI chr19:15,878,023...15,898,074
Ensembl chr19:15,878,023...15,898,077
G
CYP4X1
cytochrome P450 family 4 subfamily X member 1
decreases expression
EXP
methyleugenol results in decreased expression of CYP4X1 mRNA
CTD
PMID:32234424
NCBI chr 1:46,961,364...47,055,432
Ensembl chr 1:47,023,669...47,050,751
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
decreases expression
EXP
methyleugenol results in decreased expression of CYP7A1 mRNA
CTD
PMID:32234424
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
CYP7B1
cytochrome P450 family 7 subfamily B member 1
decreases expression
EXP
methyleugenol results in decreased expression of CYP7B1 mRNA
CTD
PMID:32234424
NCBI chr 8:64,586,575...64,798,737
Ensembl chr 8:64,587,763...64,798,737
G
CYP8B1
cytochrome P450 family 8 subfamily B member 1
decreases expression
EXP
methyleugenol results in decreased expression of CYP8B1 mRNA
CTD
PMID:32234424
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
G
DAB1
DAB adaptor protein 1
decreases expression
EXP
methyleugenol results in decreased expression of DAB1 mRNA
CTD
PMID:32234424
NCBI chr 1:56,994,778...58,546,726
Ensembl chr 1:56,994,778...58,546,734
G
DACH2
dachshund family transcription factor 2
decreases expression
EXP
methyleugenol results in decreased expression of DACH2 mRNA
CTD
PMID:32234424
NCBI chr X:86,148,451...86,832,602
Ensembl chr X:86,148,451...86,832,604
G
DAO
D-amino acid oxidase
decreases expression
EXP
methyleugenol results in decreased expression of DAO mRNA
CTD
PMID:32234424
NCBI chr12:108,880,092...108,901,043
Ensembl chr12:108,858,932...108,901,043
G
DBH-AS1
DBH antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of DBH-AS1 mRNA
CTD
PMID:32234424
NCBI chr 9:133,654,587...133,657,408
Ensembl chr 9:133,654,586...133,657,313
G
DBNDD1
dysbindin domain containing 1
increases expression
EXP
methyleugenol results in increased expression of DBNDD1 mRNA
CTD
PMID:32234424
NCBI chr16:90,004,871...90,019,890
Ensembl chr16:90,004,871...90,019,890
G
DCAF11
DDB1 and CUL4 associated factor 11
decreases expression
EXP
methyleugenol results in decreased expression of DCAF11 mRNA
CTD
PMID:32234424
NCBI chr14:24,114,777...24,125,242
Ensembl chr14:24,114,195...24,125,242
G
DCDC1
doublecortin domain containing 1
decreases expression
EXP
methyleugenol results in decreased expression of DCDC1 mRNA
CTD
PMID:32234424
NCBI chr11:30,863,603...31,369,739
Ensembl chr11:30,830,369...31,369,810
G
DCHS2
dachsous cadherin-related 2
decreases expression
EXP
methyleugenol results in decreased expression of DCHS2 mRNA
CTD
PMID:32234424
NCBI chr 4:154,231,742...154,491,799
Ensembl chr 4:154,231,742...154,491,799
G
DCXR
dicarbonyl and L-xylulose reductase
decreases expression
EXP
methyleugenol results in decreased expression of DCXR mRNA
CTD
PMID:32234424
NCBI chr17:82,035,858...82,037,697
Ensembl chr17:82,035,136...82,037,709
G
DDC
dopa decarboxylase
decreases expression
EXP
methyleugenol results in decreased expression of DDC mRNA
CTD
PMID:32234424
NCBI chr 7:50,458,442...50,565,405
Ensembl chr 7:50,458,436...50,565,405
G
DDR2
discoidin domain receptor tyrosine kinase 2
decreases expression
EXP
methyleugenol results in decreased expression of DDR2 mRNA
CTD
PMID:32234424
NCBI chr 1:162,630,863...162,787,405
Ensembl chr 1:162,631,373...162,787,405
G
DDT
D-dopachrome tautomerase
decreases expression
EXP
methyleugenol results in decreased expression of DDT mRNA
CTD
PMID:32234424
NCBI chr22:23,971,370...23,980,504
Ensembl chr22:23,970,542...23,980,525
G
DEFB1
defensin beta 1
increases expression
EXP
methyleugenol results in increased expression of DEFB1 mRNA
CTD
PMID:32234424
NCBI chr 8:6,870,592...6,877,936
Ensembl chr 8:6,870,592...6,877,936
G
DENND1A
DENN domain containing 1A
decreases expression
EXP
methyleugenol results in decreased expression of DENND1A mRNA
CTD
PMID:32234424
NCBI chr 9:123,379,658...123,930,126
Ensembl chr 9:123,379,654...123,930,152
G
DGAT1
diacylglycerol O-acyltransferase 1
decreases expression
EXP
methyleugenol results in decreased expression of DGAT1 mRNA
CTD
PMID:32234424
NCBI chr 8:144,314,584...144,326,852
Ensembl chr 8:144,314,584...144,326,910
G
DGAT2
diacylglycerol O-acyltransferase 2
decreases expression
EXP
methyleugenol results in decreased expression of DGAT2 mRNA
CTD
PMID:32234424
NCBI chr11:75,768,778...75,801,534
Ensembl chr11:75,759,512...75,801,535
G
DHRS2
dehydrogenase/reductase 2
decreases expression
EXP
methyleugenol results in decreased expression of DHRS2 mRNA
CTD
PMID:32234424
NCBI chr14:23,630,115...23,645,639
Ensembl chr14:23,630,115...23,645,639
G
DHRS9
dehydrogenase/reductase 9
increases expression
EXP
methyleugenol results in increased expression of DHRS9 mRNA
CTD
PMID:32234424
NCBI chr 2:169,067,077...169,096,167
Ensembl chr 2:169,064,789...169,096,167
G
DHRSX
dehydrogenase/reductase X-linked
decreases expression
EXP
methyleugenol results in decreased expression of DHRSX mRNA
CTD
PMID:32234424
NCBI chr X:2,219,506...2,500,976 NCBI chr Y:2,219,506...2,500,976
Ensembl chr X:2,219,506...2,502,805 Ensembl chr Y:2,219,506...2,502,805
G
DHTKD1
dehydrogenase E1 and transketolase domain containing 1
decreases expression
EXP
methyleugenol results in decreased expression of DHTKD1 mRNA
CTD
PMID:32234424
NCBI chr10:12,068,954...12,123,221
Ensembl chr10:12,068,954...12,123,221
G
DIAPH2
diaphanous related formin 2
decreases expression
EXP
methyleugenol results in decreased expression of DIAPH2 mRNA
CTD
PMID:32234424
NCBI chr X:96,684,842...97,604,997
Ensembl chr X:96,684,712...97,604,997
G
DIO1
iodothyronine deiodinase 1
decreases expression
EXP
methyleugenol results in decreased expression of DIO1 mRNA
CTD
PMID:32234424
NCBI chr 1:53,894,187...53,911,086
Ensembl chr 1:53,891,239...53,911,086
G
DIP2C
disco interacting protein 2 homolog C
decreases expression
EXP
methyleugenol results in decreased expression of DIP2C mRNA
CTD
PMID:32234424
NCBI chr10:274,201...689,668
Ensembl chr10:274,201...689,668
G
DIRAS3
DIRAS family GTPase 3
decreases expression
EXP
methyleugenol results in decreased expression of DIRAS3 mRNA
CTD
PMID:32234424
NCBI chr 1:68,045,962...68,050,627
Ensembl chr 1:68,045,886...68,051,717
G
DISC1
DISC1 scaffold protein
decreases expression
EXP
methyleugenol results in decreased expression of DISC1 mRNA
CTD
PMID:32234424
NCBI chr 1:231,626,790...232,041,272
Ensembl chr 1:231,626,790...232,041,272
G
DLG2
discs large MAGUK scaffold protein 2
decreases expression
EXP
methyleugenol results in decreased expression of DLG2 mRNA
CTD
PMID:32234424
NCBI chr11:83,455,012...85,628,373
Ensembl chr11:83,455,012...85,628,335
G
DMGDH
dimethylglycine dehydrogenase
decreases expression
EXP
methyleugenol results in decreased expression of DMGDH mRNA
CTD
PMID:32234424
NCBI chr 5:78,997,564...79,069,674
Ensembl chr 5:78,997,564...79,236,038
G
DNAH1
dynein axonemal heavy chain 1
decreases expression
EXP
methyleugenol results in decreased expression of DNAH1 mRNA
CTD
PMID:32234424
NCBI chr 3:52,310,920...52,400,492
Ensembl chr 3:52,316,319...52,400,492
G
DNAH11
dynein axonemal heavy chain 11
decreases expression
EXP
methyleugenol results in decreased expression of DNAH11 mRNA
CTD
PMID:32234424
NCBI chr 7:21,543,039...21,901,839
Ensembl chr 7:21,543,039...21,901,839
G
DNAH12
dynein axonemal heavy chain 12
decreases expression
EXP
methyleugenol results in decreased expression of DNAH12 mRNA
CTD
PMID:32234424
NCBI chr 3:57,293,700...57,556,034
Ensembl chr 3:57,293,699...57,544,344
G
DNAH5
dynein axonemal heavy chain 5
decreases expression
EXP
methyleugenol results in decreased expression of DNAH5 mRNA
CTD
PMID:32234424
NCBI chr 5:13,690,328...14,011,818
Ensembl chr 5:13,690,328...14,011,818
G
DNAH6
dynein axonemal heavy chain 6
decreases expression
EXP
methyleugenol results in decreased expression of DNAH6 mRNA
CTD
PMID:32234424
NCBI chr 2:84,459,572...84,819,589
Ensembl chr 2:84,516,455...84,819,589
G
DNASE2
deoxyribonuclease 2, lysosomal
increases expression
ISO
methyleugenol results in increased expression of DNASE2A mRNA
CTD
PMID:15618236
NCBI chr19:12,875,209...12,881,449
Ensembl chr19:12,875,209...12,881,595
G
DOCK1
dedicator of cytokinesis 1
decreases expression
EXP
methyleugenol results in decreased expression of DOCK1 mRNA
CTD
PMID:32234424
NCBI chr10:126,905,428...127,452,516
Ensembl chr10:126,905,409...127,452,517
G
DOCK8
dedicator of cytokinesis 8
decreases expression
EXP
methyleugenol results in decreased expression of DOCK8 mRNA
CTD
PMID:32234424
NCBI chr 9:211,257...465,255
Ensembl chr 9:214,854...465,259
G
DPF3
double PHD fingers 3
decreases expression
EXP
methyleugenol results in decreased expression of DPF3 mRNA
CTD
PMID:32234424
NCBI chr14:72,609,034...72,894,101
Ensembl chr14:72,609,034...72,894,101
G
DPYD
dihydropyrimidine dehydrogenase
decreases expression
EXP
methyleugenol results in decreased expression of DPYD mRNA
CTD
PMID:32234424
NCBI chr 1:97,077,743...97,921,059
Ensembl chr 1:97,077,743...97,995,000
G
DPYS
dihydropyrimidinase
decreases expression
EXP
methyleugenol results in decreased expression of DPYS mRNA
CTD
PMID:32234424
NCBI chr 8:104,379,431...104,467,055
Ensembl chr 8:104,330,324...104,467,055
G
DRAXIN
dorsal inhibitory axon guidance protein
increases expression
EXP
methyleugenol results in increased expression of DRAXIN mRNA
CTD
PMID:32234424
NCBI chr 1:11,686,635...11,725,857
Ensembl chr 1:11,691,710...11,725,857
G
DRGX
dorsal root ganglia homeobox
decreases expression
EXP
methyleugenol results in decreased expression of DRGX mRNA
CTD
PMID:32234424
NCBI chr10:49,364,066...49,396,089
Ensembl chr10:49,364,066...49,396,089
G
DSC2
desmocollin 2
increases expression
EXP
methyleugenol results in increased expression of DSC2 mRNA
CTD
PMID:32234424
NCBI chr18:31,058,840...31,102,421
Ensembl chr18:31,058,545...31,102,600
G
DUSP15
dual specificity phosphatase 15
increases expression
EXP
methyleugenol results in increased expression of DUSP15 mRNA
CTD
PMID:32234424
NCBI chr20:31,845,593...31,870,664
Ensembl chr20:31,847,637...31,870,664
G
DUSP9
dual specificity phosphatase 9
decreases expression
EXP
methyleugenol results in decreased expression of DUSP9 mRNA
CTD
PMID:32234424
NCBI chr X:153,642,441...153,651,326
Ensembl chr X:153,642,492...153,651,326
G
DYNC2H1
dynein cytoplasmic 2 heavy chain 1
decreases expression
EXP
methyleugenol results in decreased expression of DYNC2H1 mRNA
CTD
PMID:32234424
NCBI chr11:103,109,426...103,479,863
Ensembl chr11:103,109,410...103,479,863
G
EBF1
EBF transcription factor 1
decreases expression
EXP
methyleugenol results in decreased expression of EBF1 mRNA
CTD
PMID:32234424
NCBI chr 5:158,695,920...159,099,916
Ensembl chr 5:158,695,920...159,099,916
G
ECM2
extracellular matrix protein 2
decreases expression
EXP
methyleugenol results in decreased expression of ECM2 mRNA
CTD
PMID:32234424
NCBI chr 9:92,493,547...92,559,106
Ensembl chr 9:92,493,554...92,536,655
G
EDIL3
EGF like repeats and discoidin domains 3
decreases expression
EXP
methyleugenol results in decreased expression of EDIL3 mRNA
CTD
PMID:32234424
NCBI chr 5:83,940,554...84,384,880
Ensembl chr 5:83,940,554...84,384,880
G
EEF1A2
eukaryotic translation elongation factor 1 alpha 2
increases expression
EXP
methyleugenol results in increased expression of EEF1A2 mRNA
CTD
PMID:32234424
NCBI chr20:63,488,014...63,499,083
Ensembl chr20:63,488,013...63,499,239
G
EFCAB11
EF-hand calcium binding domain 11
decreases expression
EXP
methyleugenol results in decreased expression of EFCAB11 mRNA
CTD
PMID:32234424
NCBI chr14:89,794,669...89,954,777
Ensembl chr14:89,794,669...89,954,777
G
EFCAB6
EF-hand calcium binding domain 6
decreases expression
EXP
methyleugenol results in decreased expression of EFCAB6 mRNA
CTD
PMID:32234424
NCBI chr22:43,528,778...43,812,305
Ensembl chr22:43,528,744...43,812,337
G
EGFR
epidermal growth factor receptor
decreases expression
ISO
methyleugenol results in decreased expression of EGFR protein
CTD
PMID:15618236
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
G
EGR1
early growth response 1
increases expression
ISO
methyleugenol results in increased expression of EGR1 mRNA
CTD
PMID:15618236
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
EHBP1L1
EH domain binding protein 1 like 1
increases expression
EXP
methyleugenol results in increased expression of EHBP1L1 mRNA
CTD
PMID:32234424
NCBI chr11:65,576,053...65,592,650
Ensembl chr11:65,576,046...65,592,650
G
EHHADH
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
decreases expression
EXP
methyleugenol results in decreased expression of EHHADH mRNA
CTD
PMID:32234424
NCBI chr 3:185,190,624...185,254,049
Ensembl chr 3:185,190,624...185,281,990
G
ELAPOR1
endosome-lysosome associated apoptosis and autophagy regulator 1
increases expression
EXP
methyleugenol results in increased expression of ELAPOR1 mRNA
CTD
PMID:32234424
NCBI chr 1:109,114,115...109,206,781
Ensembl chr 1:109,113,679...109,206,781
G
ELMO1
engulfment and cell motility 1
decreases expression
EXP
methyleugenol results in decreased expression of ELMO1 mRNA
CTD
PMID:32234424
NCBI chr 7:36,852,906...37,449,326
Ensembl chr 7:36,852,906...37,449,223
G
ELP4
elongator acetyltransferase complex subunit 4
decreases expression
EXP
methyleugenol results in decreased expression of ELP4 mRNA
CTD
PMID:32234424
NCBI chr11:31,509,767...31,790,324
Ensembl chr11:31,509,755...31,790,324
G
EML6
EMAP like 6
decreases expression
EXP
methyleugenol results in decreased expression of EML6 mRNA
CTD
PMID:32234424
NCBI chr 2:54,723,552...54,972,025
Ensembl chr 2:54,723,499...54,972,025
G
ENOX1
ecto-NOX disulfide-thiol exchanger 1
decreases expression
EXP
methyleugenol results in decreased expression of ENOX1 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr13:43,213,130...43,786,972
Ensembl chr13:43,213,130...43,786,972
G
ENPP3
ectonucleotide pyrophosphatase/phosphodiesterase 3
decreases expression
EXP
methyleugenol results in decreased expression of ENPP3 mRNA
CTD
PMID:32234424
NCBI chr 6:131,637,302...131,747,410
Ensembl chr 6:131,628,442...131,747,418
G
ENPP6
ectonucleotide pyrophosphatase/phosphodiesterase 6
decreases expression
EXP
methyleugenol results in decreased expression of ENPP6 mRNA
CTD
PMID:32234424
NCBI chr 4:184,088,706...184,217,873
Ensembl chr 4:184,088,706...184,221,230
G
ENTPD8
ectonucleoside triphosphate diphosphohydrolase 8
decreases expression
EXP
methyleugenol results in decreased expression of ENTPD8 mRNA
CTD
PMID:32234424
NCBI chr 9:137,434,364...137,441,357
Ensembl chr 9:137,434,364...137,441,816
G
EPHX2
epoxide hydrolase 2
decreases expression
EXP
methyleugenol results in decreased expression of EPHX2 mRNA
CTD
PMID:32234424
NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564
G
EPM2A
EPM2A glucan phosphatase, laforin
decreases expression
EXP
methyleugenol results in decreased expression of EPM2A mRNA
CTD
PMID:32234424
NCBI chr 6:145,383,353...145,736,023
Ensembl chr 6:145,382,535...145,736,023
G
EPS8L3
EPS8 signaling adaptor L3
increases expression
EXP
methyleugenol results in increased expression of EPS8L3 mRNA
CTD
PMID:32234424
NCBI chr 1:109,750,080...109,763,923
Ensembl chr 1:109,750,080...109,764,027
G
ERBB4
erb-b2 receptor tyrosine kinase 4
decreases expression
EXP
methyleugenol results in decreased expression of ERBB4 mRNA
CTD
PMID:32234424
NCBI chr 2:211,375,717...212,538,802
Ensembl chr 2:211,375,717...212,538,841
G
EREG
epiregulin
increases expression
EXP
methyleugenol results in increased expression of EREG mRNA
CTD
PMID:32234424
NCBI chr 4:74,365,145...74,388,749
Ensembl chr 4:74,365,145...74,388,749
G
ERICH4
glutamate rich 4
decreases expression
EXP
methyleugenol results in decreased expression of ERICH4 mRNA
CTD
PMID:32234424
NCBI chr19:41,443,156...41,444,765
Ensembl chr19:41,443,156...41,444,765
G
ERP27
endoplasmic reticulum protein 27
decreases expression
EXP
methyleugenol results in decreased expression of ERP27 mRNA
CTD
PMID:32234424
NCBI chr12:14,914,039...14,938,537
Ensembl chr12:14,914,039...14,938,537
G
ESAM
endothelial cell adhesion molecule
increases expression
EXP
methyleugenol results in increased expression of ESAM mRNA
CTD
PMID:32234424
NCBI chr11:124,753,126...124,762,290
Ensembl chr11:124,752,583...124,762,290
G
ESCO1
establishment of sister chromatid cohesion N-acetyltransferase 1
decreases expression
ISO
methyleugenol results in decreased expression of ESCO1 mRNA
CTD
PMID:26011634
NCBI chr18:21,529,284...21,600,704
Ensembl chr18:21,529,284...21,600,884
G
ESPL1
extra spindle pole bodies like 1, separase
decreases expression
EXP
methyleugenol results in decreased expression of ESPL1 mRNA
CTD
PMID:32234424
NCBI chr12:53,268,299...53,293,638
Ensembl chr12:53,268,299...53,293,638
G
ESPN
espin
decreases expression
EXP
methyleugenol results in decreased expression of ESPN mRNA
CTD
PMID:32234424
NCBI chr 1:6,424,776...6,461,370
Ensembl chr 1:6,424,776...6,461,367
G
ESRRG
estrogen related receptor gamma
decreases expression
EXP
methyleugenol results in decreased expression of ESRRG mRNA
CTD
PMID:32234424
NCBI chr 1:216,503,246...217,137,702
Ensembl chr 1:216,503,246...217,137,755
G
ETNK2
ethanolamine kinase 2
decreases expression
EXP
methyleugenol results in decreased expression of ETNK2 mRNA
CTD
PMID:32234424
NCBI chr 1:204,131,062...204,152,044
Ensembl chr 1:204,131,062...204,152,044
G
EVA1B
eva-1 homolog B
increases expression
EXP
methyleugenol results in increased expression of EVA1B mRNA
CTD
PMID:32234424
NCBI chr 1:36,322,030...36,324,154
Ensembl chr 1:36,322,030...36,324,154
G
EXOC3L4
exocyst complex component 3 like 4
decreases expression
EXP
methyleugenol results in decreased expression of EXOC3L4 mRNA
CTD
PMID:32234424
NCBI chr14:103,094,174...103,110,559
Ensembl chr14:103,094,725...103,110,559
G
EXOC4
exocyst complex component 4
decreases expression
EXP
methyleugenol results in decreased expression of EXOC4 mRNA
CTD
PMID:32234424
NCBI chr 7:133,253,078...134,100,951
Ensembl chr 7:133,253,073...134,066,589
G
EYA2
EYA transcriptional coactivator and phosphatase 2
decreases expression
EXP
methyleugenol results in decreased expression of EYA2 mRNA
CTD
PMID:32234424
NCBI chr20:46,894,843...47,188,844
Ensembl chr20:46,894,624...47,188,844
G
EYA4
EYA transcriptional coactivator and phosphatase 4
decreases expression
EXP
methyleugenol results in decreased expression of EYA4 mRNA
CTD
PMID:32234424
NCBI chr 6:133,240,593...133,532,128
Ensembl chr 6:133,240,514...133,532,128
G
F11
coagulation factor XI
decreases expression
EXP
methyleugenol results in decreased expression of F11 mRNA
CTD
PMID:32234424
NCBI chr 4:186,266,189...186,289,681
Ensembl chr 4:186,266,189...186,289,681
G
F12
coagulation factor XII
decreases expression
EXP
methyleugenol results in decreased expression of F12 mRNA
CTD
PMID:32234424
NCBI chr 5:177,402,141...177,409,564
Ensembl chr 5:177,402,133...177,416,583
G
F2RL2
coagulation factor II thrombin receptor like 2
increases expression
EXP
methyleugenol results in increased expression of F2RL2 mRNA
CTD
PMID:32234424
NCBI chr 5:76,615,482...76,623,403
Ensembl chr 5:76,615,482...76,623,413
G
F7
coagulation factor VII
decreases expression
EXP
methyleugenol results in decreased expression of F7 mRNA
CTD
PMID:32234424
NCBI chr13:113,105,788...113,120,685
Ensembl chr13:113,105,788...113,120,685
G
F9
coagulation factor IX
decreases expression
EXP
methyleugenol results in decreased expression of F9 mRNA
CTD
PMID:32234424
NCBI chr X:139,530,739...139,563,459
Ensembl chr X:139,530,739...139,563,459
G
FABP1
fatty acid binding protein 1
decreases expression
EXP
methyleugenol results in decreased expression of FABP1 mRNA
CTD
PMID:32234424
NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062
G
FAM151A
family with sequence similarity 151 member A
decreases expression
EXP
methyleugenol results in decreased expression of FAM151A mRNA
CTD
PMID:32234424
NCBI chr 1:54,609,181...54,623,525
Ensembl chr 1:54,609,181...54,623,556
G
FAM167A
family with sequence similarity 167 member A
increases expression
EXP
methyleugenol results in increased expression of FAM167A mRNA
CTD
PMID:32234424
NCBI chr 8:11,421,476...11,475,908
Ensembl chr 8:11,421,476...11,475,908
G
FAM171A2
family with sequence similarity 171 member A2
increases expression
EXP
methyleugenol results in increased expression of FAM171A2 mRNA
CTD
PMID:32234424
NCBI chr17:44,353,215...44,363,853
Ensembl chr17:44,353,215...44,363,853
G
FAM72B
family with sequence similarity 72 member B
decreases expression
EXP
methyleugenol results in decreased expression of FAM72B mRNA
CTD
PMID:32234424
NCBI chr 1:121,167,646...121,184,340
Ensembl chr 1:121,167,646...121,185,539
G
FAM78B
family with sequence similarity 78 member B
decreases expression
EXP
methyleugenol results in decreased expression of FAM78B mRNA
CTD
PMID:32234424
NCBI chr 1:166,055,918...166,167,001
Ensembl chr 1:166,057,426...166,167,001
G
FAM83D
family with sequence similarity 83 member D
decreases expression
EXP
methyleugenol results in decreased expression of FAM83D mRNA
CTD
PMID:32234424
NCBI chr20:38,926,417...38,953,106
Ensembl chr20:38,926,312...38,953,106
G
FANK1
fibronectin type III and ankyrin repeat domains 1
decreases expression
EXP
methyleugenol results in decreased expression of FANK1 mRNA
CTD
PMID:32234424
NCBI chr10:125,896,564...126,009,592
Ensembl chr10:125,896,564...126,009,592
G
FAR1
fatty acyl-CoA reductase 1
decreases expression
EXP
methyleugenol results in decreased expression of FAR1 mRNA
CTD
PMID:32234424
NCBI chr11:13,668,668...13,732,346
Ensembl chr11:13,668,659...13,732,346
G
FARS2
phenylalanyl-tRNA synthetase 2, mitochondrial
decreases expression
EXP
methyleugenol results in decreased expression of FARS2 mRNA
CTD
PMID:32234424
NCBI chr 6:5,249,934...5,771,583
Ensembl chr 6:5,261,044...5,829,192
G
FASN
fatty acid synthase
decreases expression
EXP
methyleugenol results in decreased expression of FASN mRNA
CTD
PMID:32234424
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
G
FAT3
FAT atypical cadherin 3
decreases expression
EXP
methyleugenol results in decreased expression of FAT3 mRNA
CTD
PMID:32234424
NCBI chr11:92,224,818...92,896,473
Ensembl chr11:92,224,818...92,896,473
G
FBLIM1
filamin binding LIM protein 1
increases expression
EXP
methyleugenol results in increased expression of FBLIM1 mRNA
CTD
PMID:32234424
NCBI chr 1:15,756,638...15,786,589
Ensembl chr 1:15,756,607...15,786,594
G
FBP1
fructose-bisphosphatase 1
decreases expression
EXP
methyleugenol results in decreased expression of FBP1 mRNA
CTD
PMID:32234424
NCBI chr 9:94,603,133...94,640,263
Ensembl chr 9:94,603,133...94,640,249
G
FBXL17
F-box and leucine rich repeat protein 17
decreases expression
EXP
methyleugenol results in decreased expression of FBXL17 mRNA
CTD
PMID:32234424
NCBI chr 5:107,859,035...108,382,098
Ensembl chr 5:107,859,035...108,382,098
G
FBXO15
F-box protein 15
decreases expression
EXP
methyleugenol results in decreased expression of FBXO15 mRNA
CTD
PMID:32234424
NCBI chr18:74,073,368...74,147,834
Ensembl chr18:74,073,353...74,147,843
G
FBXO43
F-box protein 43
decreases expression
EXP
methyleugenol results in decreased expression of FBXO43 mRNA
CTD
PMID:32234424
NCBI chr 8:100,133,351...100,150,569
Ensembl chr 8:100,133,351...100,145,817
G
FER
FER tyrosine kinase
decreases expression
EXP
methyleugenol results in decreased expression of FER mRNA
CTD
PMID:32234424
NCBI chr 5:108,747,897...109,196,841
Ensembl chr 5:108,747,841...109,196,841
G
FER1L6
fer-1 like family member 6
decreases expression
EXP
methyleugenol results in decreased expression of FER1L6 mRNA
CTD
PMID:32234424
NCBI chr 8:123,851,987...124,120,061
Ensembl chr 8:123,851,987...124,120,061
G
FETUB
fetuin B
decreases expression
EXP
methyleugenol results in decreased expression of FETUB mRNA
CTD
PMID:32234424
NCBI chr 3:186,635,969...186,653,141
Ensembl chr 3:186,635,969...186,653,141
G
FGA
fibrinogen alpha chain
decreases expression
EXP
methyleugenol results in decreased expression of FGA mRNA
CTD
PMID:32234424
NCBI chr 4:154,583,126...154,590,742
Ensembl chr 4:154,583,126...154,590,742
G
FGB
fibrinogen beta chain
decreases expression
EXP
methyleugenol results in decreased expression of FGB mRNA
CTD
PMID:32234424
NCBI chr 4:154,562,980...154,572,807
Ensembl chr 4:154,563,011...154,572,807
G
FGD5
FYVE, RhoGEF and PH domain containing 5
decreases expression
EXP
methyleugenol results in decreased expression of FGD5 mRNA
CTD
PMID:32234424
NCBI chr 3:14,810,688...14,934,571
Ensembl chr 3:14,810,853...14,934,571
G
FGF12
fibroblast growth factor 12
decreases expression
EXP
methyleugenol results in decreased expression of FGF12 mRNA
CTD
PMID:32234424
NCBI chr 3:192,139,390...192,727,541
Ensembl chr 3:192,139,390...192,767,764
G
FGF13
fibroblast growth factor 13
decreases expression
EXP
methyleugenol results in decreased expression of FGF13 mRNA
CTD
PMID:32234424
NCBI chr X:138,614,727...139,205,023
Ensembl chr X:138,614,727...139,222,777
G
FGF14
fibroblast growth factor 14
decreases expression
EXP
methyleugenol results in decreased expression of FGF14 mRNA
CTD
PMID:32234424
NCBI chr13:101,710,804...102,402,443
Ensembl chr13:101,710,804...102,402,457
G
FGFR2
fibroblast growth factor receptor 2
decreases expression
EXP
methyleugenol results in decreased expression of FGFR2 mRNA
CTD
PMID:32234424
NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458
G
FGGY
FGGY carbohydrate kinase domain containing
decreases expression
EXP
methyleugenol results in decreased expression of FGGY mRNA
CTD
PMID:32234424
NCBI chr 1:59,296,378...59,762,730
Ensembl chr 1:59,296,638...59,810,647
G
FGL2
fibrinogen like 2
decreases expression
EXP
methyleugenol results in decreased expression of FGL2 mRNA
CTD
PMID:32234424
NCBI chr 7:77,193,369...77,199,819
Ensembl chr 7:77,193,369...77,199,848
G
FHIT
fragile histidine triad diadenosine triphosphatase
decreases expression
ISO EXP
methyleugenol results in decreased expression of FHIT mRNA; methyleugenol results in decreased expression of FHIT protein
CTD
PMID:15618236 PMID:32234424 PMID:35690182
NCBI chr 3:59,747,277...61,251,452
Ensembl chr 3:59,747,277...61,251,459
G
FHOD3
formin homology 2 domain containing 3
decreases expression
EXP
methyleugenol results in decreased expression of FHOD3 mRNA
CTD
PMID:32234424
NCBI chr18:36,297,713...36,780,220
Ensembl chr18:36,297,713...36,780,220
G
FILIP1
filamin A interacting protein 1
decreases expression
EXP
methyleugenol results in decreased expression of FILIP1 mRNA
CTD
PMID:32234424
NCBI chr 6:75,291,859...75,493,800
Ensembl chr 6:75,291,859...75,493,800
G
FILIP1L
filamin A interacting protein 1 like
increases expression
EXP
methyleugenol results in increased expression of FILIP1L mRNA
CTD
PMID:32234424
NCBI chr 3:99,828,811...100,114,501
Ensembl chr 3:99,828,811...100,114,513
G
FITM1
fat storage inducing transmembrane protein 1
decreases expression
EXP
methyleugenol results in decreased expression of FITM1 mRNA
CTD
PMID:32234424
NCBI chr14:24,130,659...24,132,847
Ensembl chr14:24,130,659...24,132,849
G
FLRT2
fibronectin leucine rich transmembrane protein 2
increases expression
EXP
methyleugenol results in increased expression of FLRT2 mRNA
CTD
PMID:32234424
NCBI chr14:85,530,144...85,654,428
Ensembl chr14:85,530,144...85,654,428
G
FMO1
flavin containing dimethylaniline monoxygenase 1
decreases expression
EXP
methyleugenol results in decreased expression of FMO1 mRNA
CTD
PMID:32234424
NCBI chr 1:171,248,494...171,285,978
Ensembl chr 1:171,248,471...171,285,978
G
FMO5
flavin containing dimethylaniline monoxygenase 5
decreases expression
EXP
methyleugenol results in decreased expression of FMO5 mRNA
CTD
PMID:32234424
NCBI chr 1:147,184,305...147,227,284
Ensembl chr 1:147,175,351...147,243,050
G
FOLH1B
folate hydrolase 1B (pseudogene)
decreases expression
EXP
methyleugenol results in decreased expression of FOLH1B mRNA
CTD
PMID:32234424
NCBI chr11:89,659,268...89,698,718
Ensembl chr11:89,659,297...89,698,718 Ensembl chr11:89,659,297...89,698,718
G
FOSL1
FOS like 1, AP-1 transcription factor subunit
increases expression
EXP
methyleugenol results in increased expression of FOSL1 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
G
FOXA3
forkhead box A3
increases expression
EXP
methyleugenol results in increased expression of FOXA3 mRNA
CTD
PMID:32234424
NCBI chr19:45,864,326...45,873,797
Ensembl chr19:45,863,989...45,873,797
G
FRAS1
Fraser extracellular matrix complex subunit 1
decreases expression
EXP
methyleugenol results in decreased expression of FRAS1 mRNA
CTD
PMID:32234424
NCBI chr 4:78,057,323...78,544,269
Ensembl chr 4:78,057,323...78,544,269
G
FRMPD2
FERM and PDZ domain containing 2
decreases expression
EXP
methyleugenol results in decreased expression of FRMPD2 mRNA
CTD
PMID:32234424
NCBI chr10:48,156,559...48,274,895
Ensembl chr10:48,153,088...48,274,696
G
FST
follistatin
increases expression
EXP
methyleugenol results in increased expression of FST mRNA
CTD
PMID:32234424
NCBI chr 5:53,480,629...53,487,134
Ensembl chr 5:53,480,626...53,487,134
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
decreases expression
EXP
methyleugenol results in decreased expression of FTO mRNA
CTD
PMID:32234424
NCBI chr16:53,703,963...54,121,941
Ensembl chr16:53,701,692...54,158,512
G
FUOM
fucose mutarotase
decreases expression
EXP
methyleugenol results in decreased expression of FUOM mRNA
CTD
PMID:32234424
NCBI chr10:133,352,773...133,358,019
Ensembl chr10:133,355,158...133,358,025
G
FUT6
fucosyltransferase 6
decreases expression
EXP
methyleugenol results in decreased expression of FUT6 mRNA
CTD
PMID:32234424
NCBI chr19:5,830,408...5,839,702
Ensembl chr19:5,830,408...5,839,722
G
FXYD5
FXYD domain containing ion transport regulator 5
increases expression
EXP
methyleugenol results in increased expression of FXYD5 mRNA
CTD
PMID:32234424
NCBI chr19:35,154,735...35,169,881
Ensembl chr19:35,154,730...35,169,881
G
FYB2
FYN binding protein 2
decreases expression
EXP
methyleugenol results in decreased expression of FYB2 mRNA
CTD
PMID:32234424
NCBI chr 1:56,718,789...56,826,914
Ensembl chr 1:56,718,789...56,819,696
G
FYN
FYN proto-oncogene, Src family tyrosine kinase
decreases expression
EXP
methyleugenol results in decreased expression of FYN mRNA
CTD
PMID:32234424
NCBI chr 6:111,660,332...111,873,452
Ensembl chr 6:111,660,332...111,873,452
G
G0S2
G0/G1 switch 2
decreases expression
EXP
methyleugenol results in decreased expression of G0S2 mRNA
CTD
PMID:32234424
NCBI chr 1:209,675,412...209,676,390
Ensembl chr 1:209,675,412...209,676,390
G
G6PC1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP
methyleugenol results in decreased expression of G6PC1 mRNA
CTD
PMID:32234424
NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
G
GAD1
glutamate decarboxylase 1
increases expression
EXP
methyleugenol results in increased expression of GAD1 mRNA
CTD
PMID:32234424
NCBI chr 2:170,813,210...170,861,151
Ensembl chr 2:170,813,213...170,861,151
G
GADD45B
growth arrest and DNA damage inducible beta
increases expression
ISO
methyleugenol results in increased expression of GADD45B mRNA
CTD
PMID:15618236
NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,259
G
GALNT13
polypeptide N-acetylgalactosaminyltransferase 13
decreases expression
EXP
methyleugenol results in decreased expression of GALNT13 mRNA
CTD
PMID:32234424
NCBI chr 2:153,068,293...154,456,574
Ensembl chr 2:153,871,922...154,453,979 Ensembl chr 2:153,871,922...154,453,979
G
GALNT16
polypeptide N-acetylgalactosaminyltransferase 16
decreases expression
EXP
methyleugenol results in decreased expression of GALNT16 mRNA
CTD
PMID:32234424
NCBI chr14:69,259,631...69,386,337
Ensembl chr14:69,259,277...69,357,033
G
GALNTL6
polypeptide N-acetylgalactosaminyltransferase like 6
decreases expression
EXP
methyleugenol results in decreased expression of GALNTL6 mRNA
CTD
PMID:32234424
NCBI chr 4:171,813,404...173,041,559
Ensembl chr 4:171,812,254...173,041,559
G
GAPDHP23
glyceraldehyde 3 phosphate dehydrogenase pseudogene 23
decreases expression
EXP
methyleugenol results in decreased expression of GAPDHP23 mRNA
CTD
PMID:32234424
NCBI chr 1:119,461,835...119,463,092
Ensembl chr 1:119,462,029...119,463,021
G
GAS1
growth arrest specific 1
decreases expression
EXP
methyleugenol results in decreased expression of GAS1 mRNA
CTD
PMID:32234424
NCBI chr 9:86,944,362...86,947,506
Ensembl chr 9:86,944,362...86,947,506
G
GATM
glycine amidinotransferase
decreases expression
EXP
methyleugenol results in decreased expression of GATM mRNA
CTD
PMID:32234424
NCBI chr15:45,361,124...45,402,227
Ensembl chr15:45,361,124...45,402,327
G
GBA3
glucosylceramidase beta 3 (gene/pseudogene)
decreases expression
EXP
methyleugenol results in decreased expression of GBA3 mRNA
CTD
PMID:32234424
NCBI chr 4:22,692,937...22,819,569
Ensembl chr 4:22,692,914...22,819,575
G
GBP7
guanylate binding protein 7
decreases expression
EXP
methyleugenol results in decreased expression of GBP7 mRNA
CTD
PMID:32234424
NCBI chr 1:89,131,742...89,176,003
Ensembl chr 1:89,131,742...89,176,009
G
GC
GC vitamin D binding protein
decreases expression
EXP
methyleugenol results in decreased expression of GC mRNA
CTD
PMID:32234424
NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
G
GCDH
glutaryl-CoA dehydrogenase
decreases expression
EXP
methyleugenol results in decreased expression of GCDH mRNA
CTD
PMID:32234424
NCBI chr19:12,891,129...12,899,999
Ensembl chr19:12,891,128...12,915,126
G
GCGR
glucagon receptor
decreases expression
EXP
methyleugenol results in decreased expression of GCGR mRNA
CTD
PMID:32234424
NCBI chr17:81,804,150...81,814,008
Ensembl chr17:81,804,132...81,814,008
G
GCHFR
GTP cyclohydrolase I feedback regulator
decreases expression
EXP
methyleugenol results in decreased expression of GCHFR mRNA
CTD
PMID:32234424
NCBI chr15:40,764,068...40,767,708
Ensembl chr15:40,764,068...40,767,708
G
GCNT3
glucosaminyl (N-acetyl) transferase 3, mucin type
increases expression
EXP
methyleugenol results in increased expression of GCNT3 mRNA
CTD
PMID:32234424
NCBI chr15:59,549,039...59,622,723
Ensembl chr15:59,594,875...59,640,239
G
GDF11
growth differentiation factor 11
increases expression
EXP
methyleugenol results in increased expression of GDF11 mRNA
CTD
PMID:32234424
NCBI chr12:55,743,122...55,757,264
Ensembl chr12:55,743,122...55,757,264
G
GDF15
growth differentiation factor 15
increases expression
EXP
methyleugenol results in increased expression of GDF15 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
G
GDNF
glial cell derived neurotrophic factor
increases expression
EXP
methyleugenol results in increased expression of GDNF mRNA
CTD
PMID:32234424
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
G
GEM
GTP binding protein overexpressed in skeletal muscle
increases expression
EXP
methyleugenol results in increased expression of GEM mRNA
CTD
PMID:32234424
NCBI chr 8:94,249,253...94,262,319
Ensembl chr 8:94,249,253...94,262,350
G
GFPT2
glutamine-fructose-6-phosphate transaminase 2
increases expression
EXP
methyleugenol results in increased expression of GFPT2 mRNA
CTD
PMID:32234424
NCBI chr 5:180,300,698...180,353,336
Ensembl chr 5:180,300,698...180,353,336
G
GFRA1
GDNF family receptor alpha 1
decreases expression
EXP
methyleugenol results in decreased expression of GFRA1 mRNA
CTD
PMID:32234424
NCBI chr10:116,056,925...116,274,705
Ensembl chr10:116,056,925...116,276,803
G
GHR
growth hormone receptor
decreases expression
EXP
methyleugenol results in decreased expression of GHR mRNA
CTD
PMID:32234424
NCBI chr 5:42,423,439...42,721,878
Ensembl chr 5:42,423,439...42,721,878
G
GIPC2
GIPC PDZ domain containing family member 2
decreases expression
EXP
methyleugenol results in decreased expression of GIPC2 mRNA
CTD
PMID:32234424
NCBI chr 1:78,044,970...78,138,444
Ensembl chr 1:77,979,542...78,138,444
G
GJA3
gap junction protein alpha 3
increases expression
EXP
methyleugenol results in increased expression of GJA3 mRNA
CTD
PMID:32234424
NCBI chr13:20,138,255...20,161,565
Ensembl chr13:20,138,255...20,161,052
G
GLA
galactosidase alpha
increases expression
EXP
methyleugenol results in increased expression of GLA mRNA
CTD
PMID:32234424
NCBI chr X:101,397,803...101,407,925
Ensembl chr X:101,393,273...101,408,012
G
GLDC
glycine decarboxylase
decreases expression
EXP
methyleugenol results in decreased expression of GLDC mRNA
CTD
PMID:32234424
NCBI chr 9:6,532,467...6,645,729
Ensembl chr 9:6,532,467...6,645,729
G
GLIPR1
GLI pathogenesis related 1
increases expression
EXP
methyleugenol results in increased expression of GLIPR1 mRNA
CTD
PMID:32234424
NCBI chr12:75,480,755...75,503,863
Ensembl chr12:75,480,753...75,503,863
G
GLIPR2
GLI pathogenesis related 2
increases expression
EXP
methyleugenol results in increased expression of GLIPR2 mRNA
CTD
PMID:32234424
NCBI chr 9:36,136,536...36,163,913
Ensembl chr 9:36,136,536...36,163,913
G
GLRA3
glycine receptor alpha 3
decreases expression
EXP
methyleugenol results in decreased expression of GLRA3 mRNA
CTD
PMID:32234424
NCBI chr 4:174,636,920...174,829,247
Ensembl chr 4:174,636,920...174,829,247
G
GLS2
glutaminase 2
decreases expression
EXP
methyleugenol results in decreased expression of GLS2 mRNA
CTD
PMID:32234424
NCBI chr12:56,470,952...56,488,161
Ensembl chr12:56,470,944...56,488,414
G
GLTPD2
glycolipid transfer protein domain containing 2
decreases expression
EXP
methyleugenol results in decreased expression of GLTPD2 mRNA
CTD
PMID:32234424
NCBI chr17:4,788,964...4,790,589
Ensembl chr17:4,788,964...4,790,589
G
GLUD1
glutamate dehydrogenase 1
decreases expression
EXP
methyleugenol results in decreased expression of GLUD1 mRNA
CTD
PMID:32234424
NCBI chr10:87,050,202...87,094,843
Ensembl chr10:87,050,202...87,094,843
G
GLUL
glutamate-ammonia ligase
decreases expression
EXP
methyleugenol results in decreased expression of GLUL mRNA
CTD
PMID:32234424
NCBI chr 1:182,378,098...182,391,790
Ensembl chr 1:182,378,098...182,392,206
G
GLYAT
glycine-N-acyltransferase
decreases expression
EXP
methyleugenol results in decreased expression of GLYAT mRNA
CTD
PMID:32234424
NCBI chr11:58,708,757...58,731,943
Ensembl chr11:58,640,426...58,731,974
G
GLYATL1
glycine-N-acyltransferase like 1
decreases expression
EXP
methyleugenol results in decreased expression of GLYATL1 mRNA
CTD
PMID:32234424
NCBI chr11:58,905,481...58,956,406
Ensembl chr11:58,905,398...59,043,527
G
GLYCTK
glycerate kinase
decreases expression
EXP
methyleugenol results in decreased expression of GLYCTK mRNA
CTD
PMID:32234424
NCBI chr 3:52,287,828...52,295,257
Ensembl chr 3:52,287,089...52,295,257
G
GMDS
GDP-mannose 4,6-dehydratase
decreases expression
EXP
methyleugenol results in decreased expression of GMDS mRNA
CTD
PMID:32234424
NCBI chr 6:1,623,806...2,245,605
Ensembl chr 6:1,623,806...2,245,605
G
GNG12-AS1
GNG12, DIRAS3 and WLS antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of GNG12-AS1 mRNA
CTD
PMID:32234424
NCBI chr 1:67,832,288...68,202,987
Ensembl chr 1:67,832,293...68,202,987
G
GNG7
G protein subunit gamma 7
decreases expression
EXP
methyleugenol results in decreased expression of GNG7 mRNA
CTD
PMID:32234424
NCBI chr19:2,511,219...2,702,694
Ensembl chr19:2,511,219...2,702,694
G
GNMT
glycine N-methyltransferase
decreases expression
EXP
methyleugenol results in decreased expression of GNMT mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 6:42,960,754...42,963,880
Ensembl chr 6:42,960,754...42,963,880
G
GOLGA8S
golgin A8 family member S
increases expression
EXP
methyleugenol results in increased expression of GOLGA8S mRNA
CTD
PMID:32234424
NCBI chr15:23,354,748...23,368,489
Ensembl chr15:23,354,748...23,368,341
G
GPAM
glycerol-3-phosphate acyltransferase, mitochondrial
decreases expression
EXP
methyleugenol results in decreased expression of GPAM mRNA
CTD
PMID:32234424
NCBI chr10:112,149,865...112,227,677
Ensembl chr10:112,149,865...112,215,377
G
GPC2
glypican 2
increases expression
EXP
methyleugenol results in increased expression of GPC2 mRNA
CTD
PMID:32234424
NCBI chr 7:100,169,606...100,177,381
Ensembl chr 7:100,169,606...100,177,381
G
GPC5
glypican 5
decreases expression
EXP
methyleugenol results in decreased expression of GPC5 mRNA
CTD
PMID:32234424
NCBI chr13:91,398,621...92,867,237
Ensembl chr13:91,398,621...92,873,682
G
GPC6
glypican 6
decreases expression
EXP
methyleugenol results in decreased expression of GPC6 mRNA
CTD
PMID:32234424
NCBI chr13:93,216,529...94,408,020
Ensembl chr13:93,226,807...94,408,020
G
GPD1
glycerol-3-phosphate dehydrogenase 1
decreases expression
EXP
methyleugenol results in decreased expression of GPD1 mRNA
CTD
PMID:32234424
NCBI chr12:50,104,008...50,111,313
Ensembl chr12:50,103,982...50,111,313
G
GPHN
gephyrin
decreases expression
EXP
methyleugenol results in decreased expression of GPHN mRNA
CTD
PMID:32234424
NCBI chr14:66,508,147...67,735,355
Ensembl chr14:66,507,407...67,181,803
G
GPM6A
glycoprotein M6A
decreases expression
EXP
methyleugenol results in decreased expression of GPM6A mRNA
CTD
PMID:32234424
NCBI chr 4:175,632,937...176,002,691
Ensembl chr 4:175,632,934...176,002,664
G
GPR153
G protein-coupled receptor 153
decreases expression
EXP
methyleugenol results in decreased expression of GPR153 mRNA
CTD
PMID:32234424
NCBI chr 1:6,247,353...6,261,098
Ensembl chr 1:6,247,353...6,261,098
G
GPR160
G protein-coupled receptor 160
decreases expression
EXP
methyleugenol results in decreased expression of GPR160 mRNA
CTD
PMID:32234424
NCBI chr 3:170,037,995...170,085,392
Ensembl chr 3:170,037,995...170,085,392
G
GPR87
G protein-coupled receptor 87
increases expression
EXP
methyleugenol results in increased expression of GPR87 mRNA
CTD
PMID:32234424
NCBI chr 3:151,294,086...151,316,820
Ensembl chr 3:151,294,086...151,316,820
G
GPRC5A
G protein-coupled receptor class C group 5 member A
increases expression
EXP
methyleugenol results in increased expression of GPRC5A mRNA
CTD
PMID:32234424
NCBI chr12:12,891,562...12,917,937
Ensembl chr12:12,890,782...12,917,937
G
GPRC5B
G protein-coupled receptor class C group 5 member B
increases expression
EXP
methyleugenol results in increased expression of GPRC5B mRNA
CTD
PMID:32234424
NCBI chr16:19,856,691...19,885,634
Ensembl chr16:19,856,691...19,886,167
G
GPRIN1
G protein regulated inducer of neurite outgrowth 1
increases expression
EXP
methyleugenol results in increased expression of GPRIN1 mRNA
CTD
PMID:32234424
NCBI chr 5:176,595,802...176,610,156
Ensembl chr 5:176,595,802...176,610,156
G
GPSM1
G protein signaling modulator 1
increases expression
EXP
methyleugenol results in increased expression of GPSM1 mRNA
CTD
PMID:32234424
NCBI chr 9:136,327,539...136,359,601
Ensembl chr 9:136,327,476...136,359,605
G
GPT
glutamic--pyruvic transaminase
decreases expression
EXP
methyleugenol results in decreased expression of GPT mRNA
CTD
PMID:32234424
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
GRAP
GRB2 related adaptor protein
decreases expression
EXP
methyleugenol results in decreased expression of GRAP mRNA
CTD
PMID:32234424
NCBI chr17:19,020,656...19,051,373
Ensembl chr17:19,020,656...19,047,011
G
GREB1
growth regulating estrogen receptor binding 1
decreases expression
EXP
methyleugenol results in decreased expression of GREB1 mRNA
CTD
PMID:32234424
NCBI chr 2:11,482,888...11,642,788
Ensembl chr 2:11,482,341...11,642,788
G
GRID1
glutamate ionotropic receptor delta type subunit 1
decreases expression
EXP
methyleugenol results in decreased expression of GRID1 mRNA
CTD
PMID:32234424
NCBI chr10:85,599,552...86,366,795
Ensembl chr10:85,599,552...86,366,795
G
GRID2
glutamate ionotropic receptor delta type subunit 2
decreases expression
EXP
methyleugenol results in decreased expression of GRID2 mRNA
CTD
PMID:32234424
NCBI chr 4:92,303,966...93,810,456
Ensembl chr 4:92,303,966...93,810,157
G
GRIK4
glutamate ionotropic receptor kainate type subunit 4
decreases expression
EXP
methyleugenol results in decreased expression of GRIK4 mRNA
CTD
PMID:32234424
NCBI chr11:120,511,748...120,988,906
Ensembl chr11:120,511,746...120,988,906
G
GRIK5
glutamate ionotropic receptor kainate type subunit 5
decreases expression
EXP
methyleugenol results in decreased expression of GRIK5 mRNA
CTD
PMID:32234424
NCBI chr19:41,998,324...42,070,206
Ensembl chr19:41,998,321...42,070,206
G
GRIN2C
glutamate ionotropic receptor NMDA type subunit 2C
increases expression
EXP
methyleugenol results in increased expression of GRIN2C mRNA
CTD
PMID:32234424
NCBI chr17:74,842,023...74,861,532
Ensembl chr17:74,842,023...74,861,504
G
GRIP1
glutamate receptor interacting protein 1
decreases expression
EXP
methyleugenol results in decreased expression of GRIP1 mRNA
CTD
PMID:32234424
NCBI chr12:66,347,431...67,069,338
Ensembl chr12:66,347,431...67,069,162
G
GRM3
glutamate metabotropic receptor 3
decreases expression
EXP
methyleugenol results in decreased expression of GRM3 mRNA
CTD
PMID:32234424
NCBI chr 7:86,643,909...86,864,879
Ensembl chr 7:86,643,909...86,864,879
G
GRM8
glutamate metabotropic receptor 8
decreases expression
EXP
methyleugenol results in decreased expression of GRM8 mRNA
CTD
PMID:32234424
NCBI chr 7:126,438,598...127,252,941
Ensembl chr 7:126,438,598...127,253,093
G
GSTA1
glutathione S-transferase alpha 1
decreases activity
EXP
methyleugenol results in decreased activity of GSTA1 protein
CTD
PMID:8620581
NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860
G
GSTA2
glutathione S-transferase alpha 2
decreases activity
ISO
methyleugenol results in decreased activity of GSTA2 protein
CTD
PMID:8620581
NCBI chr 6:52,750,087...52,763,475
Ensembl chr 6:52,750,087...52,763,475
G
GSTM1
glutathione S-transferase mu 1
decreases activity decreases expression
EXP ISO
methyleugenol results in decreased activity of GSTM1 protein methyleugenol results in decreased expression of GSTM1 mRNA
CTD
PMID:8620581 PMID:32234424
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
GSTM2
glutathione S-transferase mu 2
decreases activity
ISO
methyleugenol results in decreased activity of GSTM2 protein
CTD
PMID:8620581
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
G
GSTP1
glutathione S-transferase pi 1
decreases activity
EXP ISO
methyleugenol results in decreased activity of GSTP1 protein
CTD
PMID:8620581
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
GTDC1
glycosyltransferase like domain containing 1
decreases expression
EXP
methyleugenol results in decreased expression of GTDC1 mRNA
CTD
PMID:32234424
NCBI chr 2:143,938,068...144,333,069
Ensembl chr 2:143,938,068...144,332,568
G
GUCY1A2
guanylate cyclase 1 soluble subunit alpha 2
decreases expression
EXP
methyleugenol results in decreased expression of GUCY1A2 mRNA
CTD
PMID:32234424
NCBI chr11:106,674,019...107,018,476
Ensembl chr11:106,674,019...107,018,476
G
GUCY2D
guanylate cyclase 2D, retinal
decreases expression
EXP
methyleugenol results in decreased expression of GUCY2D mRNA
CTD
PMID:32234424
NCBI chr17:8,002,615...8,020,342
Ensembl chr17:8,002,615...8,020,342
G
GULP1
GULP PTB domain containing engulfment adaptor 1
decreases expression
EXP
methyleugenol results in decreased expression of GULP1 mRNA
CTD
PMID:32234424
NCBI chr 2:188,291,874...188,595,926
Ensembl chr 2:188,291,669...188,595,931
G
GYS2
glycogen synthase 2
decreases expression
EXP
methyleugenol results in decreased expression of GYS2 mRNA
CTD
PMID:32234424
NCBI chr12:21,532,577...21,604,847
Ensembl chr12:21,536,107...21,604,847
G
H2AX
H2A.X variant histone
increases expression
ISO
methyleugenol results in increased expression of H2AX protein
CTD
PMID:26011634
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
G
H2BC3
H2B clustered histone 3
decreases expression
EXP
methyleugenol results in decreased expression of H2BC3 mRNA
CTD
PMID:32234424
NCBI chr 6:26,043,227...26,043,713
Ensembl chr 6:26,043,227...26,043,713
G
H2BC8
H2B clustered histone 8
decreases expression
EXP
methyleugenol results in decreased expression of H2BC8 mRNA
CTD
PMID:32234424
NCBI chr 6:26,216,200...26,216,688
Ensembl chr 6:26,216,200...26,216,688
G
H3C1
H3 clustered histone 1
decreases expression
EXP
methyleugenol results in decreased expression of H3C1 mRNA
CTD
PMID:32234424
NCBI chr 6:26,020,451...26,020,958
Ensembl chr 6:26,020,451...26,020,958
G
HAGH
hydroxyacylglutathione hydrolase
decreases expression
EXP
methyleugenol results in decreased expression of HAGH mRNA
CTD
PMID:32234424
NCBI chr16:1,807,629...1,827,194
Ensembl chr16:1,795,620...1,827,157
G
HAO2
hydroxyacid oxidase 2
decreases expression
EXP
methyleugenol results in decreased expression of HAO2 mRNA
CTD
PMID:32234424
NCBI chr 1:119,368,785...119,394,130
Ensembl chr 1:119,368,779...119,394,130
G
HAVCR2
hepatitis A virus cellular receptor 2
decreases expression
EXP
methyleugenol results in decreased expression of HAVCR2 mRNA
CTD
PMID:32234424
NCBI chr 5:157,085,832...157,109,044
Ensembl chr 5:157,085,422...157,142,869
G
HDAC4
histone deacetylase 4
decreases expression
EXP
methyleugenol results in decreased expression of HDAC4 mRNA
CTD
PMID:32234424
NCBI chr 2:239,048,168...239,401,649
Ensembl chr 2:239,048,168...239,401,654
G
HES2
hes family bHLH transcription factor 2
increases expression
EXP
methyleugenol results in increased expression of HES2 mRNA
CTD
PMID:32234424
NCBI chr 1:6,415,232...6,419,919
Ensembl chr 1:6,412,418...6,424,670
G
HHAT
hedgehog acyltransferase
decreases expression
EXP
methyleugenol results in decreased expression of HHAT mRNA
CTD
PMID:32234424
NCBI chr 1:210,327,328...210,676,290
Ensembl chr 1:210,328,252...210,676,296
G
HJV
hemojuvelin BMP co-receptor
decreases expression
EXP
methyleugenol results in decreased expression of HJV mRNA
CTD
PMID:32234424
NCBI chr 1:146,017,470...146,021,735
Ensembl chr 1:146,017,468...146,036,746
G
HLX-AS1
HLX antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of HLX-AS1 mRNA
CTD
PMID:32234424
NCBI chr 1:220,832,763...220,880,140
Ensembl chr 1:220,832,763...220,880,140
G
HMCN1
hemicentin 1
decreases expression
EXP
methyleugenol results in decreased expression of HMCN1 mRNA
CTD
PMID:32234424
NCBI chr 1:185,734,391...186,190,949
Ensembl chr 1:185,734,391...186,190,949
G
HMCN2
hemicentin 2
decreases expression
EXP
methyleugenol results in decreased expression of HMCN2 mRNA
CTD
PMID:32234424
NCBI chr 9:130,265,760...130,434,123
Ensembl chr 9:130,265,760...130,434,123
G
HMGA1
high mobility group AT-hook 1
increases expression
EXP
methyleugenol results in increased expression of HMGA1 mRNA
CTD
PMID:32234424
NCBI chr 6:34,236,873...34,246,231
Ensembl chr 6:34,236,873...34,246,231
G
HMGCS1
3-hydroxy-3-methylglutaryl-CoA synthase 1
decreases expression
EXP
methyleugenol results in decreased expression of HMGCS1 mRNA
CTD
PMID:32234424
NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512
G
HMGCS2
3-hydroxy-3-methylglutaryl-CoA synthase 2
decreases expression
EXP
methyleugenol results in decreased expression of HMGCS2 mRNA
CTD
PMID:32234424
NCBI chr 1:119,747,996...119,768,932
Ensembl chr 1:119,748,002...119,768,905
G
HMMR
hyaluronan mediated motility receptor
decreases expression
EXP
methyleugenol results in decreased expression of HMMR mRNA
CTD
PMID:32234424
NCBI chr 5:163,460,632...163,491,941
Ensembl chr 5:163,460,203...163,491,941
G
HNF4A-AS1
HNF4A antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of HNF4A-AS1 mRNA
CTD
PMID:32234424
NCBI chr20:44,356,744...44,395,706
Ensembl chr20:44,372,746...44,395,706
G
HNMT
histamine N-methyltransferase
decreases expression
EXP
methyleugenol results in decreased expression of HNMT mRNA
CTD
PMID:32234424
NCBI chr 2:137,964,473...138,016,364
Ensembl chr 2:137,964,020...138,016,364
G
HNRNPA1P33
heterogeneous nuclear ribonucleoprotein A1 pseudogene 33
decreases expression
EXP
methyleugenol results in decreased expression of HNRNPA1P33 mRNA
CTD
PMID:32234424
NCBI chr10:46,415,853...46,416,416
Ensembl chr10:46,415,853...46,416,413
G
HOGA1
4-hydroxy-2-oxoglutarate aldolase 1
decreases expression
EXP
methyleugenol results in decreased expression of HOGA1 mRNA
CTD
PMID:32234424
NCBI chr10:97,584,389...97,612,802
Ensembl chr10:97,584,323...97,612,802
G
HOMER3
homer scaffold protein 3
increases expression
EXP
methyleugenol results in increased expression of HOMER3 mRNA
CTD
PMID:32234424
NCBI chr19:18,929,201...18,941,217
Ensembl chr19:18,929,201...18,941,261
G
HORMAD2-AS1
HORMAD2 and MTMR3 antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of HORMAD2-AS1 mRNA
CTD
PMID:32234424
NCBI chr22:30,008,746...30,080,257
Ensembl chr22:30,008,742...30,080,480
G
HOXB9
homeobox B9
increases expression
EXP
methyleugenol results in increased expression of HOXB9 mRNA
CTD
PMID:32234424
NCBI chr17:48,621,156...48,626,358
Ensembl chr17:48,621,156...48,626,358
G
HP
haptoglobin
decreases expression
EXP
methyleugenol results in decreased expression of HP mRNA
CTD
PMID:32234424
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
G
HPD
4-hydroxyphenylpyruvate dioxygenase
decreases expression
EXP
methyleugenol results in decreased expression of HPD mRNA
CTD
PMID:32234424
NCBI chr12:121,839,527...121,888,611
Ensembl chr12:121,839,527...121,863,596
G
HPN
hepsin
decreases expression
EXP
methyleugenol results in decreased expression of HPN mRNA
CTD
PMID:32234424
NCBI chr19:35,040,506...35,066,573
Ensembl chr19:35,040,506...35,066,573
G
HPR
haptoglobin-related protein
decreases expression
EXP
methyleugenol results in decreased expression of HPR mRNA
CTD
PMID:32234424
NCBI chr16:72,063,226...72,077,246
Ensembl chr16:72,063,148...72,077,246
G
HPX
hemopexin
decreases expression
EXP
methyleugenol results in decreased expression of HPX mRNA
CTD
PMID:32234424
NCBI chr11:6,431,049...6,440,987
Ensembl chr11:6,431,049...6,442,617
G
HRG
histidine rich glycoprotein
decreases expression
EXP
methyleugenol results in decreased expression of HRG mRNA
CTD
PMID:32234424
NCBI chr 3:186,666,014...186,678,234
Ensembl chr 3:186,660,216...186,678,234
G
HS6ST3
heparan sulfate 6-O-sulfotransferase 3
decreases expression
EXP
methyleugenol results in decreased expression of HS6ST3 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr13:96,090,107...96,839,562
Ensembl chr13:96,090,107...96,839,562
G
HSD17B2
hydroxysteroid 17-beta dehydrogenase 2
decreases expression
EXP
methyleugenol results in decreased expression of HSD17B2 mRNA
CTD
PMID:32234424
NCBI chr16:82,035,253...82,098,534
Ensembl chr16:82,035,004...82,098,534
G
HSD17B6
hydroxysteroid 17-beta dehydrogenase 6
decreases expression
EXP
methyleugenol results in decreased expression of HSD17B6 mRNA
CTD
PMID:32234424
NCBI chr12:56,763,324...56,787,790
Ensembl chr12:56,752,161...56,787,790
G
HTR3A
5-hydroxytryptamine receptor 3A
increases expression
EXP
methyleugenol results in increased expression of HTR3A mRNA
CTD
PMID:32234424
NCBI chr11:113,975,108...113,990,313
Ensembl chr11:113,975,075...113,990,313
G
ICMT-DT
ICMT divergent transcript
decreases expression
EXP
methyleugenol results in decreased expression of ICMT-DT mRNA
CTD
PMID:32234424
NCBI chr 1:6,236,240...6,239,444
Ensembl chr 1:6,234,692...6,239,444
G
ID2
inhibitor of DNA binding 2
decreases expression
EXP
methyleugenol results in decreased expression of ID2 mRNA
CTD
PMID:32234424
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
G
IDI1
isopentenyl-diphosphate delta isomerase 1
decreases expression
EXP
methyleugenol results in decreased expression of IDI1 mRNA
CTD
PMID:32234424
NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119
G
IDNK
IDNK gluconokinase
decreases expression
EXP
methyleugenol results in decreased expression of IDNK mRNA
CTD
PMID:32234424
NCBI chr 9:83,623,006...83,644,123
Ensembl chr 9:83,623,049...83,644,130
G
IER3
immediate early response 3
increases expression
EXP
methyleugenol results in increased expression of IER3 mRNA
CTD
PMID:32234424
NCBI chr 6:30,743,199...30,744,547
Ensembl chr 6:30,743,199...30,744,548
G
IGF1
insulin like growth factor 1
decreases expression
EXP
methyleugenol results in decreased expression of IGF1 mRNA
CTD
PMID:32234424
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGSF23
immunoglobulin superfamily member 23
decreases expression
EXP
methyleugenol results in decreased expression of IGSF23 mRNA
CTD
PMID:32234424
NCBI chr19:44,613,563...44,636,781
Ensembl chr19:44,613,563...44,636,781
G
IGSF9
immunoglobulin superfamily member 9
decreases expression
EXP
methyleugenol results in decreased expression of IGSF9 mRNA
CTD
PMID:32234424
NCBI chr 1:159,927,041...159,945,613
Ensembl chr 1:159,927,039...159,945,613
G
IL16
interleukin 16
decreases expression
EXP
methyleugenol results in decreased expression of IL16 mRNA
CTD
PMID:32234424
NCBI chr15:81,182,712...81,314,058
Ensembl chr15:81,159,575...81,314,058
G
IL1B
interleukin 1 beta
increases expression
EXP
methyleugenol results in increased expression of IL1B mRNA
CTD
PMID:32234424
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RL1
interleukin 1 receptor like 1
increases expression
EXP
methyleugenol results in increased expression of IL1RL1 mRNA
CTD
PMID:32234424
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
G
IMMP2L
inner mitochondrial membrane peptidase subunit 2
decreases expression
EXP
methyleugenol results in decreased expression of IMMP2L mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 7:110,662,644...111,562,492
Ensembl chr 7:110,662,644...111,562,517
G
IMPDH1
inosine monophosphate dehydrogenase 1
increases expression
EXP
methyleugenol results in increased expression of IMPDH1 mRNA
CTD
PMID:32234424
NCBI chr 7:128,392,277...128,409,982
Ensembl chr 7:128,392,277...128,409,986
G
IMPG2
interphotoreceptor matrix proteoglycan 2
decreases expression
EXP
methyleugenol results in decreased expression of IMPG2 mRNA
CTD
PMID:32234424
NCBI chr 3:101,222,546...101,320,575
Ensembl chr 3:101,222,546...101,320,575
G
INCENP
inner centromere protein
increases expression
ISO
methyleugenol results in increased expression of INCENP protein
CTD
PMID:23411599
NCBI chr11:62,124,011...62,153,169
Ensembl chr11:62,123,998...62,153,169
G
INHBA
inhibin subunit beta A
decreases expression
ISO EXP
methyleugenol results in decreased expression of INHBA mRNA
CTD
PMID:15618236 PMID:32234424
NCBI chr 7:41,685,114...41,705,406
Ensembl chr 7:41,667,168...41,705,834
G
INHBC
inhibin subunit beta C
decreases expression
EXP
methyleugenol results in decreased expression of INHBC mRNA
CTD
PMID:32234424
NCBI chr12:57,434,784...57,452,062
Ensembl chr12:57,434,784...57,452,062
G
INHBE
inhibin subunit beta E
decreases expression
EXP
methyleugenol results in decreased expression of INHBE mRNA
CTD
PMID:32234424
NCBI chr12:57,455,307...57,458,025
Ensembl chr12:57,452,323...57,459,280
G
INKA2
inka box actin regulator 2
increases expression
EXP
methyleugenol results in increased expression of INKA2 mRNA
CTD
PMID:32234424
NCBI chr 1:111,722,064...111,755,797
Ensembl chr 1:111,680,630...111,755,824
G
INPP4B
inositol polyphosphate-4-phosphatase type II B
decreases expression
EXP
methyleugenol results in decreased expression of INPP4B mRNA
CTD
PMID:32234424
NCBI chr 4:142,023,160...142,846,535
Ensembl chr 4:142,023,160...142,847,432
G
INSIG1
insulin induced gene 1
decreases expression
EXP
methyleugenol results in decreased expression of INSIG1 mRNA
CTD
PMID:32234424
NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
G
IQGAP2
IQ motif containing GTPase activating protein 2
decreases expression
EXP
methyleugenol results in decreased expression of IQGAP2 mRNA
CTD
PMID:32234424
NCBI chr 5:76,403,285...76,708,132
Ensembl chr 5:76,403,285...76,708,132
G
IQUB
IQ motif and ubiquitin domain containing
decreases expression
EXP
methyleugenol results in decreased expression of IQUB mRNA
CTD
PMID:32234424
NCBI chr 7:123,452,193...123,534,595
Ensembl chr 7:123,452,193...123,535,077
G
IRAG1
inositol 1,4,5-triphosphate receptor associated 1
decreases expression
EXP
methyleugenol results in decreased expression of IRAG1 mRNA
CTD
PMID:32234424
NCBI chr11:10,573,095...10,693,755
Ensembl chr11:10,573,091...10,693,988
G
ITGA11
integrin subunit alpha 11
increases expression
EXP
methyleugenol results in increased expression of ITGA11 mRNA
CTD
PMID:32234424
NCBI chr15:68,296,532...68,432,163
Ensembl chr15:68,296,532...68,432,163
G
ITGA2
integrin subunit alpha 2
increases expression
EXP
methyleugenol results in increased expression of ITGA2 mRNA
CTD
PMID:32234424
NCBI chr 5:52,989,352...53,094,779
Ensembl chr 5:52,989,340...53,094,779
G
ITGA8
integrin subunit alpha 8
decreases expression
EXP
methyleugenol results in decreased expression of ITGA8 mRNA
CTD
PMID:32234424
NCBI chr10:15,513,954...15,719,922
Ensembl chr10:15,513,954...15,719,922
G
ITGAX
integrin subunit alpha X
increases expression
EXP
methyleugenol results in increased expression of ITGAX mRNA
CTD
PMID:32234424
NCBI chr16:31,355,176...31,382,999
Ensembl chr16:31,355,134...31,382,999
G
ITIH1
inter-alpha-trypsin inhibitor heavy chain 1
decreases expression
EXP
methyleugenol results in decreased expression of ITIH1 mRNA
CTD
PMID:32234424
NCBI chr 3:52,777,599...52,792,068
Ensembl chr 3:52,777,595...52,792,068
G
ITPR1
inositol 1,4,5-trisphosphate receptor type 1
decreases expression
EXP
methyleugenol results in decreased expression of ITPR1 mRNA
CTD
PMID:32234424
NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506
G
ITPR3
inositol 1,4,5-trisphosphate receptor type 3
increases expression
EXP
methyleugenol results in increased expression of ITPR3 mRNA
CTD
PMID:32234424
NCBI chr 6:33,621,322...33,696,562
Ensembl chr 6:33,620,365...33,696,574
G
IYD
iodotyrosine deiodinase
decreases expression
EXP
methyleugenol results in decreased expression of IYD mRNA
CTD
PMID:32234424
NCBI chr 6:150,369,012...150,405,969
Ensembl chr 6:150,368,892...150,405,969
G
JAKMIP2
janus kinase and microtubule interacting protein 2
decreases expression
EXP
methyleugenol results in decreased expression of JAKMIP2 mRNA
CTD
PMID:32234424
NCBI chr 5:147,585,438...147,782,728
Ensembl chr 5:147,585,438...147,782,775
G
JPH2
junctophilin 2
decreases expression
EXP
methyleugenol results in decreased expression of JPH2 mRNA
CTD
PMID:32234424
NCBI chr20:44,106,590...44,187,188
Ensembl chr20:44,106,590...44,187,188
G
JUNB
JunB proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
methyleugenol results in increased expression of JUNB mRNA
CTD
PMID:15618236
NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
G
KCND3
potassium voltage-gated channel subfamily D member 3
decreases expression
EXP
methyleugenol results in decreased expression of KCND3 mRNA
CTD
PMID:32234424
NCBI chr 1:111,770,662...111,989,668
Ensembl chr 1:111,770,662...111,989,668
G
KCNH5
potassium voltage-gated channel subfamily H member 5
decreases expression
EXP
methyleugenol results in decreased expression of KCNH5 mRNA
CTD
PMID:32234424
NCBI chr14:62,699,464...63,045,458
Ensembl chr14:62,699,464...63,102,037
G
KCNH7
potassium voltage-gated channel subfamily H member 7
decreases expression
EXP
methyleugenol results in decreased expression of KCNH7 mRNA
CTD
PMID:32234424
NCBI chr 2:162,371,407...162,838,767
Ensembl chr 2:162,371,407...162,838,767
G
KCNH8
potassium voltage-gated channel subfamily H member 8
decreases expression
EXP
methyleugenol results in decreased expression of KCNH8 mRNA
CTD
PMID:32234424
NCBI chr 3:19,148,510...19,535,642
Ensembl chr 3:19,148,510...19,535,642
G
KCNJ3
potassium inwardly rectifying channel subfamily J member 3
decreases expression
EXP
methyleugenol results in decreased expression of KCNJ3 mRNA
CTD
PMID:32234424
NCBI chr 2:154,698,695...154,858,354
Ensembl chr 2:154,697,855...154,858,354
G
KCNK13
potassium two pore domain channel subfamily K member 13
decreases expression
EXP
methyleugenol results in decreased expression of KCNK13 mRNA
CTD
PMID:32234424
NCBI chr14:90,061,994...90,185,853
Ensembl chr14:90,061,994...90,185,853
G
KCNK5
potassium two pore domain channel subfamily K member 5
decreases expression
EXP
methyleugenol results in decreased expression of KCNK5 mRNA
CTD
PMID:32234424
NCBI chr 6:39,188,971...39,229,475
Ensembl chr 6:39,188,971...39,229,475
G
KCNMA1
potassium calcium-activated channel subfamily M alpha 1
decreases expression
EXP
methyleugenol results in decreased expression of KCNMA1 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr10:76,869,602...77,637,808
Ensembl chr10:76,869,601...77,638,369
G
KCNQ5
potassium voltage-gated channel subfamily Q member 5
decreases expression
EXP
methyleugenol results in decreased expression of KCNQ5 mRNA
CTD
PMID:32234424
NCBI chr 6:72,622,064...73,198,853
Ensembl chr 6:72,621,792...73,198,853
G
KCNT2
potassium sodium-activated channel subfamily T member 2
decreases expression
EXP
methyleugenol results in decreased expression of KCNT2 mRNA
CTD
PMID:32234424
NCBI chr 1:196,225,779...196,608,440
Ensembl chr 1:196,225,779...196,609,225
G
KCNV1
potassium voltage-gated channel modifier subfamily V member 1
increases expression
EXP
methyleugenol results in increased expression of KCNV1 mRNA
CTD
PMID:32234424
NCBI chr 8:109,963,636...109,975,771
Ensembl chr 8:109,963,636...109,975,771
G
KCTD15
potassium channel tetramerization domain containing 15
increases expression
EXP
methyleugenol results in increased expression of KCTD15 mRNA
CTD
PMID:32234424
NCBI chr19:33,794,040...33,815,761
Ensembl chr19:33,795,933...33,815,763
G
KCTD16
potassium channel tetramerization domain containing 16
decreases expression
EXP
methyleugenol results in decreased expression of KCTD16 mRNA
CTD
PMID:32234424
NCBI chr 5:144,170,873...144,485,686
Ensembl chr 5:144,170,873...144,485,686
G
KDM8
lysine demethylase 8
decreases expression
EXP
methyleugenol results in decreased expression of KDM8 mRNA
CTD
PMID:32234424
NCBI chr16:27,203,526...27,221,768
Ensembl chr16:27,203,508...27,221,768
G
KDR
kinase insert domain receptor
decreases expression
EXP
methyleugenol results in decreased expression of KDR mRNA
CTD
PMID:32234424
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
G
KHK
ketohexokinase
decreases expression
EXP
methyleugenol results in decreased expression of KHK mRNA
CTD
PMID:32234424
NCBI chr 2:27,086,772...27,100,762
Ensembl chr 2:27,086,772...27,100,762
G
KIAA0825
KIAA0825
decreases expression
EXP
methyleugenol results in decreased expression of KIAA0825 mRNA
CTD
PMID:32234424
NCBI chr 5:94,150,851...94,618,604
Ensembl chr 5:94,150,851...94,618,604
G
KIAA1328
KIAA1328
decreases expression
EXP
methyleugenol results in decreased expression of KIAA1328 mRNA
CTD
PMID:32234424
NCBI chr18:36,829,127...37,232,172
Ensembl chr18:36,829,106...37,232,172
G
KIF17
kinesin family member 17
decreases expression
EXP
methyleugenol results in decreased expression of KIF17 mRNA
CTD
PMID:32234424
NCBI chr 1:20,661,630...20,718,007
Ensembl chr 1:20,664,014...20,718,017
G
KIF20A
kinesin family member 20A
decreases expression
EXP
methyleugenol results in decreased expression of KIF20A mRNA
CTD
PMID:32234424
NCBI chr 5:138,179,112...138,187,723
Ensembl chr 5:138,178,719...138,187,723
G
KIF26B
kinesin family member 26B
decreases expression
EXP
methyleugenol results in decreased expression of KIF26B mRNA
CTD
PMID:32234424
NCBI chr 1:245,154,985...245,709,432
Ensembl chr 1:245,154,985...245,709,432
G
KLB
klotho beta
decreases expression
EXP
methyleugenol results in decreased expression of KLB mRNA
CTD
PMID:32234424
NCBI chr 4:39,406,930...39,451,533
Ensembl chr 4:39,406,930...39,451,533
G
KLC4
kinesin light chain 4
decreases expression
EXP
methyleugenol results in decreased expression of KLC4 mRNA
CTD
PMID:32234424
NCBI chr 6:43,059,631...43,075,093
Ensembl chr 6:43,040,777...43,075,095
G
KLF12
KLF transcription factor 12
decreases expression
EXP
methyleugenol results in decreased expression of KLF12 mRNA
CTD
PMID:32234424
NCBI chr13:73,686,089...74,306,045
Ensembl chr13:73,686,089...74,134,404
G
KLF15
KLF transcription factor 15
decreases expression
EXP
methyleugenol results in decreased expression of KLF15 mRNA
CTD
PMID:32234424
NCBI chr 3:126,288,125...126,357,408
Ensembl chr 3:126,342,635...126,357,408
G
KLF6
KLF transcription factor 6
increases expression
ISO
methyleugenol results in increased expression of KLF6 mRNA
CTD
PMID:23411599
NCBI chr10:3,775,996...3,785,209
Ensembl chr10:3,775,996...3,785,281
G
KLHL32
kelch like family member 32
decreases expression
EXP
methyleugenol results in decreased expression of KLHL32 mRNA
CTD
PMID:32234424
NCBI chr 6:96,898,083...97,140,753
Ensembl chr 6:96,924,620...97,140,754
G
KLKB1
kallikrein B1
decreases expression
EXP
methyleugenol results in decreased expression of KLKB1 mRNA
CTD
PMID:32234424
NCBI chr 4:186,210,853...186,258,471
Ensembl chr 4:186,226,438...186,258,471
G
KMO
kynurenine 3-monooxygenase
decreases expression
EXP
methyleugenol results in decreased expression of KMO mRNA
CTD
PMID:32234424
NCBI chr 1:241,532,378...241,595,642
Ensembl chr 1:241,532,134...241,595,642
G
KNG1
kininogen 1
decreases expression
EXP
methyleugenol results in decreased expression of KNG1 mRNA
CTD
PMID:32234424
NCBI chr 3:186,717,359...186,744,410
Ensembl chr 3:186,717,348...186,744,410
G
KRT20
keratin 20
increases expression
EXP
methyleugenol results in increased expression of KRT20 mRNA
CTD
PMID:32234424
NCBI chr17:40,875,889...40,885,242
Ensembl chr17:40,875,889...40,885,242
G
KRT4
keratin 4
decreases expression
EXP
methyleugenol results in decreased expression of KRT4 mRNA
CTD
PMID:32234424
NCBI chr12:52,806,549...52,814,116
Ensembl chr12:52,806,549...52,814,116
G
KRT5
keratin 5
decreases expression
EXP
methyleugenol results in decreased expression of KRT5 mRNA
CTD
PMID:32234424
NCBI chr12:52,514,575...52,520,394
Ensembl chr12:52,514,575...52,520,530
G
KRT6A
keratin 6A
decreases expression
EXP
methyleugenol results in decreased expression of KRT6A mRNA
CTD
PMID:32234424
NCBI chr12:52,487,176...52,493,257
Ensembl chr12:52,487,176...52,493,257
G
LAIR1
leukocyte associated immunoglobulin like receptor 1
decreases expression
EXP
methyleugenol results in decreased expression of LAIR1 mRNA
CTD
PMID:32234424
NCBI chr19:54,351,384...54,376,088
Ensembl chr19:54,351,384...54,370,558
G
LARGE1
LARGE xylosyl- and glucuronyltransferase 1
decreases expression
EXP
methyleugenol results in decreased expression of LARGE1 mRNA
CTD
PMID:32234424
NCBI chr22:33,066,663...33,922,824
Ensembl chr22:33,162,226...33,922,841
G
LASP1
LIM and SH3 protein 1
increases expression
EXP
methyleugenol results in increased expression of LASP1 mRNA
CTD
PMID:32234424
NCBI chr17:38,870,058...38,921,770
Ensembl chr17:38,869,859...38,921,770
G
LAT2
linker for activation of T cells family member 2
decreases expression
EXP
methyleugenol results in decreased expression of LAT2 mRNA
CTD
PMID:32234424
NCBI chr 7:74,210,006...74,229,834
Ensembl chr 7:74,199,652...74,229,834
G
LBP
lipopolysaccharide binding protein
decreases expression
EXP
methyleugenol results in decreased expression of LBP mRNA
CTD
PMID:32234424
NCBI chr20:38,346,482...38,377,013
Ensembl chr20:38,346,482...38,377,013
G
LCN12
lipocalin 12
decreases expression
EXP
methyleugenol results in decreased expression of LCN12 mRNA
CTD
PMID:32234424
NCBI chr 9:136,949,197...136,956,538
Ensembl chr 9:136,949,551...136,955,497
G
LDB2
LIM domain binding 2
decreases expression
EXP
methyleugenol results in decreased expression of LDB2 mRNA
CTD
PMID:32234424
NCBI chr 4:16,501,541...16,898,645
Ensembl chr 4:16,501,541...16,898,678
G
LDLRAD4
low density lipoprotein receptor class A domain containing 4
decreases expression
EXP
methyleugenol results in decreased expression of LDLRAD4 mRNA
CTD
PMID:32234424
NCBI chr18:13,217,682...13,652,754
Ensembl chr18:13,217,498...13,652,755
G
LEAP2
liver enriched antimicrobial peptide 2
decreases expression
EXP
methyleugenol results in decreased expression of LEAP2 mRNA
CTD
PMID:32234424
NCBI chr 5:132,873,668...132,875,046
Ensembl chr 5:132,873,444...132,875,046
G
LFNG
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
increases expression
EXP
methyleugenol results in increased expression of LFNG mRNA
CTD
PMID:32234424
NCBI chr 7:2,512,529...2,529,177
Ensembl chr 7:2,512,529...2,529,177
G
LGALS4
galectin 4
decreases expression
EXP
methyleugenol results in decreased expression of LGALS4 mRNA
CTD
PMID:32234424
NCBI chr19:38,801,674...38,812,945
Ensembl chr19:38,801,671...38,812,945
G
LHPP
phospholysine phosphohistidine inorganic pyrophosphate phosphatase
decreases expression
EXP
methyleugenol results in decreased expression of LHPP mRNA
CTD
PMID:32234424
NCBI chr10:124,461,823...124,614,141
Ensembl chr10:124,461,823...124,617,888
G
LIF
LIF interleukin 6 family cytokine
increases expression
EXP
methyleugenol results in increased expression of LIF mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr22:30,240,453...30,246,759
Ensembl chr22:30,240,453...30,246,759
G
LINC00261
long intergenic non-protein coding RNA 261
decreases expression
EXP
methyleugenol results in decreased expression of LINC00261 mRNA
CTD
PMID:32234424
NCBI chr20:22,560,553...22,578,642
Ensembl chr20:22,547,663...22,578,642
G
LINC00460
long intergenic non-protein coding RNA 460
increases expression
EXP
methyleugenol results in increased expression of LINC00460 mRNA
CTD
PMID:32234424
NCBI chr13:106,376,564...106,378,595
Ensembl chr13:106,374,477...106,384,315
G
LINC00574
long intergenic non-protein coding RNA 574
decreases expression
EXP
methyleugenol results in decreased expression of LINC00574 mRNA
CTD
PMID:32234424
NCBI chr 6:169,790,073...169,802,873
Ensembl chr 6:169,790,037...169,802,873
G
LINC00702
long intergenic non-protein coding RNA 702
decreases expression
EXP
methyleugenol results in decreased expression of LINC00702 mRNA
CTD
PMID:32234424
NCBI chr10:4,206,876...4,243,912
Ensembl chr10:4,201,141...4,243,912
G
LINC00844
long intergenic non-protein coding RNA 844
decreases expression
EXP
methyleugenol results in decreased expression of LINC00844 mRNA
CTD
PMID:32234424
NCBI chr10:58,999,518...59,001,617
Ensembl chr10:58,999,482...59,066,396
G
LINC00880
long intergenic non-protein coding RNA 880
decreases expression
EXP
methyleugenol results in decreased expression of LINC00880 mRNA
CTD
PMID:32234424
NCBI chr 3:157,081,667...157,123,002
Ensembl chr 3:157,081,667...157,128,595
G
LINC00887
long intergenic non-protein coding RNA 887
increases expression
EXP
methyleugenol results in increased expression of LINC00887 mRNA
CTD
PMID:32234424
NCBI chr 3:194,301,199...194,312,804
Ensembl chr 3:194,296,191...194,322,871
G
LINC01085
long intergenic non-protein coding RNA 1085
increases expression
EXP
methyleugenol results in increased expression of LINC01085 mRNA
CTD
PMID:32234424
NCBI chr 4:14,111,968...14,140,052
Ensembl chr 4:14,126,339...14,126,664 Ensembl chr 4:14,126,339...14,126,664
G
LINC01088
long intergenic non-protein coding RNA 1088
decreases expression
EXP
methyleugenol results in decreased expression of LINC01088 mRNA
CTD
PMID:32234424
NCBI chr 4:78,971,748...79,308,799
Ensembl chr 4:78,939,485...79,309,673
G
LINC01093
long intergenic non-protein coding RNA 1093
decreases expression
EXP
methyleugenol results in decreased expression of LINC01093 mRNA
CTD
PMID:32234424
NCBI chr 4:184,893,000...184,899,461
Ensembl chr 4:184,892,858...184,899,553
G
LINC01235
long intergenic non-protein coding RNA 1235
decreases expression
EXP
methyleugenol results in decreased expression of LINC01235 mRNA
CTD
PMID:32234424
NCBI chr 9:13,406,380...13,431,329
Ensembl chr 9:13,406,380...13,488,125
G
LINC01239
long intergenic non-protein coding RNA 1239
decreases expression
EXP
methyleugenol results in decreased expression of LINC01239 mRNA
CTD
PMID:32234424
NCBI chr 9:22,646,200...22,824,213
Ensembl chr 9:22,646,200...22,824,213
G
LINC01340
long intergenic non-protein coding RNA 1340
decreases expression
EXP
methyleugenol results in decreased expression of LINC01340 mRNA
CTD
PMID:32234424
NCBI chr 5:97,504,696...97,671,051
Ensembl chr 5:97,504,663...97,690,180
G
LINC01411
long intergenic non-protein coding RNA 1411
increases expression
EXP
methyleugenol results in increased expression of LINC01411 mRNA
CTD
PMID:32234424
NCBI chr 5:174,336,354...174,527,139
Ensembl chr 5:174,336,295...174,532,457
G
LINC01524
long intergenic non-protein coding RNA 1524
decreases expression
EXP
methyleugenol results in decreased expression of LINC01524 mRNA
CTD
PMID:32234424
NCBI chr20:52,620,838...52,650,426
Ensembl chr20:52,192,159...52,670,578
G
LINC01564
long intergenic non-protein coding RNA 1564
increases expression
EXP
methyleugenol results in increased expression of LINC01564 mRNA
CTD
PMID:32234424
NCBI chr 6:53,628,380...53,631,394
Ensembl chr 6:53,616,471...53,707,024
G
LINC01572
long intergenic non-protein coding RNA 1572
decreases expression
EXP
methyleugenol results in decreased expression of LINC01572 mRNA
CTD
PMID:32234424
NCBI chr16:72,280,902...72,664,970
Ensembl chr16:72,236,281...72,665,014
G
LINC01580
long intergenic non-protein coding RNA 1580
decreases expression
EXP
methyleugenol results in decreased expression of LINC01580 mRNA
CTD
PMID:32234424
NCBI chr15:93,900,701...93,984,150
Ensembl chr15:93,894,431...93,984,150
G
LINC01787
long intergenic non-protein coding RNA 1787
decreases expression
EXP
methyleugenol results in decreased expression of LINC01787 mRNA
CTD
PMID:32234424
NCBI chr 1:96,254,069...96,374,125
Ensembl chr 1:96,254,069...96,374,125
G
LINC01954
long intergenic non-protein coding RNA 1954
decreases expression
EXP
methyleugenol results in decreased expression of LINC01954 mRNA
CTD
PMID:32234424
NCBI chr 2:10,878,267...10,885,118
Ensembl chr 2:10,844,224...10,885,152
G
LINC02027
long intergenic non-protein coding RNA 2027
decreases expression
EXP
methyleugenol results in decreased expression of LINC02027 mRNA
CTD
PMID:32234424
NCBI chr 3:80,993,868...81,095,647
Ensembl chr 3:80,993,811...81,105,182
G
LINC02166
long intergenic non-protein coding RNA 2166
decreases expression
EXP
methyleugenol results in decreased expression of LINC02166 mRNA
CTD
PMID:32234424
NCBI chr16:89,682,507...89,686,912
Ensembl chr16:89,682,620...89,686,569
G
LINC02257
long intergenic non-protein coding RNA 2257
decreases expression
EXP
methyleugenol results in decreased expression of LINC02257 mRNA
CTD
PMID:32234424
NCBI chr 1:221,913,645...221,978,520
Ensembl chr 1:221,819,842...222,064,773
G
LINC02269
long intergenic non-protein coding RNA 2269
decreases expression
EXP
methyleugenol results in decreased expression of LINC02269 mRNA
CTD
PMID:32234424
NCBI chr 4:173,897,273...173,929,525
Ensembl chr 4:173,699,082...174,001,488
G
LINC02381
long intergenic non-protein coding RNA 2381
increases expression
EXP
methyleugenol results in increased expression of LINC02381 mRNA
CTD
PMID:32234424
NCBI chr12:54,126,071...54,132,843
Ensembl chr12:54,126,019...54,147,485
G
LINC02499
long intergenic non-protein coding RNA 2499
decreases expression
EXP
methyleugenol results in decreased expression of LINC02499 mRNA
CTD
PMID:32234424
NCBI chr 4:73,508,803...73,528,533
Ensembl chr 4:73,508,803...73,534,128
G
LINC02535
long intergenic non-protein coding RNA 2535
decreases expression
EXP
methyleugenol results in decreased expression of LINC02535 mRNA
CTD
PMID:32234424
NCBI chr 6:85,387,219...85,404,802
Ensembl chr 6:85,387,219...85,390,186
G
LINC02762
long intergenic non-protein coding RNA 2762
increases expression
EXP
methyleugenol results in increased expression of LINC02762 mRNA
CTD
PMID:32234424
NCBI chr11:112,270,749...112,362,534
Ensembl chr11:112,270,748...112,362,534
G
LINGO2
leucine rich repeat and Ig domain containing 2
decreases expression
EXP
methyleugenol results in decreased expression of LINGO2 mRNA
CTD
PMID:32234424
NCBI chr 9:27,937,617...29,213,601
Ensembl chr 9:27,937,617...29,213,601
G
LINGO4
leucine rich repeat and Ig domain containing 4
decreases expression
EXP
methyleugenol results in decreased expression of LINGO4 mRNA
CTD
PMID:32234424
NCBI chr 1:151,800,264...151,805,419
Ensembl chr 1:151,800,264...151,805,419
G
LIPC
lipase C, hepatic type
decreases expression
EXP
methyleugenol results in decreased expression of LIPC mRNA
CTD
PMID:32234424
NCBI chr15:58,431,991...58,569,844
Ensembl chr15:58,410,569...58,569,844
G
LIPG
lipase G, endothelial type
decreases expression
EXP
methyleugenol results in decreased expression of LIPG mRNA
CTD
PMID:32234424
NCBI chr18:49,561,479...49,599,185
Ensembl chr18:49,560,699...49,599,185
G
LMO2
LIM domain only 2
increases expression
EXP
methyleugenol results in increased expression of LMO2 mRNA
CTD
PMID:32234424
NCBI chr11:33,858,576...33,892,076
Ensembl chr11:33,858,576...33,892,076
G
LNCOC1
lncRNA associated with ovarian cancer 1
decreases expression
EXP
methyleugenol results in decreased expression of LNCOC1 mRNA
CTD
PMID:32234424
NCBI chr 8:142,702,252...142,726,973
Ensembl chr 8:142,701,857...142,727,056
G
LPCAT3
lysophosphatidylcholine acyltransferase 3
decreases expression
EXP
methyleugenol results in decreased expression of LPCAT3 mRNA
CTD
PMID:32234424
NCBI chr12:6,976,185...7,018,476
Ensembl chr12:6,976,185...7,018,477
G
LRBA
LPS responsive beige-like anchor protein
decreases expression
EXP
methyleugenol results in decreased expression of LRBA mRNA
CTD
PMID:32234424
NCBI chr 4:150,264,435...151,015,727
Ensembl chr 4:150,264,435...151,015,727
G
LRFN1
leucine rich repeat and fibronectin type III domain containing 1
increases expression
EXP
methyleugenol results in increased expression of LRFN1 mRNA
CTD
PMID:32234424
NCBI chr19:39,306,566...39,320,863
Ensembl chr19:39,306,566...39,320,863
G
LRMDA
leucine rich melanocyte differentiation associated
decreases expression
EXP
methyleugenol results in decreased expression of LRMDA mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr10:75,431,624...76,560,168
Ensembl chr10:75,431,624...76,560,168
G
LRP1B
LDL receptor related protein 1B
decreases expression
EXP
methyleugenol results in decreased expression of LRP1B mRNA
CTD
PMID:32234424
NCBI chr 2:140,231,423...142,131,016
Ensembl chr 2:140,231,423...142,131,016
G
LRP2
LDL receptor related protein 2
decreases expression
EXP
methyleugenol results in decreased expression of LRP2 mRNA
CTD
PMID:32234424
NCBI chr 2:169,127,109...169,362,534
Ensembl chr 2:169,127,109...169,362,534
G
LRP8
LDL receptor related protein 8
increases expression
EXP
methyleugenol results in increased expression of LRP8 mRNA
CTD
PMID:32234424
NCBI chr 1:53,242,364...53,328,070
Ensembl chr 1:53,242,364...53,328,469
G
LRRC37A11P
leucine rich repeat containing 37 member A11, pseudogene
decreases expression
EXP
methyleugenol results in decreased expression of LRRC37A11P mRNA
CTD
PMID:32234424
NCBI chr17:39,029,906...39,053,205
Ensembl chr17:39,027,277...39,045,347 Ensembl chr17:39,027,277...39,045,347
G
LTBP1
latent transforming growth factor beta binding protein 1
decreases expression
EXP
methyleugenol results in decreased expression of LTBP1 mRNA
CTD
PMID:32234424
NCBI chr 2:32,946,953...33,399,509
Ensembl chr 2:32,946,953...33,399,509
G
LUCAT1
lung cancer associated transcript 1
increases expression
EXP
methyleugenol results in increased expression of LUCAT1 mRNA
CTD
PMID:32234424
NCBI chr 5:91,302,986...91,314,402
Ensembl chr 5:91,054,834...91,314,547
G
LY96
lymphocyte antigen 96
increases expression
EXP
methyleugenol results in increased expression of LY96 mRNA
CTD
PMID:32234424
NCBI chr 8:73,991,392...74,099,857
Ensembl chr 8:73,991,392...74,029,079
G
LYPD1
LY6/PLAUR domain containing 1
increases expression
EXP
methyleugenol results in increased expression of LYPD1 mRNA
CTD
PMID:32234424
NCBI chr 2:132,643,286...132,671,526
Ensembl chr 2:132,643,286...132,671,579
G
MAB21L4
mab-21 like 4
decreases expression
EXP
methyleugenol results in decreased expression of MAB21L4 mRNA
CTD
PMID:32234424
NCBI chr 2:240,886,048...240,896,839
Ensembl chr 2:240,886,048...240,896,889
G
MACROD2
mono-ADP ribosylhydrolase 2
decreases expression
EXP
methyleugenol results in decreased expression of MACROD2 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr20:13,995,516...16,053,197
Ensembl chr20:13,995,369...16,053,197
G
MAD1L1
mitotic arrest deficient 1 like 1
decreases expression
ISO EXP
methyleugenol results in decreased expression of MAD1L1 mRNA
CTD
PMID:26011634 PMID:32234424
NCBI chr 7:1,815,795...2,232,945
Ensembl chr 7:1,815,793...2,233,243
G
MAD2L1
mitotic arrest deficient 2 like 1
affects expression
ISO
methyleugenol affects the expression of MAD2L1 mRNA
CTD
PMID:26011634
NCBI chr 4:120,055,623...120,066,848
Ensembl chr 4:120,055,623...120,066,858
G
MAGI1
membrane associated guanylate kinase, WW and PDZ domain containing 1
decreases expression
EXP
methyleugenol results in decreased expression of MAGI1 mRNA
CTD
PMID:32234424
NCBI chr 3:65,353,526...66,038,918
Ensembl chr 3:65,353,525...66,038,918
G
MALRD1
MAM and LDL receptor class A domain containing 1
decreases expression
EXP
methyleugenol results in decreased expression of MALRD1 mRNA
CTD
PMID:32234424
NCBI chr10:19,046,927...19,734,478
Ensembl chr10:19,048,801...19,790,401
G
MAN1C1
mannosidase alpha class 1C member 1
decreases expression
EXP
methyleugenol results in decreased expression of MAN1C1 mRNA
CTD
PMID:32234424
NCBI chr 1:25,616,791...25,784,450
Ensembl chr 1:25,616,791...25,784,450
G
MAP3K7CL
MAP3K7 C-terminal like
decreases expression
EXP
methyleugenol results in decreased expression of MAP3K7CL mRNA
CTD
PMID:32234424
NCBI chr21:29,077,114...29,175,887
Ensembl chr21:29,077,221...29,175,889
G
MARCHF1
membrane associated ring-CH-type finger 1
decreases expression
EXP
methyleugenol results in decreased expression of MARCHF1 mRNA
CTD
PMID:32234424
NCBI chr 4:163,524,298...164,384,019
Ensembl chr 4:163,524,298...164,384,050
G
MARCKS
myristoylated alanine rich protein kinase C substrate
increases expression
EXP
methyleugenol results in increased expression of MARCKS mRNA
CTD
PMID:32234424
NCBI chr 6:113,857,345...113,863,475
Ensembl chr 6:113,857,345...113,863,475
G
MARCKSL1
MARCKS like 1
increases expression
EXP
methyleugenol results in increased expression of MARCKSL1 mRNA
CTD
PMID:32234424
NCBI chr 1:32,333,839...32,336,233
Ensembl chr 1:32,333,839...32,336,233
G
MAST4-AS1
MAST4 antisense RNA 1
increases expression
EXP
methyleugenol results in increased expression of MAST4-AS1 mRNA
CTD
PMID:32234424
NCBI chr 5:67,001,618...67,004,154
Ensembl chr 5:67,001,383...67,004,080
G
MAT1A
methionine adenosyltransferase 1A
decreases expression
EXP
methyleugenol results in decreased expression of MAT1A mRNA
CTD
PMID:32234424
NCBI chr10:80,271,820...80,289,658
Ensembl chr10:80,271,820...80,289,658
G
MATN2
matrilin 2
decreases expression
EXP
methyleugenol results in decreased expression of MATN2 mRNA
CTD
PMID:32234424
NCBI chr 8:97,869,064...98,036,724
Ensembl chr 8:97,868,840...98,036,724
G
MB
myoglobin
decreases expression
EXP
methyleugenol results in decreased expression of MB mRNA
CTD
PMID:32234424
NCBI chr22:35,606,764...35,623,354
Ensembl chr22:35,606,764...35,637,951
G
MB21D2
Mab-21 domain containing 2
increases expression
EXP
methyleugenol results in increased expression of MB21D2 mRNA
CTD
PMID:32234424
NCBI chr 3:192,796,815...192,917,856
Ensembl chr 3:192,796,815...192,917,856
G
MBL2
mannose binding lectin 2
decreases expression
EXP
methyleugenol results in decreased expression of MBL2 mRNA
CTD
PMID:32234424
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
MCF2
MCF.2 cell line derived transforming sequence
decreases expression
EXP
methyleugenol results in decreased expression of MCF2 mRNA
CTD
PMID:32234424
NCBI chr X:139,581,770...139,708,167
Ensembl chr X:139,581,770...139,708,216
G
MCHR1
melanin concentrating hormone receptor 1
decreases expression
EXP
methyleugenol results in decreased expression of MCHR1 mRNA
CTD
PMID:32234424
NCBI chr22:40,679,484...40,682,812
Ensembl chr22:40,679,273...40,682,812
G
MCTP1
multiple C2 and transmembrane domain containing 1
decreases expression
EXP
methyleugenol results in decreased expression of MCTP1 mRNA
CTD
PMID:32234424
NCBI chr 5:94,703,690...95,285,094
Ensembl chr 5:94,703,690...95,285,094
G
MDGA2
MAM domain containing glycosylphosphatidylinositol anchor 2
decreases expression
EXP
methyleugenol results in decreased expression of MDGA2 mRNA
CTD
PMID:32234424
NCBI chr14:46,839,623...47,675,605
Ensembl chr14:46,840,092...47,675,605
G
MDK
midkine
increases expression
EXP
methyleugenol results in increased expression of MDK mRNA
CTD
PMID:32234424
NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837
G
MDM2
MDM2 proto-oncogene
increases expression
ISO
methyleugenol results in increased expression of MDM2 mRNA
CTD
PMID:26011634
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
G
MELTF
melanotransferrin
increases expression
EXP
methyleugenol results in increased expression of MELTF mRNA
CTD
PMID:32234424
NCBI chr 3:197,001,740...197,029,817
Ensembl chr 3:196,980,590...197,029,835
G
MEP1B
meprin A subunit beta
decreases expression
EXP
methyleugenol results in decreased expression of MEP1B mRNA
CTD
PMID:32234424
NCBI chr18:32,190,039...32,220,404
Ensembl chr18:32,185,069...32,220,404
G
MFSD2A
MFSD2 lysolipid transporter A, lysophospholipid
decreases expression
EXP
methyleugenol results in decreased expression of MFSD2A mRNA
CTD
PMID:32234424
NCBI chr 1:39,955,145...39,969,956
Ensembl chr 1:39,955,112...39,969,968
G
MGMT
O-6-methylguanine-DNA methyltransferase
decreases expression
EXP
methyleugenol results in decreased expression of MGMT mRNA
CTD
PMID:32234424
NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
G
MILR1
mast cell immunoglobulin like receptor 1
increases expression
EXP
methyleugenol results in increased expression of MILR1 mRNA
CTD
PMID:32234424
NCBI chr17:64,449,115...64,497,356
Ensembl chr17:64,449,037...64,468,643
G
MIR3189
microRNA 3189
increases expression
EXP
methyleugenol results in increased expression of MIR3189 mRNA
CTD
PMID:32234424
NCBI chr19:18,386,562...18,386,634
Ensembl chr19:18,386,562...18,386,634
G
MKI67
marker of proliferation Ki-67
increases expression
ISO
methyleugenol results in increased expression of MKI67 protein
CTD
PMID:23411599 PMID:26011634
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
G
MLIP
muscular LMNA interacting protein
decreases expression
EXP
methyleugenol results in decreased expression of MLIP mRNA
CTD
PMID:32234424
NCBI chr 6:54,018,970...54,266,280
Ensembl chr 6:53,929,982...54,266,280
G
MLKL
mixed lineage kinase domain like pseudokinase
increases expression
EXP
methyleugenol results in increased expression of MLKL mRNA
CTD
PMID:32234424
NCBI chr16:74,671,855...74,700,862
Ensembl chr16:74,671,855...74,700,960
G
MLPH
melanophilin
increases expression
EXP
methyleugenol results in increased expression of MLPH mRNA
CTD
PMID:32234424
NCBI chr 2:237,486,410...237,555,322
Ensembl chr 2:237,485,428...237,555,322
G
MMADHC-DT
MMADHC divergent transcript
decreases expression
EXP
methyleugenol results in decreased expression of MMADHC-DT mRNA
CTD
PMID:32234424
NCBI chr 2:149,587,358...149,848,234
Ensembl chr 2:149,587,196...150,047,447
G
MMP10
matrix metallopeptidase 10
increases expression
EXP
methyleugenol results in increased expression of MMP10 mRNA
CTD
PMID:32234424
NCBI chr11:102,770,502...102,780,628
Ensembl chr11:102,770,502...102,780,628
G
MMP12
matrix metallopeptidase 12
increases expression
EXP
methyleugenol results in increased expression of MMP12 mRNA
CTD
PMID:32234424
NCBI chr11:102,862,736...102,874,982
Ensembl chr11:102,862,736...102,874,982
G
MMUT
methylmalonyl-CoA mutase
decreases expression
EXP
methyleugenol results in decreased expression of MMUT mRNA
CTD
PMID:32234424
NCBI chr 6:49,430,360...49,463,253
Ensembl chr 6:49,430,360...49,463,253
G
MOGAT2
monoacylglycerol O-acyltransferase 2
decreases expression
EXP
methyleugenol results in decreased expression of MOGAT2 mRNA
CTD
PMID:32234424
NCBI chr11:75,717,838...75,732,953
Ensembl chr11:75,717,838...75,732,958
G
MPDZ
multiple PDZ domain crumbs cell polarity complex component
decreases expression
EXP
methyleugenol results in decreased expression of MPDZ mRNA
CTD
PMID:32234424
NCBI chr 9:13,105,707...13,279,692
Ensembl chr 9:13,105,706...13,279,692
G
MPG
N-methylpurine DNA glycosylase
decreases expression
ISO
methyleugenol results in decreased expression of MPG mRNA
CTD
PMID:21659616
NCBI chr16:77,007...85,846
Ensembl chr16:77,007...85,851
G
MPP3
MAGUK p55 scaffold protein 3
increases expression
EXP
methyleugenol results in increased expression of MPP3 mRNA
CTD
PMID:32234424
NCBI chr17:43,800,811...43,833,146
Ensembl chr17:43,800,799...43,833,170
G
MROH8
maestro heat like repeat family member 8
decreases expression
EXP
methyleugenol results in decreased expression of MROH8 mRNA
CTD
PMID:32234424
NCBI chr20:37,101,167...37,179,548
Ensembl chr20:37,101,226...37,179,588
G
MSMO1
methylsterol monooxygenase 1
decreases expression
EXP
methyleugenol results in decreased expression of MSMO1 mRNA
CTD
PMID:32234424
NCBI chr 4:165,327,669...165,343,164
Ensembl chr 4:165,327,667...165,343,164
G
MSRA
methionine sulfoxide reductase A
decreases expression
EXP
methyleugenol results in decreased expression of MSRA mRNA
CTD
PMID:32234424
NCBI chr 8:10,054,292...10,428,891
Ensembl chr 8:10,054,292...10,428,891
G
MST1
macrophage stimulating 1
decreases expression
EXP
methyleugenol results in decreased expression of MST1 mRNA
CTD
PMID:32234424
NCBI chr 3:49,683,947...49,689,474
Ensembl chr 3:49,683,947...49,689,501
G
MST1R
macrophage stimulating 1 receptor
increases expression
EXP
methyleugenol results in increased expression of MST1R mRNA
CTD
PMID:32234424
NCBI chr 3:49,887,002...49,903,873
Ensembl chr 3:49,886,902...49,903,873
G
MSTN
myostatin
decreases expression
EXP
methyleugenol results in decreased expression of MSTN mRNA
CTD
PMID:32234424
NCBI chr 2:190,055,700...190,062,729
Ensembl chr 2:190,055,700...190,062,729
G
MSX2P1
msh homeobox 2 pseudogene 1
increases expression
EXP
methyleugenol results in increased expression of MSX2P1 mRNA
CTD
PMID:32234424
NCBI chr17:58,156,959...58,159,120
Ensembl chr17:58,157,028...58,157,800
G
MT1DP
metallothionein 1D, pseudogene
decreases expression
EXP
methyleugenol results in decreased expression of MT1DP mRNA
CTD
PMID:32234424
NCBI chr16:56,643,687...56,644,941
Ensembl chr16:56,643,725...56,644,765
G
MT1F
metallothionein 1F
decreases expression
EXP
methyleugenol results in decreased expression of MT1F mRNA
CTD
PMID:32234424
NCBI chr16:56,657,959...56,659,303
Ensembl chr16:56,657,731...56,660,698
G
MTMR11
myotubularin related protein 11
increases expression
EXP
methyleugenol results in increased expression of MTMR11 mRNA
CTD
PMID:32234424
NCBI chr 1:149,928,651...149,936,879
Ensembl chr 1:149,928,651...149,936,879
G
MTMR4
myotubularin related protein 4
decreases expression
EXP
methyleugenol results in decreased expression of MTMR4 mRNA
CTD
PMID:32234424
NCBI chr17:58,489,537...58,519,047
Ensembl chr17:58,489,529...58,517,905
G
MTSS1
MTSS I-BAR domain containing 1
decreases expression
EXP
methyleugenol results in decreased expression of MTSS1 mRNA
CTD
PMID:32234424
NCBI chr 8:124,550,784...124,728,473
Ensembl chr 8:124,550,784...124,728,473
G
MTTP
microsomal triglyceride transfer protein
decreases expression
EXP
methyleugenol results in decreased expression of MTTP mRNA
CTD
PMID:32234424
NCBI chr 4:99,564,130...99,623,997
Ensembl chr 4:99,564,081...99,623,997
G
MUC13
mucin 13, cell surface associated
increases expression
EXP
methyleugenol results in increased expression of MUC13 mRNA
CTD
PMID:32234424
NCBI chr 3:124,905,442...124,934,751
Ensembl chr 3:124,905,442...124,953,819
G
MUCL1
mucin like 1
decreases expression
EXP
methyleugenol results in decreased expression of MUCL1 mRNA
CTD
PMID:32234424
NCBI chr12:54,830,681...54,858,387
Ensembl chr12:54,830,518...54,896,008
G
MVD
mevalonate diphosphate decarboxylase
decreases expression
EXP
methyleugenol results in decreased expression of MVD mRNA
CTD
PMID:32234424
NCBI chr16:88,651,940...88,663,091
Ensembl chr16:88,651,935...88,663,161
G
MVK
mevalonate kinase
decreases expression
EXP
methyleugenol results in decreased expression of MVK mRNA
CTD
PMID:32234424
NCBI chr12:109,573,272...109,598,125
Ensembl chr12:109,573,255...109,598,125
G
MYLK4
myosin light chain kinase family member 4
decreases expression
EXP
methyleugenol results in decreased expression of MYLK4 mRNA
CTD
PMID:32234424
NCBI chr 6:2,663,637...2,770,376
Ensembl chr 6:2,663,629...2,770,330
G
MYO15A
myosin XVA
decreases expression
EXP
methyleugenol results in decreased expression of MYO15A mRNA
CTD
PMID:32234424
NCBI chr17:18,108,756...18,179,800
Ensembl chr17:18,108,756...18,179,802
G
MYO16
myosin XVI
decreases expression
EXP
methyleugenol results in decreased expression of MYO16 mRNA
CTD
PMID:32234424
NCBI chr13:108,495,716...109,208,005
Ensembl chr13:108,596,152...109,208,005
G
MYOM2
myomesin 2
decreases expression
EXP
methyleugenol results in decreased expression of MYOM2 mRNA
CTD
PMID:32234424
NCBI chr 8:2,045,046...2,145,456
Ensembl chr 8:2,045,046...2,165,552
G
MYOZ2
myozenin 2
decreases expression
EXP
methyleugenol results in decreased expression of MYOZ2 mRNA
CTD
PMID:32234424
NCBI chr 4:119,135,832...119,187,789
Ensembl chr 4:119,135,832...119,187,789
G
MYRF
myelin regulatory factor
increases expression
EXP
methyleugenol results in increased expression of MYRF mRNA
CTD
PMID:32234424
NCBI chr11:61,752,636...61,788,518
Ensembl chr11:61,752,636...61,788,518
G
MYRIP
myosin VIIA and Rab interacting protein
decreases expression
EXP
methyleugenol results in decreased expression of MYRIP mRNA
CTD
PMID:32234424
NCBI chr 3:39,808,914...40,260,321
Ensembl chr 3:39,808,914...40,260,321
G
NAALADL2
N-acetylated alpha-linked acidic dipeptidase like 2
decreases expression
EXP
methyleugenol results in decreased expression of NAALADL2 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 3:174,440,982...175,810,548
Ensembl chr 3:174,438,573...175,810,548
G
NAT16
N-acetyltransferase 16 (putative)
decreases expression
EXP
methyleugenol results in decreased expression of NAT16 mRNA
CTD
PMID:32234424
NCBI chr 7:101,170,496...101,180,293
Ensembl chr 7:101,170,496...101,180,293
G
NBAS
NBAS subunit of NRZ tethering complex
decreases expression
EXP
methyleugenol results in decreased expression of NBAS mRNA
CTD
PMID:32234424
NCBI chr 2:14,778,909...15,561,334
Ensembl chr 2:15,166,916...15,561,340
G
NBEAL2
neurobeachin like 2
increases expression
EXP
methyleugenol results in increased expression of NBEAL2 mRNA
CTD
PMID:32234424
NCBI chr 3:46,979,666...47,009,701
Ensembl chr 3:46,979,666...47,009,704
G
NBL1
NBL1, DAN family BMP antagonist
increases expression
EXP
methyleugenol results in increased expression of NBL1 mRNA
CTD
PMID:32234424
NCBI chr 1:19,643,229...19,658,452
Ensembl chr 1:19,596,979...19,658,456
G
NBPF13P
NBPF member 13, pseudogene
decreases expression
EXP
methyleugenol results in decreased expression of NBPF13P mRNA
CTD
PMID:32234424
NCBI chr 1:147,099,482...147,114,346
Ensembl chr 1:147,019,656...147,056,593
G
NCAN
neurocan
decreases expression
EXP
methyleugenol results in decreased expression of NCAN mRNA
CTD
PMID:32234424
NCBI chr19:19,211,958...19,252,233
Ensembl chr19:19,211,958...19,252,233
G
NCF2
neutrophil cytosolic factor 2
increases expression
EXP
methyleugenol results in increased expression of NCF2 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 1:183,555,562...183,601,849
Ensembl chr 1:183,554,461...183,590,905
G
NCKAP5
NCK associated protein 5
decreases expression
EXP
methyleugenol results in decreased expression of NCKAP5 mRNA
CTD
PMID:32234424
NCBI chr 2:132,671,788...133,674,836
Ensembl chr 2:132,671,788...133,568,463
G
NEB
nebulin
decreases expression
EXP
methyleugenol results in decreased expression of NEB mRNA
CTD
PMID:32234424
NCBI chr 2:151,485,339...151,734,476
Ensembl chr 2:151,485,336...151,734,487
G
NECAB1
N-terminal EF-hand calcium binding protein 1
decreases expression
EXP
methyleugenol results in decreased expression of NECAB1 mRNA
CTD
PMID:32234424
NCBI chr 8:90,791,775...90,959,393
Ensembl chr 8:90,791,741...90,959,393
G
NECTIN4
nectin cell adhesion molecule 4
increases expression
EXP
methyleugenol results in increased expression of NECTIN4 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 1:161,070,998...161,089,558
Ensembl chr 1:161,070,998...161,089,558
G
NEFL
neurofilament light chain
increases expression
EXP
methyleugenol results in increased expression of NEFL mRNA
CTD
PMID:32234424
NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
G
NES
nestin
increases expression
EXP
methyleugenol results in increased expression of NES mRNA
CTD
PMID:32234424
NCBI chr 1:156,668,763...156,677,407
Ensembl chr 1:156,668,763...156,677,407
G
NEU4
neuraminidase 4
decreases expression
EXP
methyleugenol results in decreased expression of NEU4 mRNA
CTD
PMID:32234424
NCBI chr 2:241,809,193...241,817,413
Ensembl chr 2:241,809,065...241,817,413
G
NEUROG3
neurogenin 3
decreases expression
EXP
methyleugenol results in decreased expression of NEUROG3 mRNA
CTD
PMID:32234424
NCBI chr10:69,571,485...69,573,422
Ensembl chr10:69,571,698...69,573,422
G
NFASC
neurofascin
decreases expression
EXP
methyleugenol results in decreased expression of NFASC mRNA
CTD
PMID:32234424
NCBI chr 1:204,828,652...205,022,822
Ensembl chr 1:204,828,651...205,022,822
G
NFE2L3
NFE2 like bZIP transcription factor 3
increases expression
EXP
methyleugenol results in increased expression of NFE2L3 mRNA
CTD
PMID:32234424
NCBI chr 7:26,152,198...26,187,137
Ensembl chr 7:26,152,198...26,187,137
G
NGFR
nerve growth factor receptor
increases expression
EXP
methyleugenol results in increased expression of NGFR mRNA
CTD
PMID:32234424
NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
G
NHEJ1
non-homologous end joining factor 1
decreases expression
EXP
methyleugenol results in decreased expression of NHEJ1 mRNA
CTD
PMID:32234424
NCBI chr 2:219,069,357...219,160,815
Ensembl chr 2:219,069,355...219,160,869
G
NINL
ninein like
decreases expression
EXP
methyleugenol results in decreased expression of NINL mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr20:25,452,697...25,585,531
Ensembl chr20:25,451,594...25,585,531
G
NKAIN2
sodium/potassium transporting ATPase interacting 2
decreases expression
EXP
methyleugenol results in decreased expression of NKAIN2 mRNA
CTD
PMID:32234424
NCBI chr 6:123,803,865...124,825,640
Ensembl chr 6:123,803,865...124,825,640
G
NKD2
NKD inhibitor of WNT signaling pathway 2
increases expression
EXP
methyleugenol results in increased expression of NKD2 mRNA
CTD
PMID:32234424
NCBI chr 5:1,008,802...1,038,943
Ensembl chr 5:1,008,802...1,038,943
G
NKPD1
NTPase KAP family P-loop domain containing 1
decreases expression
EXP
methyleugenol results in decreased expression of NKPD1 mRNA
CTD
PMID:32234424
NCBI chr19:45,149,744...45,162,841
Ensembl chr19:45,149,744...45,160,982
G
NLGN1
neuroligin 1
decreases expression
EXP
methyleugenol results in decreased expression of NLGN1 mRNA
CTD
PMID:32234424
NCBI chr 3:173,395,952...174,294,372
Ensembl chr 3:173,396,284...174,294,372
G
NLRP6
NLR family pyrin domain containing 6
decreases expression
EXP
methyleugenol results in decreased expression of NLRP6 mRNA
CTD
PMID:32234424
NCBI chr11:278,407...285,388
Ensembl chr11:278,407...285,388
G
NMRAL2P
NmrA like redox sensor 2, pseudogene
increases expression
EXP
methyleugenol results in increased expression of NMRAL2P mRNA
CTD
PMID:32234424
NCBI chr 3:185,959,943...185,980,877
Ensembl chr 3:185,959,943...185,980,872 Ensembl chr 3:185,959,943...185,980,872
G
NOL4
nucleolar protein 4
decreases expression
EXP
methyleugenol results in decreased expression of NOL4 mRNA
CTD
PMID:32234424
NCBI chr18:33,851,100...34,224,913
Ensembl chr18:33,851,100...34,224,952
G
NOS2
nitric oxide synthase 2
decreases expression
EXP
methyleugenol results in decreased expression of NOS2 mRNA
CTD
PMID:32234424
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOSTRIN
nitric oxide synthase trafficking
increases expression
EXP
methyleugenol results in increased expression of NOSTRIN mRNA
CTD
PMID:32234424
NCBI chr 2:168,786,539...168,865,514
Ensembl chr 2:168,786,539...168,865,514
G
NOXO1
NADPH oxidase organizer 1
decreases expression
EXP
methyleugenol results in decreased expression of NOXO1 mRNA
CTD
PMID:32234424
NCBI chr16:1,978,917...1,981,469
Ensembl chr16:1,978,917...1,984,192
G
NPAS1
neuronal PAS domain protein 1
increases expression
EXP
methyleugenol results in increased expression of NPAS1 mRNA
CTD
PMID:32234424
NCBI chr19:47,019,837...47,045,775
Ensembl chr19:47,019,837...47,045,775
G
NPAS3
neuronal PAS domain protein 3
decreases expression
EXP
methyleugenol results in decreased expression of NPAS3 mRNA
CTD
PMID:32234424
NCBI chr14:32,934,785...33,804,173
Ensembl chr14:32,934,396...33,820,863
G
NPSR1-AS1
NPSR1 antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of NPSR1-AS1 mRNA
CTD
PMID:32234424
NCBI chr 7:34,346,512...34,834,331
Ensembl chr 7:34,346,512...34,871,582
G
NPY1R
neuropeptide Y receptor Y1
increases expression
EXP
methyleugenol results in increased expression of NPY1R mRNA
CTD
PMID:32234424
NCBI chr 4:163,323,962...163,344,689
Ensembl chr 4:163,323,962...163,344,832
G
NPY5R
neuropeptide Y receptor Y5
increases expression
EXP
methyleugenol results in increased expression of NPY5R mRNA
CTD
PMID:32234424
NCBI chr 4:163,343,892...163,352,403
Ensembl chr 4:163,343,892...163,351,934
G
NR0B2
nuclear receptor subfamily 0 group B member 2
decreases expression
EXP
methyleugenol results in decreased expression of NR0B2 mRNA
CTD
PMID:32234424
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
G
NR1I3
nuclear receptor subfamily 1 group I member 3
decreases expression
EXP
methyleugenol results in decreased expression of NR1I3 mRNA
CTD
PMID:32234424
NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
G
NRXN2
neurexin 2
decreases expression
EXP
methyleugenol results in decreased expression of NRXN2 mRNA
CTD
PMID:32234424
NCBI chr11:64,606,174...64,723,197
Ensembl chr11:64,606,174...64,723,197
G
NRXN3
neurexin 3
decreases expression
EXP
methyleugenol results in decreased expression of NRXN3 mRNA
CTD
PMID:32234424
NCBI chr14:78,170,373...79,868,291
Ensembl chr14:78,170,373...79,868,291
G
NSDHL
NAD(P) dependent steroid dehydrogenase-like
decreases expression
EXP
methyleugenol results in decreased expression of NSDHL mRNA
CTD
PMID:32234424
NCBI chr X:152,831,063...152,869,729
Ensembl chr X:152,830,967...152,869,729
G
NTS
neurotensin
decreases expression
EXP
methyleugenol results in decreased expression of NTS mRNA
CTD
PMID:32234424
NCBI chr12:85,874,295...85,882,992
Ensembl chr12:85,874,295...85,882,992
G
NUBPL
NUBP iron-sulfur cluster assembly factor, mitochondrial
decreases expression
EXP
methyleugenol results in decreased expression of NUBPL mRNA
CTD
PMID:32234424
NCBI chr14:31,561,404...31,861,224
Ensembl chr14:31,489,956...31,861,224
G
NUGGC
nuclear GTPase, germinal center associated
decreases expression
EXP
methyleugenol results in decreased expression of NUGGC mRNA
CTD
PMID:32234424
NCBI chr 8:28,021,964...28,083,936
Ensembl chr 8:28,021,964...28,083,936
G
OGDHL
oxoglutarate dehydrogenase L
decreases expression
EXP
methyleugenol results in decreased expression of OGDHL mRNA
CTD
PMID:32234424
NCBI chr10:49,734,641...49,762,379
Ensembl chr10:49,734,641...49,762,379
G
OGFR-AS1
OGFR antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of OGFR-AS1 mRNA
CTD
PMID:32234424
NCBI chr20:62,800,627...62,805,587
Ensembl chr20:62,800,627...62,805,961
G
OGG1
8-oxoguanine DNA glycosylase
decreases expression
ISO
methyleugenol results in decreased expression of OGG1 mRNA
CTD
PMID:21659616
NCBI chr 3:9,749,952...9,783,108
Ensembl chr 3:9,749,944...9,788,219
G
OLFM3
olfactomedin 3
decreases expression
EXP
methyleugenol results in decreased expression of OLFM3 mRNA
CTD
PMID:32234424
NCBI chr 1:101,802,560...101,996,926
Ensembl chr 1:101,802,560...101,996,926
G
OLFML2A
olfactomedin like 2A
decreases expression
EXP
methyleugenol results in decreased expression of OLFML2A mRNA
CTD
PMID:32234424
NCBI chr 9:124,777,133...124,814,882
Ensembl chr 9:124,777,133...124,814,885
G
OPHN1
oligophrenin 1
decreases expression
EXP
methyleugenol results in decreased expression of OPHN1 mRNA
CTD
PMID:32234424
NCBI chr X:68,042,344...68,433,841
Ensembl chr X:67,949,349...68,433,913
G
OR10J6P
olfactory receptor family 10 subfamily J member 6 pseudogene
decreases expression
EXP
methyleugenol results in decreased expression of OR10J6P mRNA
CTD
PMID:32234424
NCBI chr 1:159,598,299...159,599,225
Ensembl chr 1:159,598,298...159,599,227
G
ORM1
orosomucoid 1
decreases expression
EXP
methyleugenol results in decreased expression of ORM1 mRNA
CTD
PMID:32234424
NCBI chr 9:114,323,098...114,326,479
Ensembl chr 9:114,323,098...114,326,479
G
ORM2
orosomucoid 2
decreases expression
EXP
methyleugenol results in decreased expression of ORM2 mRNA
CTD
PMID:32234424
NCBI chr 9:114,329,869...114,333,251
Ensembl chr 9:114,329,869...114,333,251
G
OSBP2
oxysterol binding protein 2
decreases expression
EXP
methyleugenol results in decreased expression of OSBP2 mRNA
CTD
PMID:32234424
NCBI chr22:30,693,782...30,907,813
Ensembl chr22:30,693,782...30,907,824
G
OSGEPL1-AS1
OSGEPL1 antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of OSGEPL1-AS1 mRNA
CTD
PMID:32234424
NCBI chr 2:189,762,780...189,765,556
Ensembl chr 2:189,762,704...189,765,556
G
OTC
ornithine transcarbamylase
decreases expression
EXP
methyleugenol results in decreased expression of OTC mRNA
CTD
PMID:32234424
NCBI chr X:38,327,684...38,422,928
Ensembl chr X:38,327,598...38,422,908
G
OTUD7A
OTU deubiquitinase 7A
decreases expression
EXP
methyleugenol results in decreased expression of OTUD7A mRNA
CTD
PMID:32234424
NCBI chr15:31,475,398...31,870,673
Ensembl chr15:31,475,398...31,870,789
G
OVGP1
oviductal glycoprotein 1
increases expression
EXP
methyleugenol results in increased expression of OVGP1 mRNA
CTD
PMID:32234424
NCBI chr 1:111,414,319...111,427,735
Ensembl chr 1:111,414,319...111,427,735
G
OXER1
oxoeicosanoid receptor 1
decreases expression
EXP
methyleugenol results in decreased expression of OXER1 mRNA
CTD
PMID:32234424
NCBI chr 2:42,762,499...42,764,135
Ensembl chr 2:42,762,499...42,764,135
G
PADI2
peptidyl arginine deiminase 2
decreases expression
EXP
methyleugenol results in decreased expression of PADI2 mRNA
CTD
PMID:32234424
NCBI chr 1:17,066,761...17,119,451
Ensembl chr 1:17,066,761...17,119,451
G
PAGE4
PAGE family member 4
decreases expression
EXP
methyleugenol results in decreased expression of PAGE4 mRNA
CTD
PMID:32234424
NCBI chr X:49,829,260...49,834,264
Ensembl chr X:49,793,653...49,834,264
G
PAH
phenylalanine hydroxylase
decreases expression
EXP
methyleugenol results in decreased expression of PAH mRNA
CTD
PMID:32234424
NCBI chr12:102,836,889...102,958,441
Ensembl chr12:102,836,889...102,958,410
G
PAK5
p21 (RAC1) activated kinase 5
decreases expression
EXP
methyleugenol results in decreased expression of PAK5 mRNA; methyleugenol results in decreased expression of PAK7 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr20:9,537,370...9,839,076
Ensembl chr20:9,537,370...9,839,076
G
PALM3
paralemmin 3
decreases expression
EXP
methyleugenol results in decreased expression of PALM3 mRNA
CTD
PMID:32234424
NCBI chr19:14,053,367...14,062,076
Ensembl chr19:14,053,363...14,062,076
G
PANK1
pantothenate kinase 1
decreases expression
EXP
methyleugenol results in decreased expression of PANK1 mRNA
CTD
PMID:32234424
NCBI chr10:89,579,495...89,645,242
Ensembl chr10:89,579,497...89,645,242
G
PANX2
pannexin 2
increases expression
EXP
methyleugenol results in increased expression of PANX2 mRNA
CTD
PMID:32234424
NCBI chr22:50,170,731...50,180,295
Ensembl chr22:50,170,731...50,180,295
G
PARD3B
par-3 family cell polarity regulator beta
decreases expression
EXP
methyleugenol results in decreased expression of PARD3B mRNA
CTD
PMID:32234424
NCBI chr 2:204,545,475...205,620,162
Ensembl chr 2:204,545,475...205,620,162
G
PARP1
poly(ADP-ribose) polymerase 1
increases cleavage
EXP
methyleugenol results in increased cleavage of PARP1 protein
CTD
PMID:28818686
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PBLD
phenazine biosynthesis like protein domain containing
decreases expression
EXP
methyleugenol results in decreased expression of PBLD mRNA
CTD
PMID:32234424
NCBI chr10:68,282,660...68,332,928
Ensembl chr10:68,282,660...68,333,049
G
PCCA
propionyl-CoA carboxylase subunit alpha
decreases expression
EXP
methyleugenol results in decreased expression of PCCA mRNA
CTD
PMID:32234424
NCBI chr13:100,089,093...100,530,435
Ensembl chr13:100,089,015...100,530,437
G
PCDHAC2
protocadherin alpha subfamily C, 2
increases expression
EXP
methyleugenol results in increased expression of PCDHAC2 mRNA
CTD
PMID:32234424
NCBI chr 5:140,966,476...141,012,347
Ensembl chr 5:140,966,470...141,012,347
G
PCK1
phosphoenolpyruvate carboxykinase 1
decreases expression
EXP
methyleugenol results in decreased expression of PCK1 mRNA
CTD
PMID:32234424
NCBI chr20:57,561,110...57,568,121
Ensembl chr20:57,561,080...57,568,121
G
PCK2
phosphoenolpyruvate carboxykinase 2, mitochondrial
decreases expression
EXP
methyleugenol results in decreased expression of PCK2 mRNA
CTD
PMID:32234424
NCBI chr14:24,094,171...24,104,125
Ensembl chr14:24,094,053...24,110,598
G
PCSK9
proprotein convertase subtilisin/kexin type 9
decreases expression
EXP
methyleugenol results in decreased expression of PCSK9 mRNA
CTD
PMID:32234424
NCBI chr 1:55,039,548...55,064,852
Ensembl chr 1:55,039,445...55,064,852
G
PDE11A
phosphodiesterase 11A
decreases expression
EXP
methyleugenol results in decreased expression of PDE11A mRNA
CTD
PMID:32234424
NCBI chr 2:177,623,244...178,108,339
Ensembl chr 2:177,623,244...178,108,339
G
PDE1A
phosphodiesterase 1A
decreases expression
EXP
methyleugenol results in decreased expression of PDE1A mRNA
CTD
PMID:32234424
NCBI chr 2:182,140,041...182,716,797
Ensembl chr 2:182,139,968...182,523,359
G
PDE4D
phosphodiesterase 4D
decreases expression
EXP
methyleugenol results in decreased expression of PDE4D mRNA
CTD
PMID:32234424
NCBI chr 5:58,969,038...60,522,128
Ensembl chr 5:58,969,038...60,522,120
G
PDE7B
phosphodiesterase 7B
decreases expression
EXP
methyleugenol results in decreased expression of PDE7B mRNA
CTD
PMID:32234424
NCBI chr 6:135,851,701...136,195,574
Ensembl chr 6:135,851,701...136,195,574
G
PDE8B
phosphodiesterase 8B
decreases expression
EXP
methyleugenol results in decreased expression of PDE8B mRNA
CTD
PMID:32234424
NCBI chr 5:77,086,715...77,428,256
Ensembl chr 5:77,210,449...77,428,256 Ensembl chr 5:77,210,449...77,428,256
G
PDLIM2
PDZ and LIM domain 2
decreases expression
EXP
methyleugenol results in decreased expression of PDLIM2 mRNA
CTD
PMID:32234424
NCBI chr 8:22,578,741...22,598,026
Ensembl chr 8:22,578,279...22,598,025
G
PDLIM3
PDZ and LIM domain 3
increases expression
EXP
methyleugenol results in increased expression of PDLIM3 mRNA
CTD
PMID:32234424
NCBI chr 4:185,500,660...185,535,507
Ensembl chr 4:185,500,660...185,535,507
G
PDLIM7
PDZ and LIM domain 7
increases expression
EXP
methyleugenol results in increased expression of PDLIM7 mRNA
CTD
PMID:32234424
NCBI chr 5:177,483,394...177,497,604
Ensembl chr 5:177,483,394...177,497,606
G
PDZK1
PDZ domain containing 1
decreases expression
EXP
methyleugenol results in decreased expression of PDZK1 mRNA
CTD
PMID:32234424
NCBI chr 1:145,670,852...145,707,400
Ensembl chr 1:145,670,852...145,708,148
G
PDZK1IP1
PDZK1 interacting protein 1
decreases expression
EXP
methyleugenol results in decreased expression of PDZK1IP1 mRNA
CTD
PMID:32234424
NCBI chr 1:47,183,582...47,190,036
Ensembl chr 1:47,183,582...47,191,044
G
PECR
peroxisomal trans-2-enoyl-CoA reductase
decreases expression
EXP
methyleugenol results in decreased expression of PECR mRNA
CTD
PMID:32234424
NCBI chr 2:216,029,088...216,081,809
Ensembl chr 2:215,996,329...216,082,955
G
PEG10
paternally expressed 10
decreases expression
EXP
methyleugenol results in decreased expression of PEG10 mRNA
CTD
PMID:32234424
NCBI chr 7:94,656,325...94,669,695
Ensembl chr 7:94,656,325...94,669,695
G
PEPD
peptidase D
decreases expression
EXP
methyleugenol results in decreased expression of PEPD mRNA
CTD
PMID:32234424
NCBI chr19:33,386,950...33,521,791
Ensembl chr19:33,386,950...33,521,823
G
PERM1
PPARGC1 and ESRR induced regulator, muscle 1
decreases expression
EXP
methyleugenol results in decreased expression of PERM1 mRNA
CTD
PMID:32234424
NCBI chr 1:975,198...982,093
Ensembl chr 1:975,198...982,117
G
PFKFB1
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1
decreases expression
EXP
methyleugenol results in decreased expression of PFKFB1 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr X:54,932,961...54,998,789
Ensembl chr X:54,932,961...54,998,534
G
PFKP
phosphofructokinase, platelet
increases expression
EXP
methyleugenol results in increased expression of PFKP mRNA
CTD
PMID:32234424
NCBI chr10:3,067,548...3,136,805
Ensembl chr10:3,066,333...3,137,718
G
PGLYRP2
peptidoglycan recognition protein 2
decreases expression
EXP
methyleugenol results in decreased expression of PGLYRP2 mRNA
CTD
PMID:32234424
NCBI chr19:15,468,645...15,479,501
Ensembl chr19:15,468,645...15,498,956
G
PGM2L1
phosphoglucomutase 2 like 1
increases expression
EXP
methyleugenol results in increased expression of PGM2L1 mRNA
CTD
PMID:32234424
NCBI chr11:74,330,316...74,398,433
Ensembl chr11:74,330,316...74,398,433
G
PGM5
phosphoglucomutase 5
decreases expression
EXP
methyleugenol results in decreased expression of PGM5 mRNA
CTD
PMID:32234424
NCBI chr 9:68,356,611...68,531,061
Ensembl chr 9:68,328,308...68,531,061
G
PHYHD1
phytanoyl-CoA dioxygenase domain containing 1
decreases expression
EXP
methyleugenol results in decreased expression of PHYHD1 mRNA
CTD
PMID:32234424
NCBI chr 9:128,920,982...128,942,041
Ensembl chr 9:128,920,966...128,942,041
G
PID1
phosphotyrosine interaction domain containing 1
decreases expression
EXP
methyleugenol results in decreased expression of PID1 mRNA
CTD
PMID:32234424
NCBI chr 2:229,023,973...229,271,287
Ensembl chr 2:228,850,526...229,271,287
G
PIF1
PIF1 5'-to-3' DNA helicase
decreases expression
EXP
methyleugenol results in decreased expression of PIF1 mRNA
CTD
PMID:32234424
NCBI chr15:64,815,632...64,827,062
Ensembl chr15:64,815,632...64,825,668
G
PIK3AP1
phosphoinositide-3-kinase adaptor protein 1
decreases expression
EXP
methyleugenol results in decreased expression of PIK3AP1 mRNA
CTD
PMID:32234424
NCBI chr10:96,593,315...96,720,514
Ensembl chr10:96,593,315...96,720,514
G
PIK3C2G
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma
decreases expression
EXP
methyleugenol results in decreased expression of PIK3C2G mRNA
CTD
PMID:32234424
NCBI chr12:18,242,961...18,726,817
Ensembl chr12:18,242,961...18,648,416
G
PINCR
p53-induced noncoding RNA
increases expression
EXP
methyleugenol results in increased expression of PINCR mRNA
CTD
PMID:32234424
NCBI chr X:43,176,994...43,226,598
Ensembl chr X:43,176,994...43,226,598
G
PIPOX
pipecolic acid and sarcosine oxidase
decreases expression
EXP
methyleugenol results in decreased expression of PIPOX mRNA
CTD
PMID:32234424
NCBI chr17:29,043,141...29,057,216
Ensembl chr17:28,950,513...29,057,216
G
PKD1L1
polycystin 1 like 1, transient receptor potential channel interacting
decreases expression
EXP
methyleugenol results in decreased expression of PKD1L1 mRNA
CTD
PMID:32234424
NCBI chr 7:47,774,614...47,960,906
Ensembl chr 7:47,740,202...47,948,466
G
PKD1L2
polycystin 1 like 2 (gene/pseudogene)
decreases expression
EXP
methyleugenol results in decreased expression of PKD1L2 mRNA
CTD
PMID:32234424
NCBI chr16:81,100,875...81,220,394
Ensembl chr16:81,100,875...81,220,370
G
PKHD1
PKHD1 ciliary IPT domain containing fibrocystin/polyductin
decreases expression
EXP
methyleugenol results in decreased expression of PKHD1 mRNA
CTD
PMID:32234424
NCBI chr 6:51,615,299...52,087,615
Ensembl chr 6:51,615,299...52,087,613
G
PKIG
cAMP-dependent protein kinase inhibitor gamma
decreases expression
EXP
methyleugenol results in decreased expression of PKIG mRNA
CTD
PMID:32234424
NCBI chr20:44,531,875...44,619,037
Ensembl chr20:44,531,785...44,624,247
G
PKLR
pyruvate kinase L/R
decreases expression
EXP
methyleugenol results in decreased expression of PKLR mRNA
CTD
PMID:32234424
NCBI chr 1:155,289,293...155,308,654
Ensembl chr 1:155,289,293...155,301,438
G
PKN1
protein kinase N1
increases expression
EXP
methyleugenol results in increased expression of PKN1 mRNA
CTD
PMID:32234424
NCBI chr19:14,433,306...14,471,859
Ensembl chr19:14,433,053...14,471,867
G
PKN2-AS1
PKN2 antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of PKN2-AS1 mRNA
CTD
PMID:32234424
NCBI chr 1:88,537,513...88,685,204
Ensembl chr 1:87,620,803...88,685,204
G
PLA2G12B
phospholipase A2 group XIIB
decreases expression
EXP
methyleugenol results in decreased expression of PLA2G12B mRNA
CTD
PMID:32234424
NCBI chr10:72,934,762...72,954,806
Ensembl chr10:72,934,762...72,954,806
G
PLA2G1B
phospholipase A2 group IB
decreases expression
EXP
methyleugenol results in decreased expression of PLA2G1B mRNA
CTD
PMID:32234424
NCBI chr12:120,322,115...120,327,779
Ensembl chr12:120,322,115...120,327,779
G
PLA2G4C
phospholipase A2 group IVC
increases expression
EXP
methyleugenol results in increased expression of PLA2G4C mRNA
CTD
PMID:32234424
NCBI chr19:48,047,846...48,110,817
Ensembl chr19:48,047,843...48,110,817
G
PLCB1
phospholipase C beta 1
decreases expression
EXP
methyleugenol results in decreased expression of PLCB1 mRNA
CTD
PMID:32234424
NCBI chr20:8,132,266...8,884,900
Ensembl chr20:8,077,251...8,968,360
G
PLCG2
phospholipase C gamma 2
decreases expression
EXP
methyleugenol results in decreased expression of PLCG2 mRNA
CTD
PMID:32234424
NCBI chr16:81,779,291...81,962,685
Ensembl chr16:81,779,279...81,962,685
G
PLCXD1
phosphatidylinositol specific phospholipase C X domain containing 1
decreases expression
EXP
methyleugenol results in decreased expression of PLCXD1 mRNA
CTD
PMID:32234424
NCBI chr X:276,356...303,356 NCBI chr Y:276,356...303,356
Ensembl chr Y:276,322...303,356 Ensembl chr X:276,322...303,356
G
PLEKHG4
pleckstrin homology and RhoGEF domain containing G4
increases expression
EXP
methyleugenol results in increased expression of PLEKHG4 mRNA
CTD
PMID:32234424
NCBI chr16:67,277,580...67,289,480
Ensembl chr16:67,277,510...67,289,499
G
PLEKHN1
pleckstrin homology domain containing N1
increases expression
EXP
methyleugenol results in increased expression of PLEKHN1 mRNA
CTD
PMID:32234424
NCBI chr 1:966,482...975,865
Ensembl chr 1:966,482...975,865
G
PLG
plasminogen
decreases expression
EXP
methyleugenol results in decreased expression of PLG mRNA
CTD
PMID:32234424
NCBI chr 6:160,702,193...160,754,097
Ensembl chr 6:160,702,194...160,754,097
G
PLK1
polo like kinase 1
affects expression decreases expression
ISO EXP
methyleugenol affects the expression of PLK1 mRNA methyleugenol results in decreased expression of PLK1 mRNA
CTD
PMID:26011634 PMID:32234424
NCBI chr16:23,678,889...23,690,367
Ensembl chr16:23,677,656...23,690,367
G
PLPPR1
phospholipid phosphatase related 1
decreases expression
EXP
methyleugenol results in decreased expression of PLPPR1 mRNA
CTD
PMID:32234424
NCBI chr 9:101,028,727...101,325,135
Ensembl chr 9:101,028,727...101,325,135
G
PLXNA3
plexin A3
increases expression
EXP
methyleugenol results in increased expression of PLXNA3 mRNA
CTD
PMID:32234424
NCBI chr X:154,458,281...154,477,779
Ensembl chr X:154,458,281...154,477,779
G
PMEPA1
prostate transmembrane protein, androgen induced 1
increases expression
EXP
methyleugenol results in increased expression of PMEPA1 mRNA
CTD
PMID:32234424
NCBI chr20:57,648,396...57,711,472
Ensembl chr20:57,648,392...57,711,536
G
PMS1
PMS1 homolog 1, mismatch repair system component
decreases expression
ISO
methyleugenol results in decreased expression of PMS1 mRNA
CTD
PMID:21659616
NCBI chr 2:189,784,450...189,877,629
Ensembl chr 2:189,784,085...189,877,629
G
PMS2
PMS1 homolog 2, mismatch repair system component
decreases expression
ISO
methyleugenol results in decreased expression of PMS2 mRNA
CTD
PMID:21659616
NCBI chr 7:5,970,925...6,009,106
Ensembl chr 7:5,970,925...6,009,130
G
PNMA2
PNMA family member 2
increases expression
EXP
methyleugenol results in increased expression of PNMA2 mRNA
CTD
PMID:32234424
NCBI chr 8:26,504,701...26,513,872
Ensembl chr 8:26,504,701...26,514,092
G
PNPLA3
patatin like phospholipase domain containing 3
decreases expression
EXP
methyleugenol results in decreased expression of PNPLA3 mRNA
CTD
PMID:32234424
NCBI chr22:43,923,805...43,947,582
Ensembl chr22:43,923,792...43,964,488
G
POLD3
DNA polymerase delta 3, accessory subunit
decreases expression
ISO
methyleugenol results in decreased expression of POLD3 mRNA
CTD
PMID:21659616
NCBI chr11:74,592,582...74,669,341
Ensembl chr11:74,493,851...74,669,117
G
PON1
paraoxonase 1
decreases expression
EXP
methyleugenol results in decreased expression of PON1 mRNA
CTD
PMID:32234424
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
G
PON3
paraoxonase 3
decreases expression
EXP
methyleugenol results in decreased expression of PON3 mRNA
CTD
PMID:32234424
NCBI chr 7:95,359,872...95,396,375
Ensembl chr 7:95,359,872...95,396,375
G
PPFIA2
PTPRF interacting protein alpha 2
decreases expression
EXP
methyleugenol results in decreased expression of PPFIA2 mRNA
CTD
PMID:32234424
NCBI chr12:81,257,975...81,759,350
Ensembl chr12:81,257,975...81,759,553
G
PPM1J
protein phosphatase, Mg2+/Mn2+ dependent 1J
increases expression
EXP
methyleugenol results in increased expression of PPM1J mRNA
CTD
PMID:32234424
NCBI chr 1:112,709,998...112,715,332
Ensembl chr 1:112,709,994...112,715,332
G
PPP1R1A
protein phosphatase 1 regulatory inhibitor subunit 1A
decreases expression
EXP
methyleugenol results in decreased expression of PPP1R1A mRNA
CTD
PMID:32234424
NCBI chr12:54,579,246...54,588,659
Ensembl chr12:54,575,387...54,588,659
G
PPP1R27
protein phosphatase 1 regulatory subunit 27
decreases expression
EXP
methyleugenol results in decreased expression of PPP1R27 mRNA
CTD
PMID:32234424
NCBI chr17:81,833,492...81,835,050
Ensembl chr17:81,833,492...81,835,050
G
PPP1R3B
protein phosphatase 1 regulatory subunit 3B
decreases expression
EXP
methyleugenol results in decreased expression of PPP1R3B mRNA
CTD
PMID:32234424
NCBI chr 8:9,136,255...9,151,539
Ensembl chr 8:9,136,255...9,151,574
G
PPP2R2B
protein phosphatase 2 regulatory subunit Bbeta
decreases expression
EXP
methyleugenol results in decreased expression of PPP2R2B mRNA
CTD
PMID:32234424
NCBI chr 5:146,580,742...147,081,520
Ensembl chr 5:146,580,742...147,084,784
G
PPP2R5CP
protein phosphatase 2 regulatory subunit B'gamma pseudogene
decreases expression
EXP
methyleugenol results in decreased expression of PPP2R5CP mRNA
CTD
PMID:32234424
NCBI chr 3:52,373,652...52,375,044
Ensembl chr 3:52,373,652...52,374,882
G
PRDM16
PR/SET domain 16
decreases expression
EXP
methyleugenol results in decreased expression of PRDM16 mRNA
CTD
PMID:32234424
NCBI chr 1:3,069,203...3,438,621
Ensembl chr 1:3,069,168...3,438,621
G
PRDM6
PR/SET domain 6
decreases expression
EXP
methyleugenol results in decreased expression of PRDM6 mRNA
CTD
PMID:32234424
NCBI chr 5:123,089,241...123,194,266
Ensembl chr 5:123,089,241...123,194,266
G
PREX1
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1
decreases expression
EXP
methyleugenol results in decreased expression of PREX1 mRNA
CTD
PMID:32234424
NCBI chr20:48,624,252...48,888,185
Ensembl chr20:48,624,252...48,827,999
G
PRKAG2
protein kinase AMP-activated non-catalytic subunit gamma 2
decreases expression
EXP
methyleugenol results in decreased expression of PRKAG2 mRNA
CTD
PMID:32234424
NCBI chr 7:151,556,127...151,877,115
Ensembl chr 7:151,556,124...151,877,214
G
PRKAR1B
protein kinase cAMP-dependent type I regulatory subunit beta
decreases expression
EXP
methyleugenol results in decreased expression of PRKAR1B mRNA
CTD
PMID:32234424
NCBI chr 7:549,197...728,934
Ensembl chr 7:549,197...727,650
G
PRKCE
protein kinase C epsilon
decreases expression
EXP
methyleugenol results in decreased expression of PRKCE mRNA
CTD
PMID:32234424
NCBI chr 2:45,651,279...46,187,990
Ensembl chr 2:45,651,345...46,187,990
G
PRKG1
protein kinase cGMP-dependent 1
decreases expression
EXP
methyleugenol results in decreased expression of PRKG1 mRNA
CTD
PMID:32234424
NCBI chr10:50,990,888...52,298,350
Ensembl chr10:50,990,888...52,298,423
G
PRKN
parkin RBR E3 ubiquitin protein ligase
decreases expression
EXP
methyleugenol results in decreased expression of PARK2 mRNA; methyleugenol results in decreased expression of PRKN mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775
G
PRLR
prolactin receptor
decreases expression
EXP
methyleugenol results in decreased expression of PRLR mRNA
CTD
PMID:32234424
NCBI chr 5:35,048,756...35,230,487
Ensembl chr 5:35,048,756...35,230,487
G
PROC
protein C, inactivator of coagulation factors Va and VIIIa
decreases expression
EXP
methyleugenol results in decreased expression of PROC mRNA
CTD
PMID:32234424
NCBI chr 2:127,418,427...127,429,242
Ensembl chr 2:127,418,427...127,429,242
G
PROCR
protein C receptor
increases expression
EXP
methyleugenol results in increased expression of PROCR mRNA
CTD
PMID:32234424
NCBI chr20:35,171,096...35,216,259
Ensembl chr20:35,172,072...35,216,240
G
PRODH
proline dehydrogenase 1
decreases expression
EXP
methyleugenol results in decreased expression of PRODH mRNA
CTD
PMID:32234424
NCBI chr22:18,912,781...18,936,553
Ensembl chr22:18,912,777...18,936,553
G
PROX1
prospero homeobox 1
decreases expression
EXP
methyleugenol results in decreased expression of PROX1 mRNA
CTD
PMID:32234424
NCBI chr 1:213,983,151...214,041,510
Ensembl chr 1:213,983,181...214,041,510
G
PROX1-AS1
PROX1 antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of PROX1-AS1 mRNA
CTD
PMID:32234424
NCBI chr 1:213,819,641...213,986,153
Ensembl chr 1:213,817,751...213,988,508
G
PROZ
protein Z, vitamin K dependent plasma glycoprotein
decreases expression
EXP
methyleugenol results in decreased expression of PROZ mRNA
CTD
PMID:32234424
NCBI chr13:113,158,648...113,172,386
Ensembl chr13:113,158,648...113,172,386
G
PRR11
proline rich 11
decreases expression
EXP
methyleugenol results in decreased expression of PRR11 mRNA
CTD
PMID:32234424
NCBI chr17:59,155,746...59,206,709
Ensembl chr17:59,155,732...59,206,709
G
PRR5L
proline rich 5 like
increases expression
EXP
methyleugenol results in increased expression of PRR5L mRNA
CTD
PMID:32234424
NCBI chr11:36,296,288...36,465,204
Ensembl chr11:36,296,288...36,465,204
G
PRR7
proline rich 7, synaptic
increases expression
EXP
methyleugenol results in increased expression of PRR7 mRNA
CTD
PMID:32234424
NCBI chr 5:177,445,995...177,456,286
Ensembl chr 5:177,446,445...177,456,286
G
PRRT1
proline rich transmembrane protein 1
decreases expression
EXP
methyleugenol results in decreased expression of PRRT1 mRNA
CTD
PMID:32234424
NCBI chr 6:32,148,363...32,153,083
Ensembl chr 6:32,148,359...32,153,083
G
PSMD10P2
proteasome 26S subunit, non-ATPase, 10 pseudogene 2
increases expression
EXP
methyleugenol results in increased expression of PSMD10P2 mRNA
CTD
PMID:32234424
NCBI chr 3:186,761,111...186,763,825
Ensembl chr 3:186,761,104...186,761,775
G
PTH1R
parathyroid hormone 1 receptor
decreases expression
EXP
methyleugenol results in decreased expression of PTH1R mRNA
CTD
PMID:32234424
NCBI chr 3:46,877,721...46,903,799
Ensembl chr 3:46,877,721...46,903,799
G
PTHLH
parathyroid hormone like hormone
increases expression
EXP
methyleugenol results in increased expression of PTHLH mRNA
CTD
PMID:32234424
NCBI chr12:27,958,084...27,972,733
Ensembl chr12:27,958,084...27,972,733
G
PTPRD
protein tyrosine phosphatase receptor type D
decreases expression
EXP
methyleugenol results in decreased expression of PTPRD mRNA
CTD
PMID:32234424
NCBI chr 9:8,314,246...10,613,002
Ensembl chr 9:8,314,246...10,613,002
G
PTPRQ
protein tyrosine phosphatase receptor type Q
decreases expression
EXP
methyleugenol results in decreased expression of PTPRQ mRNA
CTD
PMID:32234424
NCBI chr12:80,444,235...80,680,273
Ensembl chr12:80,402,178...80,680,273
G
PWWP2B
PWWP domain containing 2B
increases expression
EXP
methyleugenol results in increased expression of PWWP2B mRNA
CTD
PMID:32234424
NCBI chr10:132,397,200...132,417,859
Ensembl chr10:132,397,168...132,417,859
G
RAB3C
RAB3C, member RAS oncogene family
decreases expression
EXP
methyleugenol results in decreased expression of RAB3C mRNA
CTD
PMID:32234424
NCBI chr 5:58,582,152...58,859,394
Ensembl chr 5:58,582,221...58,859,394
G
RAB3IL1
RAB3A interacting protein like 1
increases expression
EXP
methyleugenol results in increased expression of RAB3IL1 mRNA
CTD
PMID:32234424
NCBI chr11:61,897,301...61,946,323
Ensembl chr11:61,897,301...61,920,269
G
RABEPK
Rab9 effector protein with kelch motifs
decreases expression
EXP
methyleugenol results in decreased expression of RABEPK mRNA
CTD
PMID:32234424
NCBI chr 9:125,200,542...125,234,161
Ensembl chr 9:125,200,542...125,234,161
G
RABGAP1L
RAB GTPase activating protein 1 like
decreases expression
EXP
methyleugenol results in decreased expression of RABGAP1L mRNA
CTD
PMID:32234424
NCBI chr 1:174,159,520...174,995,308
Ensembl chr 1:174,159,410...174,995,308
G
RABGAP1L-DT
RABGAP1L divergent transcript
decreases expression
EXP
methyleugenol results in decreased expression of RABGAP1L-DT mRNA
CTD
PMID:32234424
NCBI chr 1:174,121,638...174,159,287
Ensembl chr 1:174,110,268...174,160,165
G
RAC2
Rac family small GTPase 2
increases expression
EXP
methyleugenol results in increased expression of RAC2 mRNA
CTD
PMID:32234424
NCBI chr22:37,225,270...37,244,269
Ensembl chr22:37,225,270...37,259,594
G
RAD1
RAD1 checkpoint DNA exonuclease
decreases expression
ISO
methyleugenol results in decreased expression of RAD1 mRNA
CTD
PMID:21659616
NCBI chr 5:34,905,260...34,915,504
Ensembl chr 5:34,905,260...34,918,989
G
RAD17
RAD17 checkpoint clamp loader component
decreases expression
ISO
methyleugenol results in decreased expression of RAD17 mRNA
CTD
PMID:26011634
NCBI chr 5:69,369,293...69,414,801
Ensembl chr 5:69,369,293...69,414,801
G
RAD50
RAD50 double strand break repair protein
decreases expression
ISO
methyleugenol results in decreased expression of RAD50 mRNA
CTD
PMID:26011634
NCBI chr 5:132,556,977...132,646,349
Ensembl chr 5:132,556,019...132,646,349
G
RAD51B
RAD51 paralog B
decreases expression
EXP
methyleugenol results in decreased expression of RAD51B mRNA
CTD
PMID:32234424
NCBI chr14:67,819,779...68,683,096
Ensembl chr14:67,819,779...68,730,218
G
RAD52
RAD52 homolog, DNA repair protein
decreases expression
ISO
methyleugenol results in decreased expression of RAD52 mRNA
CTD
PMID:21659616
NCBI chr12:911,736...991,122
Ensembl chr12:911,736...990,053
G
RAD9A
RAD9 checkpoint clamp component A
decreases expression
ISO
methyleugenol results in decreased expression of RAD9A mRNA
CTD
PMID:21659616
NCBI chr11:67,391,986...67,398,412
Ensembl chr11:67,317,871...67,398,410
G
RALGPS1
Ral GEF with PH domain and SH3 binding motif 1
decreases expression
EXP
methyleugenol results in decreased expression of RALGPS1 mRNA
CTD
PMID:32234424
NCBI chr 9:126,914,782...127,223,166
Ensembl chr 9:126,914,774...127,223,166
G
RAP1GAP
RAP1 GTPase activating protein
increases expression
EXP
methyleugenol results in increased expression of RAP1GAP mRNA
CTD
PMID:32234424
NCBI chr 1:21,596,221...21,669,357
Ensembl chr 1:21,596,221...21,669,357
G
RAP2C-AS1
RAP2C antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of RAP2C-AS1 mRNA
CTD
PMID:32234424
NCBI chr X:132,218,507...132,432,811
Ensembl chr X:132,217,053...132,432,862
G
RASD1
ras related dexamethasone induced 1
increases expression
EXP
methyleugenol results in increased expression of RASD1 mRNA
CTD
PMID:32234424
NCBI chr17:17,494,437...17,496,395
Ensembl chr17:17,494,437...17,496,395
G
RASGRF2
Ras protein specific guanine nucleotide releasing factor 2
decreases expression
EXP
methyleugenol results in decreased expression of RASGRF2 mRNA
CTD
PMID:32234424
NCBI chr 5:80,960,363...81,230,162
Ensembl chr 5:80,960,363...81,230,162
G
RASGRP1
RAS guanyl releasing protein 1
increases expression
EXP
methyleugenol results in increased expression of RASGRP1 mRNA
CTD
PMID:32234424
NCBI chr15:38,488,103...38,564,814
Ensembl chr15:38,488,103...38,565,575
G
RASL10B
RAS like family 10 member B
decreases expression
EXP
methyleugenol results in decreased expression of RASL10B mRNA
CTD
PMID:32234424
NCBI chr17:35,731,639...35,743,521
Ensembl chr17:35,731,639...35,743,521
G
RASL11A
RAS like family 11 member A
decreases expression
EXP
methyleugenol results in decreased expression of RASL11A mRNA
CTD
PMID:32234424
NCBI chr13:27,270,830...27,275,192
Ensembl chr13:27,270,830...27,275,192
G
RASSF3
Ras association domain family member 3
increases expression
EXP
methyleugenol results in increased expression of RASSF3 mRNA
CTD
PMID:32234424
NCBI chr12:64,506,964...64,697,564
Ensembl chr12:64,507,001...64,697,564
G
RASSF6
Ras association domain family member 6
increases expression
EXP
methyleugenol results in increased expression of RASSF6 mRNA
CTD
PMID:32234424
NCBI chr 4:73,571,550...73,620,631
Ensembl chr 4:73,571,550...73,620,631
G
RB1
RB transcriptional corepressor 1
decreases expression
ISO
methyleugenol results in decreased expression of RB1 mRNA
CTD
PMID:26011634
NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
G
RBL2
RB transcriptional corepressor like 2
decreases expression
ISO
methyleugenol results in decreased expression of RBL2 mRNA
CTD
PMID:26011634
NCBI chr16:53,434,471...53,491,648
Ensembl chr16:53,433,977...53,491,648
G
RBP4
retinol binding protein 4
decreases expression
EXP
methyleugenol results in decreased expression of RBP4 mRNA
CTD
PMID:32234424
NCBI chr10:93,591,694...93,601,744
Ensembl chr10:93,591,687...93,601,744
G
RBP5
retinol binding protein 5
decreases expression
EXP
methyleugenol results in decreased expression of RBP5 mRNA
CTD
PMID:32234424
NCBI chr12:7,115,736...7,130,005
Ensembl chr12:7,115,736...7,128,889
G
RDH16
retinol dehydrogenase 16
decreases expression
EXP
methyleugenol results in decreased expression of RDH16 mRNA
CTD
PMID:32234424
NCBI chr12:56,951,431...56,957,608
Ensembl chr12:56,951,431...56,959,374
G
REEP1
receptor accessory protein 1
decreases expression
EXP
methyleugenol results in decreased expression of REEP1 mRNA
CTD
PMID:32234424
NCBI chr 2:86,213,993...86,338,083
Ensembl chr 2:86,213,993...86,338,083
G
REEP6
receptor accessory protein 6
decreases expression
EXP
methyleugenol results in decreased expression of REEP6 mRNA
CTD
PMID:32234424
NCBI chr19:1,491,181...1,497,927
Ensembl chr19:1,491,166...1,497,927
G
REN
renin
decreases expression
EXP
methyleugenol results in decreased expression of REN mRNA
CTD
PMID:32234424
NCBI chr 1:204,154,819...204,166,337
Ensembl chr 1:204,154,819...204,190,324
G
RETREG1
reticulophagy regulator 1
decreases expression
EXP
methyleugenol results in decreased expression of RETREG1 mRNA
CTD
PMID:32234424
NCBI chr 5:16,473,053...16,616,997
Ensembl chr 5:16,473,038...16,617,101
G
RFPL4A
ret finger protein like 4A
increases expression
EXP
methyleugenol results in increased expression of RFPL4A mRNA
CTD
PMID:32234424
NCBI chr19:55,757,294...55,763,421
Ensembl chr19:55,759,097...55,763,421
G
RFTN1
raftlin, lipid raft linker 1
decreases expression
EXP
methyleugenol results in decreased expression of RFTN1 mRNA
CTD
PMID:32234424
NCBI chr 3:16,315,845...16,513,699
Ensembl chr 3:16,313,574...16,514,026
G
RGN
regucalcin
decreases expression
EXP
methyleugenol results in decreased expression of RGN mRNA
CTD
PMID:32234424
NCBI chr X:47,078,443...47,093,313
Ensembl chr X:47,078,355...47,093,314
G
RGS5
regulator of G protein signaling 5
decreases expression
EXP
methyleugenol results in decreased expression of RGS5 mRNA
CTD
PMID:32234424
NCBI chr 1:163,142,299...163,321,735
Ensembl chr 1:163,111,121...163,321,791
G
RHBDF2
rhomboid 5 homolog 2
increases expression
EXP
methyleugenol results in increased expression of RHBDF2 mRNA
CTD
PMID:32234424
NCBI chr17:76,470,893...76,501,427
Ensembl chr17:76,470,891...76,501,790
G
RHBG
Rh family B glycoprotein
decreases expression
EXP
methyleugenol results in decreased expression of RHBG mRNA
CTD
PMID:32234424
NCBI chr 1:156,369,211...156,385,219
Ensembl chr 1:156,369,211...156,385,219
G
RHCE
Rh blood group CcEe antigens
decreases expression
EXP
methyleugenol results in decreased expression of RHCE mRNA
CTD
PMID:32234424
NCBI chr 1:25,362,249...25,430,203
Ensembl chr 1:25,362,249...25,430,192
G
RHEBL1
RHEB like 1
increases expression
EXP
methyleugenol results in increased expression of RHEBL1 mRNA
CTD
PMID:32234424
NCBI chr12:49,064,676...49,069,979
Ensembl chr12:49,064,676...49,070,025
G
RHEX
regulator of hemoglobinization and erythroid cell expansion
decreases expression
EXP
methyleugenol results in decreased expression of RHEX mRNA
CTD
PMID:32234424
NCBI chr 1:206,053,173...206,102,449
Ensembl chr 1:206,053,173...206,102,449
G
RHPN1
rhophilin Rho GTPase binding protein 1
increases expression
EXP
methyleugenol results in increased expression of RHPN1 mRNA
CTD
PMID:32234424
NCBI chr 8:143,364,255...143,384,221
Ensembl chr 8:143,368,876...143,384,221
G
RIDA
reactive intermediate imine deaminase A homolog
decreases expression
EXP
methyleugenol results in decreased expression of RIDA mRNA
CTD
PMID:32234424
NCBI chr 8:98,102,344...98,117,171
Ensembl chr 8:98,102,344...98,117,171
G
RIMS2
regulating synaptic membrane exocytosis 2
decreases expression
EXP
methyleugenol results in decreased expression of RIMS2 mRNA
CTD
PMID:32234424
NCBI chr 8:103,500,610...104,256,094
Ensembl chr 8:103,500,610...104,254,430
G
RIN1
Ras and Rab interactor 1
increases expression
EXP
methyleugenol results in increased expression of RIN1 mRNA
CTD
PMID:32234424
NCBI chr11:66,330,241...66,336,774
Ensembl chr11:66,330,241...66,336,840
G
RNF125
ring finger protein 125
decreases expression
EXP
methyleugenol results in decreased expression of RNF125 mRNA
CTD
PMID:32234424
NCBI chr18:32,018,825...32,088,144
Ensembl chr18:32,018,825...32,073,219
G
RNF133
ring finger protein 133
decreases expression
EXP
methyleugenol results in decreased expression of RNF133 mRNA
CTD
PMID:32234424
NCBI chr 7:122,697,735...122,699,117
Ensembl chr 7:122,697,735...122,699,117
G
RNF152
ring finger protein 152
decreases expression
EXP
methyleugenol results in decreased expression of RNF152 mRNA
CTD
PMID:32234424
NCBI chr18:61,808,067...61,894,412
Ensembl chr18:61,808,067...61,894,247
G
RNF157
ring finger protein 157
decreases expression
EXP
methyleugenol results in decreased expression of RNF157 mRNA
CTD
PMID:32234424
NCBI chr17:76,142,474...76,240,493
Ensembl chr17:76,142,465...76,240,493
G
RNF217-AS1
RNF217 antisense RNA 1 (head to head)
decreases expression
EXP
methyleugenol results in decreased expression of RNF217-AS1 mRNA
CTD
PMID:32234424
NCBI chr 6:124,908,243...124,963,027
Ensembl chr 6:124,644,434...124,963,165
G
RNF32-DT
RNF32 divergent transcript
decreases expression
EXP
methyleugenol results in decreased expression of RNF32-DT mRNA
CTD
PMID:32234424
NCBI chr 7:156,472,099...156,640,535
Ensembl chr 7:156,388,922...156,640,654
G
RNFT2
ring finger protein, transmembrane 2
decreases expression
EXP
methyleugenol results in decreased expression of RNFT2 mRNA
CTD
PMID:32234424
NCBI chr12:116,738,315...116,853,631
Ensembl chr12:116,738,178...116,853,631
G
RNLS
renalase, FAD dependent amine oxidase
decreases expression
EXP
methyleugenol results in decreased expression of RNLS mRNA
CTD
PMID:32234424
NCBI chr10:88,171,523...88,583,318
Ensembl chr10:88,273,864...88,584,530
G
RNU1-70P
RNA, U1 small nuclear 70, pseudogene
decreases expression
EXP
methyleugenol results in decreased expression of RNU1-70P mRNA
CTD
PMID:32234424
NCBI chr 3:170,994,870...170,995,032
Ensembl chr 3:170,994,870...170,995,033
G
ROBO2
roundabout guidance receptor 2
decreases expression
EXP
methyleugenol results in decreased expression of ROBO2 mRNA
CTD
PMID:32234424
NCBI chr 3:75,906,675...77,649,964
Ensembl chr 3:75,906,695...77,649,964
G
RORC
RAR related orphan receptor C
decreases expression
EXP
methyleugenol results in decreased expression of RORC mRNA
CTD
PMID:32234424
NCBI chr 1:151,806,071...151,831,802
Ensembl chr 1:151,806,071...151,831,845
G
RPL7AP34
ribosomal protein L7a pseudogene 34
decreases expression
EXP
methyleugenol results in decreased expression of RPL7AP34 mRNA
CTD
PMID:32234424
NCBI chr 6:63,548,650...63,549,507
Ensembl chr 6:63,548,708...63,549,508
G
RPL9P11
ribosomal protein L9 pseudogene 11
decreases expression
EXP
methyleugenol results in decreased expression of RPL9P11 mRNA
CTD
PMID:32234424
NCBI chr 1:9,576,405...9,577,081
Ensembl chr 1:9,576,427...9,576,985
G
RPS6P25
ribosomal protein S6 pseudogene 25
decreases expression
EXP
methyleugenol results in decreased expression of RPS6P25 mRNA
CTD
PMID:32234424
NCBI chr19:12,894,094...12,894,911
Ensembl chr19:12,894,133...12,894,880
G
RRAD
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
increases expression
EXP
methyleugenol results in increased expression of RRAD mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr16:66,921,685...66,925,535
Ensembl chr16:66,921,685...66,925,535
G
RRN3P2
RRN3 pseudogene 2
increases expression
EXP
methyleugenol results in increased expression of RRN3P2 mRNA
CTD
PMID:32234424
NCBI chr16:29,074,842...29,116,718
Ensembl chr16:29,074,976...29,116,718
G
RSRC1
arginine and serine rich coiled-coil 1
decreases expression
EXP
methyleugenol results in decreased expression of RSRC1 mRNA
CTD
PMID:32234424
NCBI chr 3:158,110,089...158,545,730
Ensembl chr 3:158,105,855...158,545,730
G
RTL9
retrotransposon Gag like 9
decreases expression
EXP
methyleugenol results in decreased expression of RTL9 mRNA
CTD
PMID:32234424
NCBI chr X:110,358,848...110,456,334
Ensembl chr X:110,358,848...110,456,334
G
RUNDC3B
RUN domain containing 3B
decreases expression
EXP
methyleugenol results in decreased expression of RUNDC3B mRNA
CTD
PMID:32234424
NCBI chr 7:87,628,398...87,832,296
Ensembl chr 7:87,627,548...87,832,296
G
RYR2
ryanodine receptor 2
decreases expression
EXP
methyleugenol results in decreased expression of RYR2 mRNA
CTD
PMID:32234424
NCBI chr 1:237,042,184...237,833,988
Ensembl chr 1:237,042,184...237,833,988
G
S100A11
S100 calcium binding protein A11
increases expression
EXP
methyleugenol results in increased expression of S100A11 mRNA
CTD
PMID:32234424
NCBI chr 1:152,032,506...152,037,004
Ensembl chr 1:152,032,506...152,047,907
G
S100A14
S100 calcium binding protein A14
increases expression
EXP
methyleugenol results in increased expression of S100A14 mRNA
CTD
PMID:32234424
NCBI chr 1:153,614,255...153,616,325
Ensembl chr 1:153,614,255...153,616,986
G
S100A2
S100 calcium binding protein A2
increases expression
EXP
methyleugenol results in increased expression of S100A2 mRNA
CTD
PMID:32234424
NCBI chr 1:153,561,108...153,565,844
Ensembl chr 1:153,561,108...153,567,890
G
S1PR2
sphingosine-1-phosphate receptor 2
increases expression
EXP
methyleugenol results in increased expression of S1PR2 mRNA
CTD
PMID:32234424
NCBI chr19:10,221,433...10,231,331
Ensembl chr19:10,221,433...10,231,331
G
SAA2
serum amyloid A2
decreases expression
EXP
methyleugenol results in decreased expression of SAA2 mRNA
CTD
PMID:32234424
NCBI chr11:18,238,236...18,248,668
Ensembl chr11:18,239,223...18,248,668
G
SARDH
sarcosine dehydrogenase
decreases expression
EXP
methyleugenol results in decreased expression of SARDH mRNA
CTD
PMID:32234424
NCBI chr 9:133,659,418...133,739,955
Ensembl chr 9:133,663,560...133,739,955
G
SAXO1
stabilizer of axonemal microtubules 1
decreases expression
EXP
methyleugenol results in decreased expression of SAXO1 mRNA
CTD
PMID:32234424
NCBI chr 9:18,927,650...19,049,339
Ensembl chr 9:18,858,906...19,049,358
G
SC5D
sterol-C5-desaturase
decreases expression
EXP
methyleugenol results in decreased expression of SC5D mRNA
CTD
PMID:32234424
NCBI chr11:121,292,771...121,313,410
Ensembl chr11:121,292,681...121,313,410
G
SCAPER
S-phase cyclin A associated protein in the ER
decreases expression
EXP
methyleugenol results in decreased expression of SCAPER mRNA
CTD
PMID:32234424
NCBI chr15:76,347,904...76,905,340
Ensembl chr15:76,347,904...76,905,444
G
SCART1
scavenger receptor family member expressed on T cells 1
decreases expression
EXP
methyleugenol results in decreased expression of SCART1 mRNA
CTD
PMID:32234424
NCBI chr10:133,453,945...133,469,760
Ensembl chr10:133,453,928...133,523,558
G
SCFD2
sec1 family domain containing 2
decreases expression
EXP
methyleugenol results in decreased expression of SCFD2 mRNA
CTD
PMID:32234424
NCBI chr 4:52,872,982...53,366,061
Ensembl chr 4:52,872,982...53,366,066
G
SCGN
secretagogin, EF-hand calcium binding protein
decreases expression
EXP
methyleugenol results in decreased expression of SCGN mRNA
CTD
PMID:32234424
NCBI chr 6:25,652,215...25,701,783
Ensembl chr 6:25,652,201...25,701,783
G
SCP2
sterol carrier protein 2
decreases expression
EXP
methyleugenol results in decreased expression of SCP2 mRNA
CTD
PMID:32234424
NCBI chr 1:52,927,276...53,051,698
Ensembl chr 1:52,927,276...53,051,698
G
SCRN1
secernin 1
increases expression
EXP
methyleugenol results in increased expression of SCRN1 mRNA
CTD
PMID:32234424
NCBI chr 7:29,920,103...29,990,289
Ensembl chr 7:29,920,104...29,990,289
G
SDK1
sidekick cell adhesion molecule 1
decreases expression
EXP
methyleugenol results in decreased expression of SDK1 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 7:3,301,252...4,269,000
Ensembl chr 7:3,301,252...4,269,000
G
SDK2
sidekick cell adhesion molecule 2
decreases expression
EXP
methyleugenol results in decreased expression of SDK2 mRNA
CTD
PMID:32234424
NCBI chr17:73,334,384...73,644,445
Ensembl chr17:73,334,384...73,644,445
G
SDR16C5
short chain dehydrogenase/reductase family 16C member 5
increases expression
EXP
methyleugenol results in increased expression of SDR16C5 mRNA
CTD
PMID:32234424
NCBI chr 8:56,300,005...56,320,175
Ensembl chr 8:56,300,005...56,320,776
G
SEC14L5
SEC14 like lipid binding 5
decreases expression
EXP
methyleugenol results in decreased expression of SEC14L5 mRNA
CTD
PMID:32234424
NCBI chr16:4,958,330...5,019,157
Ensembl chr16:4,958,330...5,019,157
G
SELENBP1
selenium binding protein 1
decreases expression
EXP
methyleugenol results in decreased expression of SELENBP1 mRNA
CTD
PMID:32234424
NCBI chr 1:151,364,304...151,372,705
Ensembl chr 1:151,364,304...151,372,707
G
SEMA5B
semaphorin 5B
decreases expression
EXP
methyleugenol results in decreased expression of SEMA5B mRNA
CTD
PMID:32234424
NCBI chr 3:122,909,082...123,028,605
Ensembl chr 3:122,909,082...123,028,605
G
SEMA6A-AS1
SEMA6A antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of SEMA6A-AS1 mRNA
CTD
PMID:32234424
NCBI chr 5:116,447,498...116,471,673
Ensembl chr 5:116,447,547...116,508,276
G
SEPTIN4
septin 4
decreases expression
EXP
methyleugenol results in decreased expression of SEPTIN4 mRNA
CTD
PMID:32234424
NCBI chr17:58,520,256...58,544,328
Ensembl chr17:58,520,250...58,544,368
G
SERINC2
serine incorporator 2
increases expression
EXP
methyleugenol results in increased expression of SERINC2 mRNA
CTD
PMID:32234424
NCBI chr 1:31,409,777...31,434,678
Ensembl chr 1:31,409,565...31,434,680
G
SERPINA10
serpin family A member 10
decreases expression
EXP
methyleugenol results in decreased expression of SERPINA10 mRNA
CTD
PMID:32234424
NCBI chr14:94,280,460...94,293,268
Ensembl chr14:94,280,460...94,293,268
G
SERPINA11
serpin family A member 11
decreases expression
EXP
methyleugenol results in decreased expression of SERPINA11 mRNA
CTD
PMID:32234424
NCBI chr14:94,442,464...94,452,800
Ensembl chr14:94,442,464...94,452,800
G
SERPINA4
serpin family A member 4
decreases expression
EXP
methyleugenol results in decreased expression of SERPINA4 mRNA
CTD
PMID:32234424
NCBI chr14:94,561,442...94,569,906
Ensembl chr14:94,561,442...94,569,913
G
SERPINB2
serpin family B member 2
increases expression
EXP
methyleugenol results in increased expression of SERPINB2 mRNA
CTD
PMID:32234424
NCBI chr18:63,887,705...63,903,888
Ensembl chr18:63,871,692...63,903,888
G
SERPINC1
serpin family C member 1
decreases expression
EXP
methyleugenol results in decreased expression of SERPINC1 mRNA
CTD
PMID:32234424
NCBI chr 1:173,903,800...173,917,327
Ensembl chr 1:173,903,800...173,917,327
G
SERPIND1
serpin family D member 1
decreases expression
EXP
methyleugenol results in decreased expression of SERPIND1 mRNA
CTD
PMID:32234424
NCBI chr22:20,774,113...20,787,720
Ensembl chr22:20,774,113...20,787,720
G
SERPINE2
serpin family E member 2
increases expression
EXP
methyleugenol results in increased expression of SERPINE2 mRNA
CTD
PMID:32234424
NCBI chr 2:223,975,045...224,039,286
Ensembl chr 2:223,975,045...224,039,318
G
SERPINF1
serpin family F member 1
decreases expression
EXP
methyleugenol results in decreased expression of SERPINF1 mRNA
CTD
PMID:32234424
NCBI chr17:1,762,060...1,777,565
Ensembl chr17:1,762,029...1,777,565
G
SERPINF2
serpin family F member 2
decreases expression
EXP
methyleugenol results in decreased expression of SERPINF2 mRNA
CTD
PMID:32234424
NCBI chr17:1,742,871...1,755,265
Ensembl chr17:1,742,836...1,755,265
G
SFTPD
surfactant protein D
decreases expression
EXP
methyleugenol results in decreased expression of SFTPD mRNA
CTD
PMID:32234424
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
G
SGCZ
sarcoglycan zeta
decreases expression
EXP
methyleugenol results in decreased expression of SGCZ mRNA
CTD
PMID:32234424
NCBI chr 8:14,084,845...15,238,431
Ensembl chr 8:14,084,845...15,238,431
G
SH3GL2
SH3 domain containing GRB2 like 2, endophilin A1
decreases expression
EXP
methyleugenol results in decreased expression of SH3GL2 mRNA
CTD
PMID:32234424
NCBI chr 9:17,579,066...17,797,124
Ensembl chr 9:17,579,066...17,797,124
G
SH3PXD2A
SH3 and PX domains 2A
decreases expression
EXP
methyleugenol results in decreased expression of SH3PXD2A mRNA
CTD
PMID:32234424
NCBI chr10:103,594,027...103,855,576
Ensembl chr10:103,594,027...103,855,584
G
SH3RF3
SH3 domain containing ring finger 3
decreases expression
EXP
methyleugenol results in decreased expression of SH3RF3 mRNA
CTD
PMID:32234424
NCBI chr 2:109,129,205...109,504,634
Ensembl chr 2:109,129,205...109,504,634
G
SH3TC2
SH3 domain and tetratricopeptide repeats 2
decreases expression
EXP
methyleugenol results in decreased expression of SH3TC2 mRNA
CTD
PMID:32234424
NCBI chr 5:148,982,150...149,063,062
Ensembl chr 5:148,923,639...149,063,163
G
SHANK2
SH3 and multiple ankyrin repeat domains 2
decreases expression
EXP
methyleugenol results in decreased expression of SHANK2 mRNA
CTD
PMID:32234424
NCBI chr11:70,467,854...71,253,228
Ensembl chr11:70,467,854...71,252,577
G
SHD
Src homology 2 domain containing transforming protein D
decreases expression
EXP
methyleugenol results in decreased expression of SHD mRNA
CTD
PMID:32234424
NCBI chr19:4,279,069...4,290,722
Ensembl chr19:4,279,266...4,290,722
G
SHLD1
shieldin complex subunit 1
decreases expression
EXP
methyleugenol results in decreased expression of SHLD1 mRNA
CTD
PMID:32234424
NCBI chr20:5,750,193...5,864,395
Ensembl chr20:5,750,393...5,864,395
G
SHMT1
serine hydroxymethyltransferase 1
decreases expression
EXP
methyleugenol results in decreased expression of SHMT1 mRNA
CTD
PMID:32234424
NCBI chr17:18,327,873...18,363,550
Ensembl chr17:18,327,873...18,363,550
G
SHMT2
serine hydroxymethyltransferase 2
decreases expression
EXP
methyleugenol results in decreased expression of SHMT2 mRNA
CTD
PMID:32234424
NCBI chr12:57,229,711...57,234,935
Ensembl chr12:57,229,573...57,234,935
G
SIGLEC1
sialic acid binding Ig like lectin 1
decreases expression
EXP
methyleugenol results in decreased expression of SIGLEC1 mRNA
CTD
PMID:32234424
NCBI chr20:3,686,970...3,712,600
Ensembl chr20:3,686,970...3,712,600
G
SIM1
SIM bHLH transcription factor 1
decreases expression
EXP
methyleugenol results in decreased expression of SIM1 mRNA
CTD
PMID:32234424
NCBI chr 6:100,385,009...100,464,921
Ensembl chr 6:100,385,009...100,464,921
G
SLAMF7
SLAM family member 7
increases expression
EXP
methyleugenol results in increased expression of SLAMF7 mRNA
CTD
PMID:32234424
NCBI chr 1:160,739,057...160,754,821
Ensembl chr 1:160,739,057...160,754,821
G
SLC10A1
solute carrier family 10 member 1
decreases expression
EXP
methyleugenol results in decreased expression of SLC10A1 mRNA
CTD
PMID:32234424
NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
G
SLC10A5
solute carrier family 10 member 5
decreases expression
EXP
methyleugenol results in decreased expression of SLC10A5 mRNA
CTD
PMID:32234424
NCBI chr 8:81,693,631...81,695,058
Ensembl chr 8:81,693,631...81,695,058
G
SLC10A7
solute carrier family 10 member 7
decreases expression
EXP
methyleugenol results in decreased expression of SLC10A7 mRNA
CTD
PMID:32234424
NCBI chr 4:146,253,981...146,521,940
Ensembl chr 4:146,253,975...146,522,372
G
SLC15A1
solute carrier family 15 member 1
decreases expression
EXP
methyleugenol results in decreased expression of SLC15A1 mRNA
CTD
PMID:32234424
NCBI chr13:98,683,801...98,752,672
Ensembl chr13:98,683,801...98,752,672
G
SLC16A12
solute carrier family 16 member 12
decreases expression
EXP
methyleugenol results in decreased expression of SLC16A12 mRNA
CTD
PMID:32234424
NCBI chr10:89,430,299...89,556,704
Ensembl chr10:89,430,299...89,556,641
G
SLC16A2
solute carrier family 16 member 2
decreases expression
EXP
methyleugenol results in decreased expression of SLC16A2 mRNA
CTD
PMID:32234424
NCBI chr X:74,421,493...74,533,916
Ensembl chr X:74,421,493...74,533,917
G
SLC22A1
solute carrier family 22 member 1
decreases expression
EXP
methyleugenol results in decreased expression of SLC22A1 mRNA
CTD
PMID:32234424
NCBI chr 6:160,121,815...160,158,718
Ensembl chr 6:160,121,815...160,158,718
G
SLC22A10
solute carrier family 22 member 10
decreases expression
EXP
methyleugenol results in decreased expression of SLC22A10 mRNA
CTD
PMID:32234424
NCBI chr11:63,289,903...63,363,144
Ensembl chr11:63,268,022...63,311,783
G
SLC22A25
solute carrier family 22 member 25
decreases expression
EXP
methyleugenol results in decreased expression of SLC22A25 mRNA
CTD
PMID:32234424
NCBI chr11:63,158,437...63,243,599
Ensembl chr11:63,158,437...63,243,599
G
SLC22A7
solute carrier family 22 member 7
decreases expression
EXP
methyleugenol results in decreased expression of SLC22A7 mRNA
CTD
PMID:32234424
NCBI chr 6:43,295,714...43,305,538
Ensembl chr 6:43,295,694...43,305,538
G
SLC22A9
solute carrier family 22 member 9
decreases expression
EXP
methyleugenol results in decreased expression of SLC22A9 mRNA
CTD
PMID:32234424
NCBI chr11:63,369,785...63,410,294
Ensembl chr11:63,369,785...63,410,294
G
SLC23A1
solute carrier family 23 member 1
decreases expression
EXP
methyleugenol results in decreased expression of SLC23A1 mRNA
CTD
PMID:32234424
NCBI chr 5:139,367,196...139,385,676
Ensembl chr 5:139,367,196...139,384,553
G
SLC25A21
solute carrier family 25 member 21
decreases expression
EXP
methyleugenol results in decreased expression of SLC25A21 mRNA
CTD
PMID:32234424
NCBI chr14:36,677,921...37,172,606
Ensembl chr14:36,677,921...37,172,606
G
SLC25A33
solute carrier family 25 member 33
decreases expression
EXP
methyleugenol results in decreased expression of SLC25A33 mRNA
CTD
PMID:32234424
NCBI chr 1:9,539,465...9,585,173
Ensembl chr 1:9,539,465...9,585,173
G
SLC25A34
solute carrier family 25 member 34
decreases expression
EXP
methyleugenol results in decreased expression of SLC25A34 mRNA
CTD
PMID:32234424
NCBI chr 1:15,736,258...15,741,392
Ensembl chr 1:15,736,258...15,741,392
G
SLC26A3
solute carrier family 26 member 3
decreases expression
EXP
methyleugenol results in decreased expression of SLC26A3 mRNA
CTD
PMID:32234424
NCBI chr 7:107,765,469...107,803,223
Ensembl chr 7:107,765,467...107,803,225
G
SLC27A5
solute carrier family 27 member 5
decreases expression
EXP
methyleugenol results in decreased expression of SLC27A5 mRNA
CTD
PMID:32234424
NCBI chr19:58,498,333...58,511,992
Ensembl chr19:58,479,512...58,512,413
G
SLC29A1
solute carrier family 29 member 1 (Augustine blood group)
increases expression
EXP
methyleugenol results in increased expression of SLC29A1 mRNA
CTD
PMID:32234424
NCBI chr 6:44,219,615...44,234,142
Ensembl chr 6:44,219,553...44,234,142
G
SLC2A14
solute carrier family 2 member 14
decreases expression
EXP
methyleugenol results in decreased expression of SLC2A14 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr12:7,812,514...7,891,196
Ensembl chr12:7,812,512...7,891,148
G
SLC2A2
solute carrier family 2 member 2
decreases expression
EXP
methyleugenol results in decreased expression of SLC2A2 mRNA
CTD
PMID:32234424
NCBI chr 3:170,996,347...171,026,720
Ensembl chr 3:170,996,347...171,026,743
G
SLC2A9
solute carrier family 2 member 9
decreases expression
EXP
methyleugenol results in decreased expression of SLC2A9 mRNA
CTD
PMID:32234424
NCBI chr 4:9,771,025...10,040,270
Ensembl chr 4:9,771,153...10,054,936
G
SLC37A2
solute carrier family 37 member 2
increases expression
EXP
methyleugenol results in increased expression of SLC37A2 mRNA
CTD
PMID:32234424
NCBI chr11:125,063,305...125,090,516
Ensembl chr11:125,063,302...125,090,516
G
SLC37A4
solute carrier family 37 member 4
decreases expression
EXP
methyleugenol results in decreased expression of SLC37A4 mRNA
CTD
PMID:32234424
NCBI chr11:119,024,112...119,030,877
Ensembl chr11:119,023,751...119,030,906
G
SLC38A11
solute carrier family 38 member 11
decreases expression
EXP
methyleugenol results in decreased expression of SLC38A11 mRNA
CTD
PMID:32234424
NCBI chr 2:164,894,354...164,955,525
Ensembl chr 2:164,894,354...164,955,525
G
SLC38A3
solute carrier family 38 member 3
decreases expression
EXP
methyleugenol results in decreased expression of SLC38A3 mRNA
CTD
PMID:32234424
NCBI chr 3:50,205,271...50,221,486
Ensembl chr 3:50,205,246...50,221,486
G
SLC38A4
solute carrier family 38 member 4
decreases expression
EXP
methyleugenol results in decreased expression of SLC38A4 mRNA
CTD
PMID:32234424
NCBI chr12:46,764,761...46,832,431
Ensembl chr12:46,764,761...46,832,408
G
SLC39A11
solute carrier family 39 member 11
decreases expression
EXP
methyleugenol results in decreased expression of SLC39A11 mRNA
CTD
PMID:32234424
NCBI chr17:72,645,949...73,092,688
Ensembl chr17:72,645,949...73,092,712
G
SLC39A5
solute carrier family 39 member 5
decreases expression
EXP
methyleugenol results in decreased expression of SLC39A5 mRNA
CTD
PMID:32234424
NCBI chr12:56,230,051...56,237,846
Ensembl chr12:56,230,049...56,237,846
G
SLC3A1
solute carrier family 3 member 1
increases expression
EXP
methyleugenol results in increased expression of SLC3A1 mRNA
CTD
PMID:32234424
NCBI chr 2:44,275,480...44,322,437
Ensembl chr 2:44,275,458...44,321,494
G
SLC3A2
solute carrier family 3 member 2
increases expression
EXP
methyleugenol results in increased expression of SLC3A2 mRNA
CTD
PMID:32234424
NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,856,004...62,888,880
G
SLC44A2
solute carrier family 44 member 2 (CTL2 blood group)
increases expression
EXP
methyleugenol results in increased expression of SLC44A2 mRNA
CTD
PMID:32234424
NCBI chr19:10,602,455...10,644,557
Ensembl chr19:10,602,457...10,644,557
G
SLC47A1
solute carrier family 47 member 1
decreases expression
EXP
methyleugenol results in decreased expression of SLC47A1 mRNA
CTD
PMID:32234424
NCBI chr17:19,533,854...19,579,034
Ensembl chr17:19,495,385...19,579,034
G
SLC4A11
solute carrier family 4 member 11
increases expression
EXP
methyleugenol results in increased expression of SLC4A11 mRNA
CTD
PMID:32234424
NCBI chr20:3,227,417...3,239,559
Ensembl chr20:3,227,417...3,239,559
G
SLC4A4
solute carrier family 4 member 4
decreases expression
EXP
methyleugenol results in decreased expression of SLC4A4 mRNA
CTD
PMID:32234424
NCBI chr 4:71,062,660...71,572,083
Ensembl chr 4:71,062,667...71,572,087
G
SLC4A5
solute carrier family 4 member 5
decreases expression
EXP
methyleugenol results in decreased expression of SLC4A5 mRNA
CTD
PMID:32234424
NCBI chr 2:74,216,242...74,343,416
Ensembl chr 2:74,216,242...74,343,416
G
SLC51A
solute carrier family 51 member A
decreases expression
EXP
methyleugenol results in decreased expression of SLC51A mRNA
CTD
PMID:32234424
NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178
G
SLC5A1
solute carrier family 5 member 1
decreases expression
EXP
methyleugenol results in decreased expression of SLC5A1 mRNA
CTD
PMID:32234424
NCBI chr22:32,043,261...32,113,029
Ensembl chr22:32,043,261...32,113,029
G
SLC5A11
solute carrier family 5 member 11
increases expression
EXP
methyleugenol results in increased expression of SLC5A11 mRNA
CTD
PMID:32234424
NCBI chr16:24,845,963...24,911,626
Ensembl chr16:24,845,841...24,911,628
G
SLC5A12
solute carrier family 5 member 12
decreases expression
EXP
methyleugenol results in decreased expression of SLC5A12 mRNA
CTD
PMID:32234424
NCBI chr11:26,667,020...26,723,389
Ensembl chr11:26,667,020...26,723,427
G
SLC5A2
solute carrier family 5 member 2
decreases expression
EXP
methyleugenol results in decreased expression of SLC5A2 mRNA
CTD
PMID:32234424
NCBI chr16:31,483,123...31,490,769
Ensembl chr16:31,483,002...31,490,860
G
SLC5A9
solute carrier family 5 member 9
decreases expression
EXP
methyleugenol results in decreased expression of SLC5A9 mRNA
CTD
PMID:32234424
NCBI chr 1:48,222,716...48,248,638
Ensembl chr 1:48,222,685...48,248,644
G
SLC6A13
solute carrier family 6 member 13
decreases expression
EXP
methyleugenol results in decreased expression of SLC6A13 mRNA
CTD
PMID:32234424
NCBI chr12:220,622...262,836
Ensembl chr12:220,621...262,873
G
SLC6A20
solute carrier family 6 member 20
decreases expression
EXP
methyleugenol results in decreased expression of SLC6A20 mRNA
CTD
PMID:32234424
NCBI chr 3:45,755,449...45,796,536
Ensembl chr 3:45,755,449...45,796,574
G
SLC6A4
solute carrier family 6 member 4
decreases expression
EXP
methyleugenol results in decreased expression of SLC6A4 mRNA
CTD
PMID:32234424
NCBI chr17:30,194,319...30,235,697
Ensembl chr17:30,194,319...30,236,002
G
SLC6A6
solute carrier family 6 member 6
increases expression
EXP
methyleugenol results in increased expression of SLC6A6 mRNA
CTD
PMID:32234424
NCBI chr 3:14,402,576...14,489,349
Ensembl chr 3:14,402,576...14,489,349
G
SLC7A11
solute carrier family 7 member 11
increases expression
EXP
methyleugenol results in increased expression of SLC7A11 mRNA
CTD
PMID:32234424
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
SLC7A9
solute carrier family 7 member 9
decreases expression
EXP
methyleugenol results in decreased expression of SLC7A9 mRNA
CTD
PMID:32234424
NCBI chr19:32,830,511...32,869,767
Ensembl chr19:32,830,509...32,869,767
G
SLC8A1
solute carrier family 8 member A1
decreases expression
EXP
methyleugenol results in decreased expression of SLC8A1 mRNA
CTD
PMID:32234424
NCBI chr 2:40,097,270...40,512,435
Ensembl chr 2:40,097,270...40,611,053
G
SLC8A3
solute carrier family 8 member A3
decreases expression
EXP
methyleugenol results in decreased expression of SLC8A3 mRNA
CTD
PMID:32234424
NCBI chr14:70,044,215...70,189,405
Ensembl chr14:70,044,215...70,189,480
G
SLCO2B1
solute carrier organic anion transporter family member 2B1
decreases expression
EXP
methyleugenol results in decreased expression of SLCO2B1 mRNA
CTD
PMID:32234424
NCBI chr11:75,151,107...75,206,549
Ensembl chr11:75,100,563...75,206,549
G
SLIT2
slit guidance ligand 2
decreases expression
EXP
methyleugenol results in decreased expression of SLIT2 mRNA
CTD
PMID:32234424
NCBI chr 4:20,251,905...20,620,561
Ensembl chr 4:20,251,905...20,620,561
G
SMIM24
small integral membrane protein 24
decreases expression
EXP
methyleugenol results in decreased expression of SMIM24 mRNA
CTD
PMID:32234424
NCBI chr19:3,473,986...3,480,525
Ensembl chr19:3,473,986...3,480,525
G
SMIM6
small integral membrane protein 6
increases expression
EXP
methyleugenol results in increased expression of SMIM6 mRNA
CTD
PMID:32234424
NCBI chr17:75,646,251...75,647,974
Ensembl chr17:75,646,243...75,647,975
G
SMOC1
SPARC related modular calcium binding 1
decreases expression
EXP
methyleugenol results in decreased expression of SMOC1 mRNA
CTD
PMID:32234424
NCBI chr14:69,879,416...70,032,366
Ensembl chr14:69,854,131...70,032,366
G
SMPD3
sphingomyelin phosphodiesterase 3
decreases expression
EXP
methyleugenol results in decreased expression of SMPD3 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr16:68,358,327...68,448,508
Ensembl chr16:68,358,327...68,448,508
G
SMPX
small muscle protein X-linked
decreases expression
EXP
methyleugenol results in decreased expression of SMPX mRNA
CTD
PMID:32234424
NCBI chr X:21,705,978...21,758,116
Ensembl chr X:21,705,978...21,758,116
G
SMYD3
SET and MYND domain containing 3
decreases expression
EXP
methyleugenol results in decreased expression of SMYD3 mRNA
CTD
PMID:32234424
NCBI chr 1:245,749,347...246,507,279
Ensembl chr 1:245,749,342...246,507,312
G
SNHG27
small nucleolar RNA host gene 27
increases expression
EXP
methyleugenol results in increased expression of SNHG27 mRNA
CTD
PMID:32234424
NCBI chr 4:131,764,838...131,791,482
Ensembl chr 4:131,727,587...131,791,492
G
SNHG31
small nucleolar RNA host gene 31
decreases expression
EXP
methyleugenol results in decreased expression of SNHG31 mRNA
CTD
PMID:32234424
NCBI chr 2:214,810,229...214,963,605
Ensembl chr 2:214,810,181...214,963,575
G
SNORA13
small nucleolar RNA, H/ACA box 13
increases expression
EXP
methyleugenol results in increased expression of SNORA13 mRNA
CTD
PMID:32234424
NCBI chr 5:112,161,485...112,161,617
Ensembl chr 5:112,161,485...112,161,617
G
SNORD108
small nucleolar RNA, C/D box 108
decreases expression
EXP
methyleugenol results in decreased expression of SNORD108 mRNA
CTD
PMID:32234424
NCBI chr15:24,986,925...24,986,993
Ensembl chr15:24,986,925...24,986,995
G
SNTB1
syntrophin beta 1
decreases expression
EXP
methyleugenol results in decreased expression of SNTB1 mRNA
CTD
PMID:32234424
NCBI chr 8:120,535,756...120,812,046
Ensembl chr 8:120,535,745...120,813,273
G
SNTG2
syntrophin gamma 2
decreases expression
EXP
methyleugenol results in decreased expression of SNTG2 mRNA
CTD
PMID:32234424
NCBI chr 2:950,849...1,367,613
Ensembl chr 2:950,849...1,367,613
G
SNX29
sorting nexin 29
decreases expression
EXP
methyleugenol results in decreased expression of SNX29 mRNA
CTD
PMID:32234424
NCBI chr16:11,976,734...12,574,287
Ensembl chr16:11,976,734...12,574,287
G
SORD
sorbitol dehydrogenase
decreases expression
EXP
methyleugenol results in decreased expression of SORD mRNA
CTD
PMID:32234424
NCBI chr15:45,023,195...45,077,185
Ensembl chr15:45,023,147...45,077,185
G
SORD2P
sorbitol dehydrogenase 2, pseudogene
decreases expression
EXP
methyleugenol results in decreased expression of SORD2P mRNA
CTD
PMID:32234424
NCBI chr15:44,825,747...44,884,694
Ensembl chr15:44,825,747...44,884,694 Ensembl chr15:44,825,747...44,884,694
G
SORL1
sortilin related receptor 1
decreases expression
EXP
methyleugenol results in decreased expression of SORL1 mRNA
CTD
PMID:32234424
NCBI chr11:121,452,314...121,633,763
Ensembl chr11:121,452,314...121,633,763
G
SOX4
SRY-box transcription factor 4
increases expression
EXP
methyleugenol results in increased expression of SOX4 mRNA
CTD
PMID:32234424
NCBI chr 6:21,593,751...21,598,619
Ensembl chr 6:21,593,751...21,598,619
G
SOX5
SRY-box transcription factor 5
decreases expression
EXP
methyleugenol results in decreased expression of SOX5 mRNA
CTD
PMID:32234424
NCBI chr12:23,529,504...24,562,650
Ensembl chr12:23,529,504...24,562,544
G
SOX9-AS1
SOX9 antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of SOX9-AS1 mRNA
CTD
PMID:32234424
NCBI chr17:72,071,042...72,120,793
Ensembl chr17:72,067,099...72,237,203
G
SPARCL1
SPARC like 1
decreases expression
EXP
methyleugenol results in decreased expression of SPARCL1 mRNA
CTD
PMID:32234424
NCBI chr 4:87,473,335...87,529,376
Ensembl chr 4:87,473,335...87,531,061
G
SPATA17
spermatogenesis associated 17
decreases expression
EXP
methyleugenol results in decreased expression of SPATA17 mRNA
CTD
PMID:32234424
NCBI chr 1:217,631,344...217,871,696
Ensembl chr 1:217,631,324...217,871,696
G
SPNS2
SPNS lysolipid transporter 2, sphingosine-1-phosphate
decreases expression
EXP
methyleugenol results in decreased expression of SPNS2 mRNA
CTD
PMID:32234424
NCBI chr17:4,498,881...4,539,035
Ensembl chr17:4,498,881...4,539,035
G
SPOCK3
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3
decreases expression
EXP
methyleugenol results in decreased expression of SPOCK3 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 4:166,733,384...167,234,945
Ensembl chr 4:166,733,384...167,234,796
G
SPON1
spondin 1
decreases expression
EXP
methyleugenol results in decreased expression of SPON1 mRNA
CTD
PMID:32234424
NCBI chr11:13,962,723...14,268,133
Ensembl chr11:13,962,723...14,268,133
G
SPP1
secreted phosphoprotein 1
increases expression
EXP
methyleugenol results in increased expression of SPP1 mRNA
CTD
PMID:32234424
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
SPP2
secreted phosphoprotein 2
decreases expression
EXP
methyleugenol results in decreased expression of SPP2 mRNA
CTD
PMID:32234424
NCBI chr 2:234,050,702...234,077,134
Ensembl chr 2:234,050,679...234,077,134
G
SPRN
shadow of prion protein
decreases expression
EXP
methyleugenol results in decreased expression of SPRN mRNA
CTD
PMID:32234424
NCBI chr10:133,420,666...133,424,625
Ensembl chr10:133,420,666...133,424,625
G
SPTB
spectrin beta, erythrocytic
decreases expression
EXP
methyleugenol results in decreased expression of SPTB mRNA
CTD
PMID:32234424
NCBI chr14:64,746,283...64,879,907
Ensembl chr14:64,746,283...64,879,907
G
SRC
SRC proto-oncogene, non-receptor tyrosine kinase
increases expression
EXP
methyleugenol results in increased expression of SRC mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,685...37,406,050
G
SRD5A2
steroid 5 alpha-reductase 2
decreases expression
EXP
methyleugenol results in decreased expression of SRD5A2 mRNA
CTD
PMID:32234424
NCBI chr 2:31,522,480...31,663,009
Ensembl chr 2:31,522,480...31,580,938
G
SREBF1
sterol regulatory element binding transcription factor 1
decreases expression
EXP
methyleugenol results in decreased expression of SREBF1 mRNA
CTD
PMID:32234424
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
G
SRPX2
sushi repeat containing protein X-linked 2
increases expression
EXP
methyleugenol results in increased expression of SRPX2 mRNA
CTD
PMID:32234424
NCBI chr X:100,644,199...100,675,788
Ensembl chr X:100,644,195...100,675,788
G
ST18
ST18 C2H2C-type zinc finger transcription factor
decreases expression
EXP
methyleugenol results in decreased expression of ST18 mRNA
CTD
PMID:32234424
NCBI chr 8:52,110,838...52,409,879
Ensembl chr 8:52,110,838...52,460,959
G
ST6GAL1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
decreases expression
EXP
methyleugenol results in decreased expression of ST6GAL1 mRNA
CTD
PMID:32234424
NCBI chr 3:186,930,526...187,078,553
Ensembl chr 3:186,930,325...187,078,553
G
STC1
stanniocalcin 1
decreases expression
EXP
methyleugenol results in decreased expression of STC1 mRNA
CTD
PMID:32234424
NCBI chr 8:23,841,929...23,854,806
Ensembl chr 8:23,841,929...23,854,806
G
STK31
serine/threonine kinase 31
decreases expression
EXP
methyleugenol results in decreased expression of STK31 mRNA
CTD
PMID:32234424
NCBI chr 7:23,710,082...23,832,513
Ensembl chr 7:23,710,203...23,832,513
G
STPG2
sperm tail PG-rich repeat containing 2
decreases expression
EXP
methyleugenol results in decreased expression of STPG2 mRNA
CTD
PMID:32234424
NCBI chr 4:97,441,249...98,143,476
Ensembl chr 4:97,184,093...98,143,476
G
STX18-AS1
STX18 antisense RNA 1 (head to head)
decreases expression
EXP
methyleugenol results in decreased expression of STX18-AS1 mRNA
CTD
PMID:32234424
NCBI chr 4:4,542,131...4,710,938
Ensembl chr 4:4,542,131...4,787,359
G
STX8
syntaxin 8
decreases expression
EXP
methyleugenol results in decreased expression of STX8 mRNA
CTD
PMID:32234424
NCBI chr17:9,250,471...9,575,820
Ensembl chr17:9,250,471...9,576,591
G
STXBP5-AS1
STXBP5 antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of STXBP5-AS1 mRNA
CTD
PMID:32234424
NCBI chr 6:146,841,388...147,204,614
Ensembl chr 6:146,824,539...147,204,614
G
SUCNR1
succinate receptor 1
decreases expression
EXP
methyleugenol results in decreased expression of SUCNR1 mRNA
CTD
PMID:32234424
NCBI chr 3:151,873,643...151,884,619
Ensembl chr 3:151,873,643...151,884,619
G
SUGCT
succinyl-CoA:glutarate-CoA transferase
decreases expression
EXP
methyleugenol results in decreased expression of SUGCT mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 7:40,135,005...41,038,816
Ensembl chr 7:40,135,005...40,860,763
G
SULT1A2
sulfotransferase family 1A member 2
decreases expression
EXP
methyleugenol results in decreased expression of SULT1A2 mRNA
CTD
PMID:32234424
NCBI chr16:28,591,943...28,597,050
Ensembl chr16:28,591,943...28,597,050
G
SULT1B1
sulfotransferase family 1B member 1
decreases expression
EXP
methyleugenol results in decreased expression of SULT1B1 mRNA
CTD
PMID:32234424
NCBI chr 4:69,721,167...69,760,620
Ensembl chr 4:69,721,167...69,787,961
G
SULT1E1
sulfotransferase family 1E member 1
decreases expression
EXP
methyleugenol results in decreased expression of SULT1E1 mRNA
CTD
PMID:32234424
NCBI chr 4:69,821,122...69,860,145
Ensembl chr 4:69,841,212...69,860,145
G
SULT2A1
sulfotransferase family 2A member 1
decreases expression
EXP
methyleugenol results in decreased expression of SULT2A1 mRNA
CTD
PMID:32234424
NCBI chr19:47,870,467...47,886,315
Ensembl chr19:47,870,467...47,886,315
G
SUPT3H
SPT3 homolog, SAGA and STAGA complex component
decreases expression
EXP
methyleugenol results in decreased expression of SUPT3H mRNA
CTD
PMID:32234424
NCBI chr 6:44,809,057...45,377,934
Ensembl chr 6:44,809,317...45,377,953
G
SUSD3
sushi domain containing 3
decreases expression
EXP
methyleugenol results in decreased expression of SUSD3 mRNA
CTD
PMID:32234424
NCBI chr 9:93,058,701...93,085,133
Ensembl chr 9:93,058,688...93,085,133
G
SUSD4
sushi domain containing 4
decreases expression
EXP
methyleugenol results in decreased expression of SUSD4 mRNA
CTD
PMID:32234424
NCBI chr 1:223,220,831...223,365,235
Ensembl chr 1:223,220,819...223,364,233
G
SYNDIG1L
synapse differentiation inducing 1 like
decreases expression
EXP
methyleugenol results in decreased expression of SYNDIG1L mRNA
CTD
PMID:32234424
NCBI chr14:74,405,899...74,480,143
Ensembl chr14:74,405,894...74,426,210
G
SYNPO2
synaptopodin 2
decreases expression
EXP
methyleugenol results in decreased expression of SYNPO2 mRNA
CTD
PMID:32234424
NCBI chr 4:118,850,681...119,061,247
Ensembl chr 4:118,850,688...119,061,247
G
SYT13
synaptotagmin 13
increases expression
EXP
methyleugenol results in increased expression of SYT13 mRNA
CTD
PMID:32234424
NCBI chr11:45,240,302...45,286,341
Ensembl chr11:45,240,302...45,286,341
G
SYT7
synaptotagmin 7
decreases expression
EXP
methyleugenol results in decreased expression of SYT7 mRNA
CTD
PMID:32234424
NCBI chr11:61,513,714...61,588,387
Ensembl chr11:61,513,714...61,581,148
G
SYT9
synaptotagmin 9
decreases expression
EXP
methyleugenol results in decreased expression of SYT9 mRNA
CTD
PMID:32234424
NCBI chr11:7,238,778...7,469,043
Ensembl chr11:7,238,778...7,469,043
G
SYTL1
synaptotagmin like 1
increases expression
EXP
methyleugenol results in increased expression of SYTL1 mRNA
CTD
PMID:32234424
NCBI chr 1:27,342,022...27,353,932
Ensembl chr 1:27,342,020...27,353,937
G
SYTL5
synaptotagmin like 5
decreases expression
EXP
methyleugenol results in decreased expression of SYTL5 mRNA
CTD
PMID:32234424
NCBI chr X:37,888,915...38,128,820
Ensembl chr X:38,006,553...38,128,819
G
TAC1
tachykinin precursor 1
increases expression
EXP
methyleugenol results in increased expression of TAC1 mRNA
CTD
PMID:32234424
NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
G
TAFA2
TAFA chemokine like family member 2
decreases expression
EXP
methyleugenol results in decreased expression of TAFA2 mRNA
CTD
PMID:32234424
NCBI chr12:61,708,273...62,260,034
Ensembl chr12:61,708,273...62,279,150
G
TAT
tyrosine aminotransferase
decreases expression
EXP
methyleugenol results in decreased expression of TAT mRNA
CTD
PMID:32234424
NCBI chr16:71,565,660...71,577,092
Ensembl chr16:71,565,660...71,577,092
G
TDO2
tryptophan 2,3-dioxygenase
decreases expression
EXP
methyleugenol results in decreased expression of TDO2 mRNA
CTD
PMID:32234424
NCBI chr 4:155,903,696...155,920,406
Ensembl chr 4:155,854,738...155,920,406
G
TEAD2
TEA domain transcription factor 2
increases expression
EXP
methyleugenol results in increased expression of TEAD2 mRNA
CTD
PMID:32234424
NCBI chr19:49,340,595...49,362,416
Ensembl chr19:49,340,595...49,362,457
G
TECTA
tectorin alpha
decreases expression
EXP
methyleugenol results in decreased expression of TECTA mRNA
CTD
PMID:32234424
NCBI chr11:121,101,243...121,191,490
Ensembl chr11:121,101,243...121,191,490
G
TENM1
teneurin transmembrane protein 1
decreases expression
EXP
methyleugenol results in decreased expression of TENM1 mRNA
CTD
PMID:32234424
NCBI chr X:124,375,903...125,204,312
Ensembl chr X:124,375,903...125,204,312
G
TENM2
teneurin transmembrane protein 2
decreases expression
EXP
methyleugenol results in decreased expression of TENM2 mRNA
CTD
PMID:32234424
NCBI chr 5:166,979,029...168,264,157
Ensembl chr 5:166,979,029...168,264,157
G
TF
transferrin
decreases expression
EXP
methyleugenol results in decreased expression of TF mRNA
CTD
PMID:32234424
NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641
G
TFPI2
tissue factor pathway inhibitor 2
increases expression
EXP
methyleugenol results in increased expression of TFPI2 mRNA
CTD
PMID:32234424
NCBI chr 7:93,885,396...93,890,753
Ensembl chr 7:93,885,396...93,890,753
G
TG
thyroglobulin
decreases expression
EXP
methyleugenol results in decreased expression of TG mRNA
CTD
PMID:32234424
NCBI chr 8:132,866,958...133,134,899
Ensembl chr 8:132,866,958...133,134,903
G
THRSP
thyroid hormone responsive
decreases expression
EXP
methyleugenol results in decreased expression of THRSP mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr11:78,063,861...78,068,351
Ensembl chr11:78,063,861...78,068,351
G
THSD1
thrombospondin type 1 domain containing 1
increases expression
EXP
methyleugenol results in increased expression of THSD1 mRNA
CTD
PMID:32234424
NCBI chr13:52,377,167...52,406,172
Ensembl chr13:52,377,167...52,416,373
G
THSD7A
thrombospondin type 1 domain containing 7A
decreases expression
EXP
methyleugenol results in decreased expression of THSD7A mRNA
CTD
PMID:32234424
NCBI chr 7:11,370,365...11,832,198
Ensembl chr 7:11,370,365...11,832,198
G
TINAGL1
tubulointerstitial nephritis antigen like 1
decreases expression
EXP
methyleugenol results in decreased expression of TINAGL1 mRNA
CTD
PMID:32234424
NCBI chr 1:31,576,515...31,587,686
Ensembl chr 1:31,576,485...31,587,686
G
TJP3
tight junction protein 3
decreases expression
EXP
methyleugenol results in decreased expression of TJP3 mRNA
CTD
PMID:32234424
NCBI chr19:3,708,384...3,750,813
Ensembl chr19:3,708,362...3,750,813
G
TLN2
talin 2
decreases expression
EXP
methyleugenol results in decreased expression of TLN2 mRNA
CTD
PMID:32234424
NCBI chr15:62,390,550...62,844,631
Ensembl chr15:62,390,526...62,844,631
G
TLR6
toll like receptor 6
increases expression
EXP
methyleugenol results in increased expression of TLR6 mRNA
CTD
PMID:32234424
NCBI chr 4:38,822,897...38,868,390
Ensembl chr 4:38,822,897...38,856,817
G
TLX1
T cell leukemia homeobox 1
decreases expression
EXP
methyleugenol results in decreased expression of TLX1 mRNA
CTD
PMID:32234424
NCBI chr10:101,131,300...101,137,789
Ensembl chr10:101,131,300...101,137,789
G
TM6SF2
transmembrane 6 superfamily member 2
decreases expression
EXP
methyleugenol results in decreased expression of TM6SF2 mRNA
CTD
PMID:32234424
NCBI chr19:19,264,366...19,273,301
Ensembl chr19:19,264,364...19,273,391
G
TMC6
transmembrane channel like 6
increases expression
EXP
methyleugenol results in increased expression of TMC6 mRNA
CTD
PMID:32234424
NCBI chr17:78,107,397...78,132,427
Ensembl chr17:78,107,397...78,132,407
G
TMEM100
transmembrane protein 100
decreases expression
EXP
methyleugenol results in decreased expression of TMEM100 mRNA
CTD
PMID:32234424
NCBI chr17:55,719,627...55,732,081
Ensembl chr17:55,719,627...55,732,121
G
TMEM117
transmembrane protein 117
decreases expression
EXP
methyleugenol results in decreased expression of TMEM117 mRNA
CTD
PMID:32234424
NCBI chr12:43,795,802...44,399,108
Ensembl chr12:43,835,967...44,389,762
G
TMEM132A
transmembrane protein 132A
increases expression
EXP
methyleugenol results in increased expression of TMEM132A mRNA
CTD
PMID:32234424
NCBI chr11:60,924,460...60,937,159
Ensembl chr11:60,924,460...60,937,159
G
TMEM135
transmembrane protein 135
decreases expression
EXP
methyleugenol results in decreased expression of TMEM135 mRNA
CTD
PMID:32234424
NCBI chr11:87,037,934...87,328,824
Ensembl chr11:87,037,844...87,328,824
G
TMEM139
transmembrane protein 139
decreases expression
EXP
methyleugenol results in decreased expression of TMEM139 mRNA
CTD
PMID:32234424
NCBI chr 7:143,284,899...143,288,049
Ensembl chr 7:143,279,957...143,288,048
G
TMEM156
transmembrane protein 156
increases expression
EXP
methyleugenol results in increased expression of TMEM156 mRNA
CTD
PMID:32234424
NCBI chr 4:38,966,744...39,032,409
Ensembl chr 4:38,966,744...39,032,922
G
TMEM176A
transmembrane protein 176A
decreases expression
EXP
methyleugenol results in decreased expression of TMEM176A mRNA
CTD
PMID:32234424
NCBI chr 7:150,800,769...150,805,118
Ensembl chr 7:150,800,403...150,805,118
G
TMEM178A
transmembrane protein 178A
decreases expression
EXP
methyleugenol results in decreased expression of TMEM178A mRNA
CTD
PMID:32234424
NCBI chr 2:39,665,483...39,735,960
Ensembl chr 2:39,664,982...39,717,963
G
TMEM178B
transmembrane protein 178B
decreases expression
EXP
methyleugenol results in decreased expression of TMEM178B mRNA
CTD
PMID:32234424
NCBI chr 7:141,074,064...141,511,296
Ensembl chr 7:141,074,064...141,480,380
G
TMEM200A
transmembrane protein 200A
decreases expression
EXP
methyleugenol results in decreased expression of TMEM200A mRNA
CTD
PMID:32234424
NCBI chr 6:130,365,531...130,443,067
Ensembl chr 6:130,366,017...130,443,067
G
TMEM232
transmembrane protein 232
decreases expression
EXP
methyleugenol results in decreased expression of TMEM232 mRNA
CTD
PMID:32234424
NCBI chr 5:110,387,431...110,738,954
Ensembl chr 5:110,289,233...110,738,956
G
TMEM254-AS1
TMEM254 antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of TMEM254-AS1 mRNA
CTD
PMID:32234424
NCBI chr10:80,046,233...80,079,193
Ensembl chr10:80,046,860...80,078,912
G
TMEM266
transmembrane protein 266
decreases expression
EXP
methyleugenol results in decreased expression of TMEM266 mRNA
CTD
PMID:32234424
NCBI chr15:76,059,985...76,204,963
Ensembl chr15:76,059,958...76,229,121
G
TMEM44
transmembrane protein 44
increases expression
EXP
methyleugenol results in increased expression of TMEM44 mRNA
CTD
PMID:32234424
NCBI chr 3:194,587,678...194,633,419
Ensembl chr 3:194,587,673...194,633,689
G
TMEM82
transmembrane protein 82
decreases expression
EXP
methyleugenol results in decreased expression of TMEM82 mRNA
CTD
PMID:32234424
NCBI chr 1:15,742,499...15,747,982
Ensembl chr 1:15,742,499...15,747,982
G
TMPRSS6
transmembrane serine protease 6
decreases expression
EXP
methyleugenol results in decreased expression of TMPRSS6 mRNA
CTD
PMID:32234424
NCBI chr22:37,065,436...37,110,536
Ensembl chr22:37,065,436...37,109,713
G
TMSB10
thymosin beta 10
increases expression
EXP
methyleugenol results in increased expression of TMSB10 mRNA
CTD
PMID:32234424
NCBI chr 2:84,905,656...84,906,671
Ensembl chr 2:84,905,656...84,906,671
G
TNFRSF10A
TNF receptor superfamily member 10a
increases expression
EXP
methyleugenol results in increased expression of TNFRSF10A mRNA
CTD
PMID:32234424
NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102
G
TNFRSF11A
TNF receptor superfamily member 11a
increases expression
EXP
methyleugenol results in increased expression of TNFRSF11A mRNA
CTD
PMID:32234424
NCBI chr18:62,325,310...62,391,288
Ensembl chr18:62,325,287...62,391,288
G
TNFRSF11B
TNF receptor superfamily member 11b
decreases expression
EXP
methyleugenol results in decreased expression of TNFRSF11B mRNA
CTD
PMID:32234424
NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885
G
TNFRSF9
TNF receptor superfamily member 9
increases expression
EXP
methyleugenol results in increased expression of TNFRSF9 mRNA
CTD
PMID:32234424
NCBI chr 1:7,915,871...7,940,839
Ensembl chr 1:7,915,871...7,943,165
G
TNFSF4
TNF superfamily member 4
decreases expression
EXP
methyleugenol results in decreased expression of TNFSF4 mRNA
CTD
PMID:32234424
NCBI chr 1:173,172,870...173,450,733
Ensembl chr 1:173,162,645...173,477,583
G
TNIP3
TNFAIP3 interacting protein 3
decreases expression
EXP
methyleugenol results in decreased expression of TNIP3 mRNA
CTD
PMID:32234424
NCBI chr 4:121,131,408...121,227,483
Ensembl chr 4:121,131,408...121,227,466
G
TNS1
tensin 1
decreases expression
EXP
methyleugenol results in decreased expression of TNS1 mRNA
CTD
PMID:32234424
NCBI chr 2:217,799,791...218,033,982
Ensembl chr 2:217,799,588...218,033,982
G
TOP2A
DNA topoisomerase II alpha
affects expression
ISO
methyleugenol affects the expression of TOP2A protein
CTD
PMID:26011634
NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896
G
TOX3
TOX high mobility group box family member 3
increases expression
EXP
methyleugenol results in increased expression of TOX3 mRNA
CTD
PMID:32234424
NCBI chr16:52,436,416...52,547,802
Ensembl chr16:52,436,417...52,547,802
G
TP53
tumor protein p53
increases expression decreases expression
ISO
methyleugenol results in increased expression of TP53 protein methyleugenol results in decreased expression of TP53 mRNA
CTD
PMID:23411599 PMID:26011634
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
TPH2
tryptophan hydroxylase 2
decreases expression
EXP
methyleugenol results in decreased expression of TPH2 mRNA
CTD
PMID:32234424
NCBI chr12:71,938,845...72,032,440
Ensembl chr12:71,938,845...72,186,618
G
TPK1
thiamin pyrophosphokinase 1
decreases expression
EXP
methyleugenol results in decreased expression of TPK1 mRNA
CTD
PMID:32234424
NCBI chr 7:144,451,941...144,836,437
Ensembl chr 7:144,451,941...144,836,395
G
TPRG1
tumor protein p63 regulated 1
decreases expression
EXP
methyleugenol results in decreased expression of TPRG1 mRNA
CTD
PMID:32234424
NCBI chr 3:188,997,227...189,325,304
Ensembl chr 3:188,947,214...189,325,304
G
TRAPPC9
trafficking protein particle complex subunit 9
decreases expression
EXP
methyleugenol results in decreased expression of TRAPPC9 mRNA
CTD
PMID:32234424
NCBI chr 8:139,727,725...140,458,579
Ensembl chr 8:139,727,725...140,458,579
G
TRAV8-5
T cell receptor alpha variable 8-5 (pseudogene)
increases expression
EXP
methyleugenol results in increased expression of TRAV8-5 mRNA
CTD
PMID:32234424
NCBI chr14:21,903,077...21,904,598
Ensembl chr14:21,903,077...21,904,598
G
TRHDE
thyrotropin releasing hormone degrading enzyme
decreases expression
EXP
methyleugenol results in decreased expression of TRHDE mRNA
CTD
PMID:32234424
NCBI chr12:72,087,266...72,670,758
Ensembl chr12:72,087,266...72,670,758
G
TRIM31
tripartite motif containing 31
increases expression
EXP
methyleugenol results in increased expression of TRIM31 mRNA
CTD
PMID:32234424
NCBI chr 6:30,102,897...30,113,090
Ensembl chr 6:30,102,897...30,113,090
G
TRIM63
tripartite motif containing 63
decreases expression
EXP
methyleugenol results in decreased expression of TRIM63 mRNA
CTD
PMID:32234424
NCBI chr 1:26,051,301...26,067,630
Ensembl chr 1:26,051,301...26,068,436
G
TSPAN15
tetraspanin 15
increases expression
EXP
methyleugenol results in increased expression of TSPAN15 mRNA
CTD
PMID:32234424
NCBI chr10:69,451,465...69,549,508
Ensembl chr10:69,451,465...69,507,666
G
TST
thiosulfate sulfurtransferase
decreases expression
EXP
methyleugenol results in decreased expression of TST mRNA
CTD
PMID:32234424
NCBI chr22:37,010,859...37,020,183
Ensembl chr22:37,010,859...37,020,183
G
TTC28
tetratricopeptide repeat domain 28
decreases expression
EXP
methyleugenol results in decreased expression of TTC28 mRNA
CTD
PMID:32234424
NCBI chr22:27,978,014...28,679,840
Ensembl chr22:27,978,014...28,679,840
G
TTC39A-AS1
TTC39A antisense RNA 1
increases expression
EXP
methyleugenol results in increased expression of TTC39A-AS1 mRNA
CTD
PMID:32234424
NCBI chr 1:51,329,654...51,331,281
Ensembl chr 1:51,329,654...51,335,324
G
TTC7B
tetratricopeptide repeat domain 7B
decreases expression
EXP
methyleugenol results in decreased expression of TTC7B mRNA
CTD
PMID:32234424
NCBI chr14:90,524,564...90,816,430
Ensembl chr14:90,524,564...90,816,479
G
TTN
titin
decreases expression
EXP
methyleugenol results in decreased expression of TTN mRNA
CTD
PMID:32234424
NCBI chr 2:178,525,989...178,807,423
Ensembl chr 2:178,525,989...178,830,802
G
TTPA
alpha tocopherol transfer protein
decreases expression
EXP
methyleugenol results in decreased expression of TTPA mRNA
CTD
PMID:32234424
NCBI chr 8:63,058,409...63,086,053
Ensembl chr 8:63,048,553...63,086,053
G
TUBA1A
tubulin alpha 1a
increases expression
EXP
methyleugenol results in increased expression of TUBA1A mRNA
CTD
PMID:32234424
NCBI chr12:49,184,795...49,189,080
Ensembl chr12:49,184,686...49,189,324
G
TUBA3D
tubulin alpha 3d
decreases expression
EXP
methyleugenol results in decreased expression of TUBA3D mRNA
CTD
PMID:32234424
NCBI chr 2:131,476,119...131,482,934
Ensembl chr 2:131,476,119...131,482,934
G
TUBA3E
tubulin alpha 3e
decreases expression
EXP
methyleugenol results in decreased expression of TUBA3E mRNA
CTD
PMID:32234424
NCBI chr 2:130,191,745...130,198,439
Ensembl chr 2:130,191,745...130,198,439
G
TYRO3
TYRO3 protein tyrosine kinase
increases expression
EXP
methyleugenol results in increased expression of TYRO3 mRNA
CTD
PMID:32234424
NCBI chr15:41,559,212...41,583,589
Ensembl chr15:41,557,675...41,583,589
G
TYRP1
tyrosinase related protein 1
decreases expression
EXP
methyleugenol results in decreased expression of TYRP1 mRNA
CTD
PMID:32234424
NCBI chr 9:12,693,385...12,710,285
Ensembl chr 9:12,685,439...12,710,285
G
UBD
ubiquitin D
affects expression
ISO
methyleugenol affects the expression of UBD protein
CTD
PMID:26011634
NCBI chr 6:29,555,515...29,559,732
Ensembl chr 6:29,555,515...29,559,732
G
UGT2B11
UDP glucuronosyltransferase family 2 member B11
increases expression
EXP
methyleugenol results in increased expression of UGT2B11 mRNA
CTD
PMID:32234424
NCBI chr 4:69,199,951...69,224,984
Ensembl chr 4:69,199,951...69,214,748
G
UGT2B15
UDP glucuronosyltransferase family 2 member B15
increases expression
EXP
methyleugenol results in increased expression of UGT2B15 mRNA
CTD
PMID:32234424
NCBI chr 4:68,646,597...68,670,652
Ensembl chr 4:68,646,597...68,670,652
G
UGT2B17
UDP glucuronosyltransferase family 2 member B17
decreases expression
EXP
methyleugenol results in decreased expression of UGT2B17 mRNA
CTD
PMID:32234424
NCBI chr 4:68,537,173...68,576,322
Ensembl chr 4:68,537,173...68,576,413
G
ULK4
unc-51 like kinase 4
decreases expression
EXP
methyleugenol results in decreased expression of ULK4 mRNA
CTD
PMID:32234424
NCBI chr 3:41,246,599...41,962,103
Ensembl chr 3:41,246,599...41,962,130
G
UPB1
beta-ureidopropionase 1
decreases expression
EXP
methyleugenol results in decreased expression of UPB1 mRNA
CTD
PMID:32234424
NCBI chr22:24,495,332...24,528,390
Ensembl chr22:24,494,107...24,528,390
G
UPP2
uridine phosphorylase 2
decreases expression
EXP
methyleugenol results in decreased expression of UPP2 mRNA
CTD
PMID:32234424
NCBI chr 2:157,995,179...158,136,154
Ensembl chr 2:157,876,679...158,136,154
G
UROC1
urocanate hydratase 1
decreases expression
EXP
methyleugenol results in decreased expression of UROC1 mRNA
CTD
PMID:32234424
NCBI chr 3:126,481,166...126,517,773
Ensembl chr 3:126,481,166...126,517,773
G
USH2A
usherin
decreases expression
EXP
methyleugenol results in decreased expression of USH2A mRNA
CTD
PMID:32234424
NCBI chr 1:215,622,891...216,423,448
Ensembl chr 1:215,622,891...216,423,448
G
USP30-AS1
USP30 antisense RNA 1
decreases expression
EXP
methyleugenol results in decreased expression of USP30-AS1 mRNA
CTD
PMID:32234424
NCBI chr12:109,052,041...109,053,965
Ensembl chr12:109,052,344...109,053,986
G
VDR
vitamin D receptor
increases expression
EXP
methyleugenol results in increased expression of VDR mRNA
CTD
PMID:32234424
NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
G
VEPH1
ventricular zone expressed PH domain containing 1
decreases expression
EXP
methyleugenol results in decreased expression of VEPH1 mRNA
CTD
PMID:32234424
NCBI chr 3:157,259,742...157,503,605
Ensembl chr 3:157,259,742...157,533,619
G
VPS13B
vacuolar protein sorting 13 homolog B
decreases expression
EXP
methyleugenol results in decreased expression of VPS13B mRNA
CTD
PMID:32234424
NCBI chr 8:99,013,274...99,877,580
Ensembl chr 8:99,013,266...99,877,580
G
VSIG1
V-set and immunoglobulin domain containing 1
increases expression
EXP
methyleugenol results in increased expression of VSIG1 mRNA
CTD
PMID:32234424
NCBI chr X:108,018,879...108,079,184
Ensembl chr X:108,044,970...108,079,184
G
VSNL1
visinin like 1
decreases expression
EXP
methyleugenol results in decreased expression of VSNL1 mRNA
CTD
PMID:32234424
NCBI chr 2:17,539,972...17,657,018
Ensembl chr 2:17,539,126...17,657,018
G
VTN
vitronectin
decreases expression
EXP
methyleugenol results in decreased expression of VTN mRNA
CTD
PMID:32234424
NCBI chr17:28,367,284...28,370,307
Ensembl chr17:28,367,284...28,373,091
G
VWA5B2
von Willebrand factor A domain containing 5B2
increases expression
EXP
methyleugenol results in increased expression of VWA5B2 mRNA
CTD
PMID:32234424
NCBI chr 3:184,229,585...184,242,329
Ensembl chr 3:184,229,585...184,242,329
G
WDPCP
WD repeat containing planar cell polarity effector
decreases expression
EXP
methyleugenol results in decreased expression of WDPCP mRNA
CTD
PMID:32234424
NCBI chr 2:63,119,559...63,840,826
Ensembl chr 2:63,119,559...63,827,843
G
WDR72
WD repeat domain 72
decreases expression
EXP
methyleugenol results in decreased expression of WDR72 mRNA
CTD
PMID:32234424
NCBI chr15:53,513,741...53,762,878
Ensembl chr15:53,513,741...53,762,878
G
WNK3
WNK lysine deficient protein kinase 3
decreases expression
EXP
methyleugenol results in decreased expression of WNK3 mRNA
CTD
PMID:32234424
NCBI chr X:54,192,823...54,358,900
Ensembl chr X:54,192,823...54,358,642
G
WNT10B
Wnt family member 10B
increases expression
EXP
methyleugenol results in increased expression of WNT10B mRNA
CTD
PMID:32234424
NCBI chr12:48,965,340...48,971,735
Ensembl chr12:48,965,340...48,971,735
G
WNT4
Wnt family member 4
increases expression
EXP
methyleugenol results in increased expression of WNT4 mRNA
CTD
PMID:32234424
NCBI chr 1:22,117,313...22,143,097
Ensembl chr 1:22,117,313...22,143,969
G
WNT5B
Wnt family member 5B
decreases expression
EXP
methyleugenol results in decreased expression of WNT5B mRNA
CTD
PMID:32234424
NCBI chr12:1,617,056...1,647,212
Ensembl chr12:1,529,891...1,647,212
G
WNT6
Wnt family member 6
decreases expression
EXP
methyleugenol results in decreased expression of WNT6 mRNA
CTD
PMID:32234424
NCBI chr 2:218,859,805...218,874,233
Ensembl chr 2:218,859,805...218,874,233
G
WNT7B
Wnt family member 7B
increases expression
EXP
methyleugenol results in increased expression of WNT7B mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr22:45,920,366...45,977,162
Ensembl chr22:45,920,366...45,977,162
G
WWOX
WW domain containing oxidoreductase
decreases expression
ISO EXP
methyleugenol results in decreased expression of WWOX protein methyleugenol results in decreased expression of WWOX mRNA
CTD
PMID:15618236 PMID:32234424 PMID:35690182
NCBI chr16:78,099,654...79,212,667
Ensembl chr16:78,099,400...79,212,667
G
XDH
xanthine dehydrogenase
decreases expression
EXP
methyleugenol results in decreased expression of XDH mRNA
CTD
PMID:32234424
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
G
XRCC4
X-ray repair cross complementing 4
decreases expression
EXP
methyleugenol results in decreased expression of XRCC4 mRNA
CTD
PMID:32234424
NCBI chr 5:83,077,547...83,374,473
Ensembl chr 5:83,077,498...83,353,787
G
ZBTB7C
zinc finger and BTB domain containing 7C
decreases expression
EXP
methyleugenol results in decreased expression of ZBTB7C mRNA
CTD
PMID:32234424
NCBI chr18:48,026,672...48,412,585
Ensembl chr18:48,026,672...48,410,752
G
ZG16
zymogen granule protein 16
decreases expression
EXP
methyleugenol results in decreased expression of ZG16 mRNA
CTD
PMID:32234424
NCBI chr16:29,778,256...29,782,973
Ensembl chr16:29,778,256...29,782,973
G
ZG16B
zymogen granule protein 16B
increases expression
EXP
methyleugenol results in increased expression of ZG16B mRNA
CTD
PMID:32234424
NCBI chr16:2,830,303...2,832,276
Ensembl chr16:2,830,253...2,839,585
G
ZMYND12
zinc finger MYND-type containing 12
decreases expression
EXP
methyleugenol results in decreased expression of ZMYND12 mRNA
CTD
PMID:32234424
NCBI chr 1:42,430,329...42,456,022
Ensembl chr 1:42,430,329...42,456,253
G
ZNF423
zinc finger protein 423
decreases expression
EXP
methyleugenol results in decreased expression of ZNF423 mRNA
CTD
PMID:32234424
NCBI chr16:49,487,524...49,859,279
Ensembl chr16:49,487,524...49,857,919
G
ZNF470
zinc finger protein 470
decreases expression
EXP
methyleugenol results in decreased expression of ZNF470 mRNA
CTD
PMID:32234424
NCBI chr19:56,567,468...56,582,894
Ensembl chr19:56,567,468...56,588,911
G
ZNF521
zinc finger protein 521
decreases expression
EXP
methyleugenol results in decreased expression of ZNF521 mRNA
CTD
PMID:32234424
NCBI chr18:25,061,924...25,352,166
Ensembl chr18:25,061,924...25,352,190
G
ZNF648
zinc finger protein 648
decreases expression
EXP
methyleugenol results in decreased expression of ZNF648 mRNA
CTD
PMID:32234424
NCBI chr 1:182,054,570...182,069,646
Ensembl chr 1:182,054,570...182,061,712
G
ZNF662
zinc finger protein 662
decreases expression
EXP
methyleugenol results in decreased expression of ZNF662 mRNA
CTD
PMID:32234424
NCBI chr 3:42,906,142...42,919,334
Ensembl chr 3:42,906,142...42,919,334
G
ZNF709
zinc finger protein 709
increases expression
EXP
methyleugenol results in increased expression of ZNF709 mRNA
CTD
PMID:32234424
NCBI chr19:12,461,184...12,484,816
Ensembl chr19:12,461,184...12,513,854
G
ZNF726
zinc finger protein 726
increases expression
EXP
methyleugenol results in increased expression of ZNF726 mRNA
CTD
PMID:32234424
NCBI chr19:23,914,886...23,944,714
Ensembl chr19:23,914,876...23,945,159
G
ZNF878
zinc finger protein 878
increases expression
EXP
methyleugenol results in increased expression of ZNF878 mRNA
CTD
PMID:32234424
NCBI chr19:12,043,602...12,052,961
Ensembl chr19:12,043,805...12,052,961
G
ZP1
zona pellucida glycoprotein 1
increases expression
EXP
methyleugenol results in increased expression of ZP1 mRNA
CTD
PMID:32234424
NCBI chr11:60,867,542...60,875,687
Ensembl chr11:60,867,542...60,875,693
G
ZRANB2-DT
ZRANB2 divergent transcript
decreases expression
EXP
methyleugenol results in decreased expression of ZRANB2-DT mRNA
CTD
PMID:32234424
NCBI chr 1:71,081,324...71,237,723
Ensembl chr 1:71,081,324...71,489,976
G
ZRANB3
zinc finger RANBP2-type containing 3
decreases expression
EXP
methyleugenol results in decreased expression of ZRANB3 mRNA
CTD
PMID:32234424
NCBI chr 2:135,196,969...135,531,218
Ensembl chr 2:135,136,916...135,531,218
G
ZSCAN12P1
zinc finger and SCAN domain containing 12 pseudogene 1
decreases expression
EXP
methyleugenol results in decreased expression of ZSCAN12P1 mRNA
CTD
PMID:32234424
NCBI chr 6:28,090,807...28,095,715
Ensembl chr 6:28,092,427...28,092,845
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all